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Abstract 
The hair follicle (HF) is a cyclic biological system that progresses through 
stages of growth, regression and quiescence, each being characterized by 
unique patterns of gene activation and silencing. MicroRNAs (miRNAs) are 
critically important for gene silencing and delineating their role in hair cycle may 
provide new insights into mechanisms of hair growth control and epithelial tissue 
remodelling.   
The aims of this study were: 1) To define changes in the miRNA profiles 
in skin during hair cycle-associated tissue remodelling; 2) To determine the role 
of individual miRNAs in regulating gene expression programs that drive HF 
growth, involution and quiescence; 3) and to explore the role of miRNAs in 
mediating the effects of BMP signalling in the skin. 
To address Aims 1 & 2, global miRNA expression profiling in the skin was 
performed and revealed marked changes in miRNAs expression during distinct 
stages of the murine hair cycle. Specifically, miR-31 markedly increased during 
anagen and decreased during catagen and telogen. Administration of antisense 
miR-31 inhibitor into mouse skin during the early- and mid-anagen phases of the 
hair cycle resulted in accelerated anagen development, and altered 
differentiation of hair matrix keratinocytes and hair shaft formation. Microarray, 
qRT-PCR and Western blot analyses revealed that miR-31 negatively regulates 
expression of Fgf10, the components of Wnt and BMP signalling pathways 
Sclerostin and BAMBI, and Dlx3 transcription factor, as well as selected keratin 
genes. Luciferase reporter assay revealed that Krt16, Krt17, Dlx3, and Fgf10 
serve as direct miR-31 targets. 
In addition, miR-214 was identified as a potent inhibitor of the Wnt 
signalling pathway in the keratinocytes. Mutually exclusive expression patterns 
of miR-214 and β-catenin was observed during HF morphogenesis. MiR-214 
decreases the expression of β-catenin and other components of Wnt signalling 
pathways c-myc, cyclin D1, and Pten in the keratinocytes. Luciferase reporter 
assay proved that β-catenin serves as a direct target of miR-214. In addition, 
miR-214 prevented translocation of β-catenin into the nucleus in response to the 
treatment with an activator of the Wnt signalling pathway lithium chloride, and 
abrogated the lithium-induced increase of the expression of the Wnt target gene 
 VI 
Axin2. This suggests that miR-214 may indeed be involved in regulation of skin 
development and regeneration at least in part, by controlling the expression of 
β-catenin and the activity of the Wnt signalling pathway. 
To address Aim 3, the role of miRNAs in mediating the effects of the 
bone morphogenetic protein (BMP) signalling in the skin was explored. MiRNAs 
were isolated from the primary mouse keratinocytes treated with BMP4 and 
processed for analysis of global miRNA expression using the microarray 
approach. Microarray and real-time PCR analysis revealed BMP4-dependent 
changes in the expression of distinct miRNAs, including miR-21, which 
expression was strongly decreased in the keratinocytes after BMP4 treatment. 
In contrast, miR-21 expression was substantially higher in the skin of transgenic 
mice over-expressing BMP antagonist Noggin. Transfection of the keratinocytes 
with miR-21 mimic revealed existence of two groups of the BMP target genes, 
which are differentially regulated by miR-21. Thus, this suggests a novel 
mechanism controlling the effects of BMP signalling in the keratinocytes.  
Thus, miRNAs play important roles in regulating gene expression 
programs in the skin during hair cycle. By targeting a number of growth 
regulatory molecules, transcription factors and cytoskeletal proteins, miRNAs 
are involved in establishing an optimal balance of gene expression in the 
keratinocytes required for the HF and skin homeostasis. 
 
Key words: MicroRNAs, Hair follicle, Growth control, Global miRNA 
expression, Keratin 16, Keratin 17, Dlx3, and Fgf10 
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1.0 Introduction 
1.1Structure and Functions of the skin 
The skin is the largest organ of the human body and it’s most important function 
is to form a physical barrier against external environmental insults including, 
mechanical, chemical, and microbial (Proksch et al., 2009; Jensen and Proksch, 
2009).  The skin further provides protection by regulating the loss of internal 
bodily fluids by controlling changes in body temperature.  In addition, the skin is 
water resistant, and contains a advanced sensory network for pressure 
sensations and quick responses to hot and cold environments (Tobin and 
Kauser, 2005; Tobin, 2006; Fuchs 2007; Koster and Roop 2007; Brenner and 
Hearing, 2008; Fuchs and Horsely, 2008; Blanpain, 2010).   
 
The skin can be divided into two major parts, the epidermis, and dermis.  The 
epidermis and several appendages of the skin, represent the ectodermal 
compartment of the skin, while the dermis and hypodermis are of mesodermal 
origin (Holbrook and Wolff, 1993). Keratinocytes are the largest cell population in 
the skin and are responsible for the formation of terminally differentiated layers 
found within the epidermis.  Keratinocytes produce keratins, which are the 
structural proteins that create the intermediate filament in epithelial cells (Moll et 
al., 1982; Tobin, 2006).  
 
 
 
 
1.0 Introduction 
 
Exploring molecular mechanism controlling skin homeostasis and hair growth: MicroRNAs in 
Hair-cycle-Dependent Gene Regulation, Hair Growth and Associated Tissue Remodelling   
 
         P a g e  | 2 
 
 
1.1.1 Epidermis 
The epidermis is divided into the following 5 sublayers or strata: basal, spinosum, 
granulosum, lucidum, and corneum. The basal layer is attached to the basement 
membrane, which separates the epidermis from the dermis. These basal 
keratinocytes are rapidly proliferating cells and represent the unique cell 
population of epidermal stem cells and transiently amplifying progenitors cells, 
which can give rise to terminally differentiated layers of the stratum spinosum 
(spinous layer), granular layer (stratum granulosum), and stratum corneum 
(horny layer) (Alonso and Fuchs, 2003). This differentiation program of basal 
keratinocytes constantly occurs throughout the life of humans and mammals and 
allows the replenishment of terminally differentiated cells, which have been 
sloughed off (Tobin, 2006; Alonso and Fuchs, 2003). It has been shown that the 
keratinocytes of the basal layer express specific keratins including; keratin 5 and 
keratin 14, respectively (Bowden et al., 1987; Rao et al., 1996). As basal cells 
begin to differentiate and enter the first suprabasal layer, a decrease in 
expression of keratin 5 and keratin 14 is observed (Rao et al., 1996). In addition 
to the keratinocytes, the basal layer also contains other cell populations including 
Merkell, Langerhans cells, and melanocytes. Merkel cells are responsible for the 
transmission of tactile sensation through the skin’s nerve (Moll et al., 2005; 
Tobin, 2006). Langerhans cells are antigen presenting bone marrow-derived 
dentritic cells, which have a crucial role in immunological reactions. Melanocytes 
are specialized neural-crest-derived cells producing pigment (melanin), which 
provides coloration and protects humans against the damaging effects of UVR 
radiation (Tobin and Kauser, 2005; Koch et al., 2006; Costin and Hearing, 2007). 
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The next level above the basal layer is the stratum spinosum (spinous layer), 
containing 8-10 sheets of keratinocytes. The spinous layer contains a web-like 
system of interfillaments attached to a specialized cell junction known as corneo-
desmosomes, which help to resist physical trauma. The keratinocytes of spinous 
layer express keratin 1 and keratin 10 and these keratins are only expressed in 
differentiating epidermal keratinocyte cells (Bowden et al., 1987; Rao et al., 1996; 
Zhu et al., 1999; Tobin, 2006). Keratinocyte differentiation in the epidermis also 
involves induction of proteins such as: involucrin, transglutaminase, fillagrin and 
loricrin, which forms the highly cross-linked layer- the cornified cell envelope. 
This process represents the final stage of epidermal keratinocyte differentiation 
(Fuchs and Green, 1980; Eckert and Rorke, 1989; Rao et al., 1996).  
 
The next, upper layer is the granular layer of the epidermis, a 3-5 sheets of non-
proliferating keratinocytes producing two types of granules.   The keratohyaline 
granules represent a mixture of smaller proteins containing keratohyaline and 
filaggrin (Matoltsy and Matoltsy, 1970). The lamellated granules are specialized 
secretory granules, which contain lipids and their extracellular processing 
enzymes.The granules increase in number and size and as the cell nuclei 
breakdown, their cell membrane increasingly becomes impermeable. These cells 
are then flattened as proliferating cells underneath them gradually push them 
toward the skin surface (Tobin, 2006; Costin and Hearing, 2007).  
 
The stratum corneum is the outermost layer of the epidermis consisting of 15-30 
sheets of keratinocytes, which are terminally differentiated (non-viable) but 
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biochemically-active cells called corneocytes. The corneocytes are connected by 
corneo-desmosomes and embedded in a lipid-rich matrix containing specialized 
proteins and lipids (Elias, 1983; Madison, 2003; Elias, 2005; Tobin, 2006). The 
final stages of keratinocyte differentiation are linked to dramatic changes in the 
structure of keratins, leading to the transformation of these cells into flat and 
anucleated corneocytes, surrounded by a cell envelope. Overtime, these cells 
slough off and are replaced by underlying differentiating keratinocytes (Madison, 
2003; Proksch et al., 2008).  
 
1.1.2 Dermis 
Immediately below the epidermis, is the dermis. The dermis can be divided into 
two distinct layers, the upper papillary and lower reticular regions. These layers 
are different in the arrangement of collagen fibrils, connective tissue components, 
cell number, and supply of blood vessels and nerves in the dermis (Cormack, 
1987; Sorrell and Caplan, 2004; Tobin, 2006). The main cell type of the dermis is 
the fibroblast, a migratory cell that makes and degrades extracellular matrix 
components (Chang et al., 2002). The superficial papillary layer of the dermis is 
arranged into ridge-like structures, containing micro-vascular and neural 
components that maintain the epidermis (Cormack, 1987; Sorrell and Caplan, 
2004). The reticular layer of the dermis extends from the papillary layer to the 
deeper vascular plexus (Cormack, 1987; Sorrell and Caplan, 2004). The reticular 
layer makes up approximately 80% of the thickness of the dermis. The reticular 
layer ECM contains collagen and elastin fibers (Kurt, 1991). The collagen 
provides the skin with strength and tissue integrity whereas elastin provides 
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elasticity and resiliency (Kurt, 1991; Haake and Holbrook, 1999; Brucker-
Tuderman, 2003; Costin and Hearing, 2007).  
 
1.1.3 Skin appendages 
Skin appendages such as nails, hair follicles, feathers, teeth and a number of 
glands including mammary glands are all derivatives of the embryonic ectoderm. 
Even though fully formed skin appendages diverge greatly in number, shape, 
function, and regenerative capacity, the early stages in their development are 
remarkably similar both at the morphogenetic and molecular levels (Mikkola and 
Millar, 2006; Mikkola, 2007). The development of skin appendages are regulated 
by reciprocal and sequential interactions between the ectodermal epithelium and 
the mesenchyme that can originate either from the mesoderm (hair and 
mammary gland) or the neural crest (tooth, vibrissae, and cranial hair). The 
epithelial–mesenchymal interactions are mediated by a small number of 
signalling pathways including:  fibroblast growth factors, sonic hedgehog, tumour 
necrosis factor and transforming growth factor-β families and Wnt signalling, and 
their downstream transcription factors that are required for the development of 
these skin appendages (Mikkola, 2007). The molecular signals of growth and 
transcription factors are widely conserved across many species as well as across 
distinct appendages (Chuong, 1998; Mikkola and Millar, 2006; Mikkola, 2007).  
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1.2 The Hair Follicle – Epidermal Derivative of the Skin 
1.2.1 Importance and Functions  
The hair follicle (HF) is very complex but extremely organised structure. The HF 
is an attractive investigative model for studying major biological phenomena, in 
part due to the HF representing many human physiological attributes (Schlake, 
2007; Stenn and Paus, 2001; Tobin, 2005) and has the exceptional ability to 
undergo growth, involution and quiescence, through an entire life time. The HF 
has many important aspects of mammalian biology including organogenesis, 
cell-cell interactions, tissue growth, regeneration and aging (Kaufman, 1996; 
Stenn and Paus, 2001, Botchkarev and Paus, 2003). 
The HF is one of the defining features of mammalian species. Even though, hair 
is commonly dismissed as being of superficial importance. The HF is in fact one 
of human biology’s most fascinating structures (Philpott and Paus, 1998; Paus 
and Cotsarelis, 1999; Tobin, 2005). The human hair plays an essential role in 
life, where the psychological importance of the hair in humans is in inverse ratio 
to its physical function (Ebling, 1976). The principle function of the HF is to 
produce a hair shaft or a hair fiber. Even though, this is also true for other 
mammals, in the case of humans, the hair shaft acts as a physical medium of 
social communications. Indeed, scalp, facial and body hairs are the only body 
parts an individual can shape for a person's appearance and self-image, in a 
social and sexual contexts. In most societies hair is seen as a sign of 
youthfulness (Forsland, 2000; Stenn and Paus, 2001).   
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The human species is frequently considered as the 'naked ape', and this 
‘nakedness’ has interested researchers for many years as to why this was the 
case. In February’s Edition (2010) of the Scientific American magazine, an 
interesting article was written on why humans had evolutionary favoured to loss 
their hair compared to our closely living relatives, the chimpanzee. It was 
suggested that initial loss of hair was favoured when ‘global cooling’ in central 
and eastern Africa starting occurring, where ancestral humans lived (Rogers et 
al., 2004). Human ‘nakedness’ may have lead to evolutionary acquisition of 
pigmentation. The identification of human melanocortin 1 receptor (MC1R) gene 
was shown to be crucial for melanocyte stimulating hormone (MSH) to produce 
skin pigmentation (Suzuki et al., 1996). MC1R is believed to have originated 
around 1.2 million years ago in Africans, around the time where humans starting 
losing their hair around their body and acquiring ‘modern body proportions’ for 
walking, running and hunting (Rogers et al., 2004). 
 
The functions and types of the HF differ from site to site on the body. They 
produce hair shafts differing in size, shape, and colour. Coarse body hair are 
referred to as terminal hair and are found in 'hairy' areas such as the scalp, 
eyebrows, legs, arms, body and eyelashes in both sexes of adults. Fine and 
short, non-pigmented hair are refered as vellus hair, and are found on parts of 
the body, which are generally considered 'hairless', such as a child's cheek. 
These types of hair are also found in male pattern baldness (androgenic 
alopecia) (Randall, 1994; Stenn and Paus, 2001; Tobin et al., 2003). 
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These variations in hair types and the distribution of these hairs on mammals 
have many important functions. These functions include: camouflage, 
thermoregulation, sensory receptors and protection from the elements and 
dispersion of sweat gland products (pheromones) (Oro and Scott, 1998; Paus 
and Cotsarelis, 1999). Thermoregulation is one of the important features of hair 
(heat retention) for animals, and in humans the scalp hair represents this 
attribute. Hair provides camouflage for hunting animals, and provides protection 
from abrasions, trauma, UV and acts as an insulator against cold and heat. Loss 
of or abnormal hair growth would be disastrous for animals, as these 
thermoregulatory/protective attributes of hair would be lost and survival chances 
would be dramatically reduced (Johnson, 1972; Abell, 1994; Stenn and Paus, 
2001; Higgins et al., 2009; Vogt et al., 2009). 
 
In humans, the hair is seen as of less biological importance, as loss of hair by 
biological or congenital abnormalities does not lead to any reduction in health of 
the individual or reduction in life expectancy. Even though, hair is not essential 
for the survival of humans, hair loss and/or excessive hair growth in men and 
women has been identified to be at the root of some serious psychological 
distress and can affect quality of life (Abell, 1994). Therefore, not surprisingly, 
the demand for drugs that alter hair growth has led to a multi-billion pound 
industry. However, relatively few drugs have been able to effectively treat HF 
disorders (Paus and Cotsarelis, 1999).  
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1.3 Hair Follicle Anatomy 
The HF is a unique and is one of most complex mini-organs in mammal (Fig. 1). 
The mature HF is multi-layered structures, which consists of mesenchymal and 
epithelial compartments (Whiting, 2004). The hair bulb consists of the hair matrix 
keratinocytes, which are rapidly proliferating cells, surrounding the dermal papilla 
(DP), the “command centre” of the HF. The DPs communicate directly with 
dermal sheath cells, also referred to as connective tissue sheath, which are 
another type of follicular fibroblast cell populations found in the HF (Alonso and 
Fuchs, 2006).  
 
The fully developed HF can be divided into three regions including the 
infundibulum, isthmus and the inferior segment. The infundibulum and isthmus 
regions of the HF are known as ‘permanent’ portion, while the inferior segment is 
a ‘cycling’ portion, which is continuously remodelling in each hair cycle. The 
infundibulum region of the HF is a continuation of the epidermis, extending from 
the surface of the skin to the point of the sebaceous gland duct opening to the 
hair canal. The isthmus portion extends from the duct of the sebaceous gland to 
the exertion of the arrector pili muscle (APM). The inferior segment contains the 
suprabulbar area and the bulb (Randall and Botchkareva, 2009; Vogt et al., 
2009).  
 
The suprabulbar area of the follicle is located below the isthmus and above the 
bulb, and comprised of three layers from outermost to innermost: outer root 
sheath, inner root sheath, and hair shaft. The hair bulb contains highly 
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proliferative keratinocytes, and pigment-producing melanocytes (Slominski and 
Paus, 1993; Dawber and Messenger, 1994). These keratinocytes move up and 
differentiate into the hair shaft and inner root sheath (IRS). The DP contains 
specialised fibroblast-type cells embedded in an extracellular matrix and are 
separated from the hair matrix by a basement membrane (Jahoda and Oliver, 
1990). The HF is separated from the dermis by the dermal sheath, which is made 
up of a fibroblast and a basement membrane (Nutbrown and Randall, 1995; 
Schneider et al., 2009). 
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Figure 1: Hair Follicle Structure. A) Illustrative representation of a HF at anagen VI showing the different 
compartments. B) Illustrative representation of a hair bulb region. The hair follicle, sebaceous gland and arrector pili 
muscle, form the so-called pilosebaceous unit. The fibrous sheath and the epithelial compartments of the outer and inner root 
sheaths form concentric layers, which surrounds the hair shaft. Hair growth results from the proliferative activity of matrix 
keratinocytes in the bulb, which is in close proximity to the dermal papilla. The dermal papilla is a condensed “ball” of 
specialized mesenchymal cells with important inductive properties. (Figure 1A adapted from Margel et al., 2001, Figure 1B 
reproduced from Randall, 1994). 
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1.4 Hair Shaft 
The hair shaft consists of three layers: an outer cuticle, central cortex and a 
medulla (only in terminal hairs) (Harkey, 1993). The medulla expresses a specific 
hair keratin, hHa7, which has been shown to be regulated by androgen levels 
(Jave-Suarez et al., 2004). 
The main structure, forming the bulk and strength of the hair shaft, is called the 
cortex, which is made up of long keratinized cells, which are formed into long 
fibers (Harkey, 1993). The progenitor cells of the hair cortex are a group of highly 
mitotically-active matrix keratinocytes cells found adjacent to the distal portion of 
the follicular papilla (Dawber and Messenger, 1994). The hair shaft cuticle is 
formed by layers, which interlock with opposing layers of the IRS, which allows 
the hair shaft and the IRS to move upwards together (Rogers, 2004). During hair 
shaft growth, cortical cells emerging from the proliferative keratinocytes rapidly 
undergo a differentiation program and begin to synthesise large amounts of hair-
specific keratin proteins (Langbein et al., 2005). Differentiation of keratinocytes 
leads to the formation of the hair, which involves the co-ordinated activation of 
many hair specific structural genes (Powell and Rogers, 1997). The major 
proteins synthesised in the hair shaft are the keratin intermediate filament (IF) 
and keratin-associated proteins (KAP). Keratin IF (KIFs) are composed of type I 
and type II proteins, which are co-expressed in specific pairs (Steinert and Roop, 
1988). The hair shaft expresses an array of hair specific keratins and their genes 
are activated early in hair shaft formation (Kaytes et al., 1991; Powell et al., 
1992; Tobiasch et al., 1992; Winter et al., 1994; Rogers et al., 1997; Langbein et 
al., 2002). The hair shaft lineages have been shown to be extremely sensitive to 
Wnt signalling, as mature HFs express high levels of Lef-1 in the precursor hair 
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matrix cells (DasGupta and Fuchs 1999). Excessive expression of stabilized β-
catenin has shown to lead to uncontrolled cell proliferation of hair matrix cells, 
which results in hair matrix derived tumour formation (pilomatricomas) in mice 
and human skin (Gat et al., 1998; Chan et al., 1999; Millar 2002).  
 
1.5 The Inner Root Sheath 
IRS is made of three layers: the cuticle, Huxley's and Henle's layers. The IRS is 
adjacent and bound to the growing hair shaft and is responsible for the surface 
topography of the hair fibre (Montagna and Parakkal, 1974; Swift, 1977; Ito, 
1990; Rogers, 2004).  These cells originate from hair matrix keratinocytes in the 
hair bulb and move upward parallel to the hair axis (Ito, 1986). All layers of the 
IRS undergo differentiation (keratinisation) but at different rates: firstly, the Henle 
layer, then the Huxley layer and finally, the cuticle (until half way up the follicle) 
(Montagna and Van Scott, 1958).  
 
Complete keratinisation and differentiation of the IRS happens above and before 
the layers of the growing hair within it, therefore controlling the direction of hair 
growth. Keratinisation of IRS continues by increasing the production of 
trichohyalin (Dawber and Messenger, 1994). Trichohyalin is a structural protein 
that is produced and retained in the cells of the IRS (approximately one third of 
all protein in the IRS).  Trichohyalin can be used to determine the 
presence/absence of IRS during HF development (Fietz et al., 1993; Steinert et 
al., 2003). 
As the cells of the IRS cuticle keratinise, the cells become thinner and overlap in 
a manner opposite to the direction of follicle growth. This overlapping permits the 
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IRS cuticle to form a template for the opposing cuticle of the hair cortex and 
serve to anchor and direct the growth of the hair. At the level of the HF 
corresponding to the sebaceous gland duct, the IRS cells degenerate, via 
process of tricilemmal keratinisation, which involves the lysosomal cysteine 
protease, catepsin-L (Tobin et al., 2002), thereby releasing the hair shaft, which 
continues to move up and eventually protrude through the epidermis (Bertolino 
and O’Guin, 1994; Alonso and Fuchs, 2006). The IRS also functions as a 
physical barrier, which separates the hair shaft from the outer root sheath (ORS), 
which creates the external concentric layer of epithelial cells in the HF (Schlake, 
2007). Research studies have shown that together with Henle cells and Huxley 
cells, the IRS ensures the maintenance of a constant desmosomal anchorage of 
the companion layer required for an optimal moulding and guidance of the 
growing hair (Rogers, 2004). 
 
The IRS lineages have been shown to express a variety of structural keratins, 
which are required for its mechanical strength. However, little was known about 
the regulation and function of the IRS and its importance in HF development, 
until recently. Among the large number of transcription and growth factors known 
to be expressed in the skin, only a few have been functionally linked to the IRS 
and HF dsevelopment. These include the CCAAT displacement protein (CDP), 
GATA-3 transcription factor (Ellis et al., 2001; Kaufman et al., 2003) and BMPs 
(Kulessa et al., 2000). 
The Cutl1 gene encoding CDP is a transcription repressor in diverse processes. 
CDP is expressed in the progenitors and cell lineages of the IRS. Cutl1 
deficiency leads to the reduction in size of the growing IRS, accompanied by 
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deregulated transcription of Sonic hedgehog (Shh), followed by the cyst 
formation (Ellis et al., 2001). 
GATA-3 is a transcription factor, which has a crucial regulatory role in IRS 
differentiation and is expressed in the Huxley’s and cuticle layers of the IRS.  
Ablation of GATA-3 expression has been shown to lead to the structural changes 
in the IRS. In addition, GATA-3 deficient follicles are no longer spatially aligned 
and the hair shaft develops as an overdeveloped mass of irregular medulla, 
cortical, and cuticle cells. This demonstrates the importance of GATA-3 in these 
two layers of IRS, which are critical for the proper differentiation and/or 
organization of the hair shaft (Kaufman et al., 2003). 
  
BMP signalling has also been shown to be important for proper IRS 
differentiation. By overexpressing BMP antagonist noggin (under msx-2 
promoter) in the HF, it was shown that differentiation of the IRS was severely 
impaired (Kulessa et al., 2000). 
 
Specialized Huxley cells of the IRS have previously been termed “Flügelzellen”, 
in translation meaning “winged cells”, due to their characteristic foot processes. It 
has been suggested that together with the fully differentiated Henle cells, 
Flügelzellen cells ensures the maintenance of a constant desmosomal 
anchorage of the companion layer along the whole IRS and allows the diffusion 
of nutrients between cells (outer to inner cells) (Clemmensen et al., 1991; 
Langbein et al., 2002). 
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The companion layer has close association with the Henle layer rather than ORS 
and therefore was termed as “companion cell layer” (Pinkus, 1958; Langbein et 
al., 2002). It was been shown that the cells of the adjacent companion layer, 
which forms a functional unit with the IRS expresses at least four different 
keratins (Krt) including Krt6, Krt75 (Krt6hf), Krt16 and Krt17 (Winter et al., 1998; 
Langbein et al., 2002; Langbein et al., 2004). The high number of expressed 
keratins in the companion-IRS unit could be due to keratins providing a dense 
and stabilizing structure. This is required for the function of the IRS-companion 
unit in the moulding and guidance of the growing hair (Langbein et al., 2004). 
 
1.6 The Outer Root Sheath 
The ORS is a non-keratinising proliferative cellular layer of the HF, which is 
continuous with the epidermis (Tanaka et al., 1998; Forslind, 2000). The ORS 
emerges proximally in the middle of the anagen bulb and continues distally to 
combine with the infundibulum. The ORS is established during the early stages 
of anagen by the downward migration of the regenerating epithelium and then 
sustains itself independent of the bulbar matrix by basal cell growth (Reynolds 
and Jahoda, 1991, Vogt et al., 2009).  Below the sebaceous gland, slow cycling, 
relatively undifferentiated stem cells reside within a niche known as the bulge 
(Cotsarelis et al., 1990). 
 
Cells in the ORS express an array of keratins, for example, Krt5, Krt6, Krt14 and 
Krt17 (Patelevey et al., 1997; Langbein et al., 2004). Cells in the ORS also 
express adhesion molecules, growth factors, and growth factor receptors that are 
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distinctive from those expressed by epidermal cells (Chuong et al., 1998; Lyle et 
al., 1998; Danilenko et al., 1996).  
In addition to the epithelial cells, other types of the cell are present in the ORS. 
The ORS of the HF contains amelanotic melanocytes, located between the 
regions of the hair bulb and the bulge of the ORS (Botchkareva et al., 2001, 
Takada et al., 1992). In human HF, Langerhans cells (dendritic antigen-
presenting cells) have been found in the infundibular epithelium, including the 
follicular bulge, and rarely in the epithelium below the entry of sebaceous glands 
(Moresi and Horn, 2006). Merkel cells are specialized neurosecretory cells, 
located in close proximate to the bulge region of the ORS (Kim and Holbrook, 
1995).  
1.7 Hair Follicle Stem Cells 
The functional importance of stem cells in the HF have been directed towards 
their roles in tissue homeostasis (Snippert et al., 2010), HF regeneration (Rhee 
et al., 2006), and wound repair (Ito et al., 2005; Levy et al., 2005; Levy et al., 
2007). Stem cells are characterized by their slowly cycling, quiescence nature 
and their location within a niche, known as the bulge (Cotsarelis et al., 1990; 
Fuchs et al., 2004; Lowry et al., 2005).  The niche is needed to preserve stem 
cells ability to self-renew and remain undifferentiated over a lifetime (Cotsarelis 
et al., 1990; Oshima et al., 2001; Taylor et al., 2000). Recently, it was shown that 
slow-cycling bulge cells are formed during embryonic skin development (Nowak 
et al., 2008). In both neonatal and adult mice, bulge restricted cells are typified 
by certain key stem cell markers including Sox9, Lhx2, NFATc1, Tcf3, 
cytokeratins 15, 19, CD 34 (in mouse), CD 200 (in humans), leucine-rich G-
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protein-coupled receptor-5 (Lrg5) and Lrg6 (Lyle et al., 1998; Merrill et al., 2001; 
Li et al., 2003; Blanpain et al., 2004; Tumbar et al., 2004; Ma et al., 2004; Morris 
et al., 2004; Vidal et al., 2005; Nguyen et al., 2006; Rhee et al., 2006; Horsley et 
al., 2008; Jaks et al., 2008; Nowak et al., 2008; Snippert et al., 2008). 
 
Initial evidence that skin stem cells can differentiate into HF lineages, was 
demonstrated by targeting mouse stem cells. It was shown that the generation of 
all epithelial cell types within the intact follicle during normal HF cycling requires 
stem cell differentiation (Morris et al., 2004). Subsequent studies revealed that, 
in both embryonic and adult skin, bulge stem cells and their transient amplifying 
(TA)-progeny contribute to HF regeneration but not to the maintenance of the 
interfollicular epidermis (Morris et al., 2004; Ito et al., 2005; Levy et al., 2005).  
 
At the onset of anagen growth phase, the cycling portion of the HF regenerates 
and undergoes a new round of hair fiber growth.  This process requires a 
reservoir of stem cells, which reside in the lowest permanent portion of the 
follicle.  The new downward hair growth occurs adjacent to the existing club hair, 
which will eventually be shed. Bulge cells less frequently divide than other 
epithelial cells in the skin, but these stem cells are activated at anagen to 
generate a new HF (Cotsarelis et al., 1990; Taylor et al., 2000; Blanpain et al., 
2004; Fuchs, 2007; Blanpain and Fuchs, 2006; Blanpain, 2010). 
 
There are two sub-compartments of the lower follicle that exist in the resting 
period (telogen): the CD34 positive, slow-cycling bulge cells and the secondary 
hair germ (SHG) cells. SHG cells are a small cluster of P-cadherin-enriched cells 
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that forms at the end of catagen and separates bulge from underlying DP (Lyle et 
al., 1999; Muller-Rover et al., 1999; Panteleyev et al., 2001).  
 
The HF transition from telogen to anagen requires regeneration of HF 
characterized by activation of cell proliferation in the proximal follicular epithelium 
in the SHG and the bulge (Cotsarelis et al., 1990; Cotsarelis and Miller, 2001; 
Oshima et al., 2001). The identification of elevated Lef-1 nuclear staining in the 
SHG cells, initially suggested the importance of TCF3/Lef-1-mediated target 
genes in stem cell activation and subsequent anagen induction (DasGupta and 
Fuchs, 1999). Subsequently, Greco and colleagues (2009) demonstrated that at 
the end of telogen, the SHG stabilizes β-catenin and initiates mitogen-activated 
phosphokinase (MAPK) signalling. This suggests a two step mechanism of 
activation of stem cells during telogen-anagen transition (Greco et al., 2009). 
 
Stem cells label retaining ability was utilized by Fuchs and colleagues (2004), 
where they analyzed the extent of bulge stem cell involvement in giving rise to 
not only cells of the HF but also to epidermal cells. Using keratinocyte-specific 
Tet-offVP16 mice, in which only bulge cells retained fluorescence, they were able 
to show that during anagen phase of the hair cycle, newly formed GFP-positive 
stem cell populations derived from the bulge stem cells, were seen to form the 
ORS, the hair matrix cells and IRS indicating their origins in the bulge of the 
ORS. In response to wounding of the skin, these GFP-labelled stem cells exited 
the bulge, migrated, and proliferated to repopulate the infundibulum and 
epidermis (Tumbar et al., 2004).  
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Lgr5, a marker of intestinal stem cells, was also shown to be expressed in 
actively cycling cells in the bulge and SHG cells of telogen HFs and in the lower 
ORS of anagen HFs. Lgr5 positive cells represent actively proliferating and multi-
potent stem cell population, which is able to give rise to new HFs and maintain 
all cell lineages of the HF (Jaks et al., 2008). 
 
Lgr6, a closely related gene of Lrg5 in the mammalian genome, was also 
identified as a possible stem cell marker (Van Loy et al., 2008). Recently, Lgr6 
was shown to be one of the earliest expressed embryonic hair placodes markers 
along with Shh (Iseki et al., 1996) and Sox9 (Vidal et al., 2005). In adult HFs, 
Lgr6 expressing cells were shown to reside in a previously uncharacterized 
region directly above the HF bulge. Lgr6 positive cells expressed none of the 
known bulge stem cell markers, whereas Lrg5 expressing cells were strongly 
enriched for bulge markers such as CD34. Transplantation of Lgr6 positive stem 
cells from HFs of first telogen into the backs of nude mice resulted in 
reconstitution of fully formed HFs, interfollicular epidermis and sebaceous gland. 
This study identified Lgr6 as a marker for a distinct sub-population of stem cells, 
which gives rise to all lineages of the HF (Snippert et al., 2010).  
 
Lhx2, a transcriptional factor, which is a downstream target of Shh, was one of 
the first stem cell markers found to be expressed specifically in the embryonic 
placodes as well as in stem cells of the bulge region of post-natal HFs. Lhx2 has 
been shown to have a key role in HF stem cell maintenance and activation. 
Loss-of-function mutations of Lhx2 has shown to lead to formation of fewer 
number of HFs, but with the presence of more active stem cells, which are 
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unable to maintain stem-cell behaviour in mice (i.e., quiescence and slow 
cycling) (Rhee et al., 2006; Fuchs, 2007).  
 
1.8 Hair Bulb 
The hair bulb consists of epithelial and mesenchymal components, the hair 
matrix and the DP, respectively.  The HF bulb can be divided into two regions by 
the Auber line (Auber, 1952). The lower region of the hair bulb consists of 
undifferentiated, rapidly proliferating matrix cells, and the upper segment 
consists of differentiating, limited proliferative activity of matrix cells. The 
epithelial region in the bulb where keratinocytes proliferate rapidly is known as 
the critical region or the hair matrix zone (Orwin, 1979). The hair matrix also 
contains a number of dendritic melanocytes, which supply melanin pigment to 
the hair shaft (Dawber and Messenger, 1994; Slominski and Paus, 1993; 
Slominski et al., 2004). 
 
The hair matrix keratinocytes in mice express a variety of different keratins 
including Krt 14, Krt16, Krt17, Krt25, Krt27, and Krt28. Their expression extends 
from the bulb region up to the points of terminal differentiation in the IRS 
(Langbein et al., 2004). K17 expression was seen initially in the hair bulb, 
localised to keratinocytes in the developing epithelial hair bulb to the unilateral 
disc. With advancing anagen stage the expression of keratin 17 spreads along 
the proximal ORS (Panteleyev et al., 1997). 
 
The production of hair involves the proliferation of epithelial cells in the bulb 
region, which leads to the migration and the differentiation of these cells leading 
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to the formation of the hair shaft and IRS (Cotsarelis, 1997; Rogers, 2004). 
When hair is formed by rapidly proliferating keratinocytes in the bulb, it engages 
with melanocytes, which deposit their melanin into the hair shaft (Cesarin 1990; 
Slominski et al., 1994; Tobin and Bystryn, 1998; Slominski et al., 2004; Randall 
and Botchkareva, 2009). 
 
1.9 Dermal Papilla 
The DP, also known as the follicular papilla (FP), is a population of specialized 
mesenchymal-derived cells forming the connective tissue compartment, located 
at the base of the HF (Messenger et al., 1991; Hardy, 1992; Philpott and Paus, 
1998; Paus and Cotsarelis, 1999; Matsuzaki and Yoshizato, 1998; Millar, 2002). 
The DP is believed to be one of the most important drivers to instruct the HF to 
grow and form a particularly sized and pigmented hair shaft (Jahoda et al., 1984; 
Matsuzaki and Yoshizato, 1998; Van Neste and Tobin, 2004). 
 
DP is responsible for establishing, maintaining proliferation and differentiation of 
hair matrix cells during hair growth cycle. Several experiments have shown that 
the DP has powerful inductive properties. Transplant studies have indicated that 
DP cells are capable of inducing follicular development and the formation of the 
hair shaft when placed in a non-hair containing skin (Jahoda and Morris, 1984; 
Jahoda and Oliver, 1984; Jahoda et al., 1993). DP keeps a close-contact with 
the HF epithelium throughout the entire hair growth cycle (Young, 1980), which 
induces the HF epithelium to create a functional and cycling HF (Hardy, 1992; 
Oro and Scott, 1998; Matsuzaki and Yoshizato, 1998; Kishimoto et al., 2000). 
During the hair cycle, the papilla reaches maximal size by anagen VI, but 
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decreases by 25% in size during early periods of sustained hair production. This 
cell loss was shown not to be associated with intra-follicular papilla apoptosis, 
but instead it was strongly suggested that fibroblasts migrate out of the late 
anagen/early catagen papilla and re-enter the proximal connect tissue sheath 
(CTS) (Tobin et al., 2003). 
 
The DP is a crucial source of paracrine factors vital for hair growth. The DP 
provides essential stimuli, for example, noggin, which exerts a hair growth-
inducing effect by antagonising bone morphogenetic protein (BMP) signalling 
activation of the BMP receptor IA expressed in the follicular epithelium 
(Botchkarev et al., 2001). Hepatocyte growth factors (HGF) expressed in the DP 
and its receptor c-met, which is expressed in the hair matrix, have been shown to 
be crucial for hair growth.  Transgenic mice overexpressing HGF exhibit 
accelerated HF development (Lindner et al., 2000). Stem cell factor (SCF) is 
critical for proliferation, differentiation, and melanin production by follicular 
melanocytes expressing its receptor c-kit (Botchkareva et al., 2001). Insulin 
growth factor (IGF) produced by the DP also acts as an important morphogen in 
the HF (Rudman et al., 1997). In addition, many other molecules are produced 
by the DP for follicle induction, cycling and pigmentation (Paus and Cotsarelis, 
1999). 
 
The DP also displays strong alkaline phosphatase activity during the hair growth 
cycle (Handjiski et al., 1994).  The activity of alkaline phosphatase has been 
used as an indicator to detect the presence of DP during the hair cycle. Alkaline 
phosphatase activity in DP and dermal sheath has been shown to reach its 
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highest level in early anagen, and its expression was seen to decrease after mid-
anagen stage of the hair cycle. These temporal and spatial changes in alkaline 
phosphatase activity coincide with the hair-inductive property of DP and dermal 
sheath (McElwee et al., 2003; Lida et al., 2007). Even though, the role for 
alkaline phosphatase in hair growth cycle remains unclear, it has been shown 
that hair growth is reduced when alkaline phosphatase is inhibited (Lida et al., 
2007).  
 
1.10 The Connective Tissue Sheath 
The connective tissue sheath (CTS), is also known as the dermal sheath, joins 
with the base of the DP via a narrow line of tissue known as the basal stalk. This 
broadens distally to produce a rounded end to the follicle, called the basal plate. 
The basal plate encloses the remaining follicle along its whole length, which 
includes the sebaceous gland and integrates into the papillary layer of the skin 
dermis (Oliver, 1966; Jahoda and Oliver, 1990). CTS runs along the epithelial 
ORS separated by a thick and specialized basement membrane structure known 
as the glassy membrane. Dermal sheath cells act as a “pool” of papilla cells in 
injury situations, and may interchange with papilla cells as part of and during the 
catagen/telogen/early anagen phases of the hair growth cycle (Jahoda and 
Reynalds, 2001). These interchanges show significant hair cycle-associated 
plasticity and these cell interchanges are likely to be important during clinically 
important HF transformations, for example: during vellus-to-terminal and 
terminal-to-vellus and/or during androgenetic alopecia (Tobin et al., 2003). 
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1.11 Hair follicle morphogenesis 
HF morphogenesis occurs in eight distinctive morphological stages (Fig. 2) 
characterised by the downward movement of developing HFs, the positioning of 
the DP, the presence and position of the IRS and melanocytes. HF begins to 
develop from 9th to 12th week of estimated gestation age (EGA) in human skin 
embryo. The HF is first found in the chin, eyebrows and upper lips of the 
developing embryo (Breathnach and Smith, 1968) and then HFs progressively 
cover the entire body (Hashimoto, 1970; Philpott and Paus, 1998; McElwee and 
Sinclair, 2008).  
 
The early stages of HF morphogenesis (stages 0-3), is initially characterised by a 
single layer of basal keratinocytes (stage 0), while over time this basal layer of 
the epidermis begins to thicken forming a hair placode (stage 1) (hair germ) 
(Breathnach and Smith, 1968; Hashimoto, 1970; Paus et al., 1999).  The 
increasing number of dermal fibroblasts gathering beneath the hair placode has 
been shown to be crucial for HF morphogenesis (Oro and Scott, 1998; Philpott 
and Paus, 1998; Panteleyev et al., 2000).  
 
The HF continues to grow downwards, with increasing number of keratinocytes 
in the developing HF. The developing HF is characterised by the cap like 
covering of dermal fibroblasts on the bottom of the ectoderm (stage 2). 
Subsequent stages of HF morphogenesis are characterised by the continuation 
of the HF to grow downwards, with the developing HF now consisting of multiple 
layers of keratinocytes that become concentrically oriented towards the follicular 
axis (stage 3) (Robins and Breathnach, 1969). This is followed by the developing 
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HF resembling an immature HF, with a bulb like thickening, the presence of the 
IRS cone and the increased surrounding of the DP by the keratinocytes of the 
developing hair bulb (stage 4). Stages 5- 7 of HF morphogenesis are 
characterised by the appearance of  the APM, presence of melanin granules, 
elongation of the IRS, the initial development of the ORS and sebocytes, and the 
visibility and enlargement of the bulge (stage 5). Stages 6-7 of HF 
morphogenesis characterised by the formation of the hair canal, by completely 
enclosed the DP by the hair bulb, by presence of sebaceous gland, and by IRS 
containing a hair shaft. The hair shaft continues to move upwards and protrudes 
into the hair canal (exclusively stage 7). During the final stage of HF 
morphogenesis (stage 8), HF is morphologically similar to mature anagen VI HF. 
During this stage the HF reaches its maximal length and reaches the 
subcutaneous layer (Parakkal, 1969; Paus et al., 1999). 
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Figure 2. Illustrative representation of the hair follicle morphogenesis and the 
molecular signalling involved in induction and subsequent HF development. 
HF morphogenesis occurs in eight distinctive stages. Upperparts: The most-
important developmental stages of murine hair follicles. Below: The best-studied 
molecular players of each stage. The early stages of HF morphogenesis 
characterised by a single layer of basal keratinocytes (stage 0). This stage is 
characterised by the balance of activators and inhibitors of hair follicle 
development. Subsequent exchanges in signals between the epithelial and 
underlying mesenchyme giving rise to the dermal papilla characterised by the 
thickening of the epidermis, gathering of dermal fibroblast (hair germ) and the HF 
keratinocytes display a vertical polarisation orientation (stage 1). The HF continues 
to grow downwards, with increasing number of dermal papillas (stage 2). The 
subsequent stages of HF development include several crucial signalling pathways 
for the proper formation of the HF including Shh, Wnt and BMP signalling. Stages 
3-4 of HF morphogenesis: HFs continue to grow downwards, with the developing 
HF now consisting of multiple layers of keratinocytes (stage 3) and consisting of 
similar characteristic of an immature HF, with a bulb like thickening, the presence of 
the IRS cone. The dermal papilla is increasingly surrounded by the keratinocytes of 
the developing hair bulb (stage 4). The following stages of HF development (stages 
5-8) are characterised by the site of the attachment of the arrector pilli muscle, 
presence of melanin granules, elongation of the IRS, the initial development of the 
ORS and sebocytes and the visibility and enlargement of the bulge (stage 5). The 
hair canal is visible, the DP is completely enclosed by the hair bulb, presence of 
sebaceous glands and IRS contains hair shaft and the hair shaft continues to move 
upwards and protrudes into the hair canal. The final stage of HF morphogenesis 
(stage 8) resembles morphologically a mature anagen VI HF. Abbreviations: KC, 
keratinocytes; DC, dermal cells; FDP, Follicular dermal papilla; IRS, inner root 
sheath; SG, sebaceous gland; BG, bulge; MEL, melanin; HS, hair shaft, BMP; Bone 
morphogenic protein, Wnt; Wingless, Lef; lymphocyte effector factor, EDAR; 
Ectodysplasin receptor, EDA; Ectodysplasin, KGF; Keratinocyte growth factor, 
EGF; Epidermal growth factor, TGF; Transforming growth factor, PDGF; Platelet-
derived growth factor, SCF; Stem cell factor CK; Cytokeratins, HGF; Hepatocyte 
growth factor. Adapted from Schmidt-Ullrich and Paus, 2005; Botchkarev and Paus, 
2003. 
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1.12 Important signalling pathways involved in hair follicle development 
Each stage of HF morphogenesis is characterized by unique expression patterns 
of regulators, which either promote HF induction and subsequently HF 
development or are inhibitors of this process (Fig. 2). These regulators come in a 
broad category of growth factors and their receptors, growth factor antagonists, 
adhesion molecules, and intracellular signal transduction components 
(Botchkarev and Paus, 2003). 
 
Studies using post-natal animals have indicated that the genetic program of HF-
specific differentiation in epidermis may be initiated after receiving the 
mesenchymal signal or ‘‘first dermal message’’ (Hardy, 1992). This ‘‘first dermal 
message’’ leads to the beginning of the formation of the focal thickening in the 
basal layer of epidermis (hair germ or hair placode, stage 1), in which cells 
become oriented vertically, change their adhesion from regular epidermal 
keratinocytes (Paus et al., 1999; Nanba et al., 2000). These keratinocytes can be 
distinguished from regular epidermal keratinocytes by the expression of several 
growth factors (Wnt-10b, Eda, BMP-2), growth factor receptors (Edar, TGF-βRII, 
BMPR-IA), and transcription regulators (β-catenin, Lef-1, Msx-2) (Zhou et al., 
1995; Paus et al., 1997; St-Jacques et al., 1998; DasGupta and Fuchs, 1999; 
Headon and Overbeek, 1999; Botchkarev et al., 1999; Foitzik et al., 2000; Reddy 
et al., 2001; Kusa et al., 2001).  
 
The Wnt/β-catenin/Lef-1 signalling pathway is one of the crucial pathways 
involved in initiating HF development. Wnt-10a, Wnt-10b, β-catenin and Lef-1 are 
all expressed in the epithelium of stage 1 HFs (Botchkarev et al., 1999; 
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DasGupta and Fuchs, 1999; Huelsken et al., 2001; Reddy et al., 2001; St-
Jacques et al., 1998). The ectopic expression of Dickkopf-1 (Dkk), a Wnt-
antagonist, in murine epidermis resulted in abrogation of induction of all HFs 
types in back skin (Andl et al., 2002). The presence of Dkks at sites of Wnt 
signalling may implicate the ‘reaction-diffusion’ model, where cell fate is 
determined by the concentration/levels of activator and/or inhibitors of HF 
induction (Jung et al., 1998). 
 
Lef-1 knockout mice showed an absence of most of the HFs in back skin and 
lack of vibrissa follicles (van Genderen et al., 1994). Transgenic expression of 
Lef-1 leads to ectopic HF development in oral epithelium (Zhou et al., 1995; Gat 
et al., 1998). Lef-1 has been shown to negatively regulate the expression of E-
cadherin in hair germ keratinocytes and promotes the loss of their adhesion to 
neighbouring epidermal keratinocytes, therefore stimulating HF induction 
(Jamora et al., 2003). Recently, it has also been shown Wnt/β–catenin signalling 
pathway has a pivotal role in the formation of de novo HFs after wounding in 
murine skin. Ito and colleagues (2007) showed that selective ablation of Wnt 
signalling leads to abrogation of wound-induced folliculogenesis (Ito et al., 2007). 
The Wnt signalling pathway was also shown to upregulate the expression of Dkk-
4 in pre-placode stage. Dkk4 is transiently expressed during the pre-placode 
stage of appendage formation to inhibit canonical Wnt signalling and/or laterally 
inhibit the surrounding epithelium from adopting a placode fate, similar to the role 
of Dkk1 in the mesenchyme (Andl et al., 2002). This suggests that canonical Wnt 
signalling not only is essential for the induction of HF, but is also responsible for 
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the upregulation of Dkk4 in the pre-placodes, which is believed to regulate the 
pattern of HFs in the epidermis (Bazzi et al., 2007) 
 
Other important regulators of initiating HF development are the ectodysplasin 
(Eda) and its receptor (Edar), and TGF-β signalling. Eda and its receptor Edar 
belong to the TNF-α family. It has been shown that deletion of both Eda and Edar 
in corresponding mouse mutants (Tabby and Downless, respectively) is 
accompanied by failure in induction of primary or tylotrich HFs (Headon and 
Overbeek, 1999). TGF-/β-2 deficient mice showed a delay of HF development 
and reduced number of HFs. In contrast, overexpression of TGF-/β-2 has been 
shown to stimulate HF initiation in embryonic skin explants (Foitzik et al., 1999). 
 
In addition to the activators of HF induction, the skin also contains a number of 
inhibitors of HF induction including, BMPs, keratinocyte growth factor (KGF) and 
epidermal growth factor (EGF) signalling (Richardson et al., 2009). During HF 
induction in mice, both BMP-2 and BMPR-IA are expressed in hair placode, while 
BMP-4 and noggin expression is seen in cells of mesenchymal condensation 
beneath the placode (Botchkarev et al., 1999). Botchkarev and colleagues (1999) 
showed that neutralization of BMP-2 and BMP-4 inhibitory activity by noggin 
stimulates the initiation phase in HF development (Botchkarev et al., 1999). 
Along with BMP signalling, EGF and KGF have been established as inhibitors of 
HF induction. KGF and EGF receptors have been shown to be markedly down-
regulated in hair placodes and elevated levels of ligands for each receptor 
resulted in the inhibition of HF formation in embryonic organ culture (Richardson 
et al., 2009). 
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Constitutive deletion of Shh has been shown to lead to arrest of HF 
morphogenesis at stage 2, which was accompanied by a reduced keratinocyte 
proliferation and appearance of rudimentary follicular papilla (St-Jacques et al., 
1998; Chiang et al., 1999). Other important molecular signals involved in HF 
development include the platelet-derived growth factor-A (PDGF-A), which 
promotes HF development by stimulating the growth of follicular papilla. PDGF-A 
null HFs show smaller follicular papillae and abnormal CTS (Karlsson et al., 
1999). Neutrophins can also regulate HF development via activation of their low 
affinity receptor p75 neurotrophin receptor (NTR). p75NTR  expression is 
restricted to the DP of the developing HF. p75NTR knockout mice showed 
acceleration of HF morphogenesis. It was shown that signalling via p75 may 
control proliferation and differentiation balance in the fibroblasts of the growing 
DP. In addition, it was also shown that p75 NTR activation prevented early onset 
of FGFR-2 expression in the DP cells (Botchkareva et al., 1999).  
 
The later stages of HF development have been shown to be dependent on 
proper IRS and hair shaft differentiation. These processes of differentiation in the 
IRS and hair shaft are dependent on several crucial signalling pathways. 
Differentiation and normal development of the IRS has been shown to be 
dependent primarily on GATA-3, Cutl1 and Foxn1. GATA-3, a transcription 
factor, which has important regulatory role in IRS differentiation, has been shown 
to lead to the structural changes of IRS when its expression is inhibited (Kaufman 
et al., 2003). The Cutl1 gene has been shown to expresses broadly in the IRS. 
Cutl1-deficient follicles exhibit an initial development and formation of IRS, but 
then both the IRS and hair shaft degenerate (Ellis et al., 2001). Foxn1 knockout 
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or nude mice show formation of abnormal globular aggregates in the IRS and 
truncated hair shafts (Prowse et al., 1999). 
 
The hair shaft undergoes differentiation via several important signalling 
pathways. This includes the Wnt/β-catenin/Lef-1 signalling, which has a critically 
important role in hair shaft formation. Lef-1 knockout mice show arrest of HF 
development prior the beginning of hair shaft formation (Van Genderen et al., 
1994; DasGupta and Fuchs, 1999). Hoxc13 is a transcription regulator that has 
also been shown to be involved in the control of hair shaft formation. Hoxc13 
overexpression in differentiating hair shaft cells resulted in fragile hairs and 
alopecia (Jave-Suarez et al., 2002). Foxn1 transcription factor, which is mutated 
in nude mice, is also expressed in differentiating hair shaft keratinocytes (Meier 
et al., 1999). Interestingly BMP signalling has been shown to be involved in 
controlling the expression and function of Lef-1, Hoxc13, and Foxn1 transcription 
factors in differentiating hair shaft precursor cells. In transgenic mice 
overexpressing noggin, showed downregulation of Foxn1 and Hoxc13 
expression in differentiating hair shaft cells, while ectopic expression of Lef-1 was 
observed in the upper portion of the hair shaft (Kulessa et al., 2000). Msx-2 
transgenic mice have been shown to have markedly reduced number of hair 
matrix keratinocytes (Jiang et al., 1999). In contrast, Msx-2 knockout mice show 
structurally abnormal hair shafts (Ma et al., 2003). 
 
A Notch signalling pathway has also been shown to have an important role in the 
control of hair shaft-specific differentiation in the HF. Notch1 and its ligands 
Jagged1/2 are expressed in differentiating cells of the IRS and hair shaft (Kopan 
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and Weintraub, 1993; Powell et al., 1998; Favier et al., 2000; Lin et al., 2000), 
and have been shown to maintain IRS precursor cells, which are required for the 
formation of IRS (Nicolas et al., 2003; Pan et al., 2004). The overexpression of 
Notch1 in these cells leads to abnormal differentiation of the hair medulla and 
wavy, sheen pelage hairs (Lin et al., 2000). 
 
1.13 Hair Growth Cycle 
The hair growth cycle is a uniquely reproducible and cyclic regenerative 
phenomenon, which occurs in a uniform manner in thousands of follicles 
simultaneously over the entire skin of humans and other mammals (Cotsarelis, 
1997). Immediately on completion of morphogenesis, the HF resembles fully 
developed anagen HF and then the HF enters into a lifelong cycle of organ 
transformation from active growth (anagen), brief period of organ involution 
(catagen), followed by a relative “resting” phase (telogen) (Paus et al., 1999; 
Paus and Foitzik, 2004).  
 
This cyclic nature of the HF is tightly controlled by various factors and 
interactions between epithelial, neuro-ectodermal and mesenchymal cells 
(Slominski and Paus, 1993; Paus et al., 1999). In humans, each active/growth or 
anagen phase of the hair cycle last 3-10 years mean duration. Duration of 
catagen is 3 week. The resting phase (telogen) is 3 month long (Paus et al., 
1999; Vogt et al., 2009) (Fig. 3). 
 
Investigations into molecular regulations of HF cycling have been widely 
elucidated using genetically engineered knockout mice or overexpression of a 
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specific gene product closely linked to an epidermal and hair phenotype (Chen 
and Roop, 2008; Nakamura et al., 2001).  It is now widely accepted that HF 
cycling is a result of exchanges of signalling between the epithelial and 
meschencymal compartments of the growing HFs (Stenn and Paus, 2001). 
 
HF cycling is controlled by an array of signalling networks within and between 
the follicular epithelium and mesenchyme (Botchkarev and Fessing, 2005). 
These two compartments employ molecules that belong to the Wnt signalling 
family, TGF-β, BMPs, Shh, Fgfs, Notch, EGF, TNF-α, and neurotrophin families, 
all of which are crucial for regeneration, maintenance and cycling capabilities of 
the HF (Botchkareva et al., 1999; Cotsarelis and Millar, 2001; Fuchs et al, 2001; 
Millar, 2002; Botchkarev and Kishimoto, 2003; Schmidt-Ullrich and Paus, 2005). 
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Figure 3. The hair growth cycle. A) Hair follicle morphogenesis with initial 
interactions/signal exchanges between the epithelial and mesenchymal cell 
populations. B) First post-natal anagen, with the hair shaft protruding through 
the epidermis and C) hair follicles then enter a regressing phase (catagen), 
which is characterized by tightly controlled levels of apoptosis. The dermal 
papilla, stem cells and secondary hair germ cells are located in close proximity 
to the dermal papilla, with minimal signal exchanges/activity occurring during 
resting phase (telogen). Activation of stem cells leads to hair growth (anagen). 
Adapted from Paus and Cotsarelis, 1999, and Fuchs, 2007. 
A 
B C 
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1.13.1 Telogen 
Telogen HFs are very short in length and characterised by a lack of pigment-
producing melanocytes and the absence of the IRS. In telogen phase, the HF 
has reduced to about one third of its previous size and does not extend beyond 
the upper dermis. The epithelial cells of the lower telogen follicle do not show 
significant DNA or RNA synthesis, nor is there any synthesis of proteins 
characteristic of the anagen follicle (Vogt et al., 2009). 
 
Telogen is currently seen as more than just a period of “resting”, as the epithelial 
‘remnants’ of the telogen HF such as the bulge, SHG and compact DP are still 
engaging with each other. Telogen stage of hair growth cycle is being intensely 
investigated due to the balance between growth activators and inhibitors 
observed during this stage. Alterations to these growth modulators may lead to 
the initiation or prevention of active growth phase (anagen). Therefore local 
balance of growth stimulators and inhibitors in the proximal part of HFs appears 
to be critical for new hair growth wave initiation (Botchkarev and Paus, 2003). 
 
The HF transition and transformation from telogen to anagen stages of the hair 
cycle are a unique process of programmed organ regeneration characterized by 
activation of cell proliferation in the follicular germinative compartment located in 
most proximal part of the telogen HFs close to DP (Stenn and Paus, 2001). 
 
Telogen skin contains inhibitors of hair growth such as BMP 2/4. Botchkarev and 
colleagues (2001) demonstrated that the initiation of anagen requires inhibition of 
BMP-4/BMPR-IA signalling by noggin. In the telogen HFs, BMP4 is produced by 
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both the DP fibroblasts and the hair matrix keratinocytes, and interacts with 
BMPR-IA, which is selectively expressed in the SHG and therefore inhibiting the 
early onset of anagen development (Botchkarev et al., 1999; Botchkarev et al., 
1999; Botchkarev et al., 2001). In telogen HFs, keratinocytes of the SHG express 
structural proteins (cytokeratins 14), growth modulatory molecules (BMP-4, Shh, 
fibroblast growth factor 5 (FGF5)), growth factor receptors (bone morphogenetic 
protein receptor IA (BMPR-IA), adhesion molecules (E- and P-cadherins), and 
transcriptional regulators (β-catenin/Lef-1, STAT3) (Botchkarev and Paus, 2003; 
Botchkarev and Khisimoto, 2003). 
 
At the end of telogen stage a new anagen phase begins as the SHG cells 
proliferate and move down into the dermis with the DP cells. A complete new 
hair bulb develops, which grows into the base of the existing resting follicle. The 
new hair then pushes up beside the existing one which is shed (exogen). SHG 
cells in telogen HFs are a small cluster of cells located between the DP and the 
bulge. SHG cells are a distinct population of stem cells, with slow-cycling 
characteristics but quicker responsiveness to activating signals compared to 
stems cells in the bulge. This suggests that while stem cells of the bulge 
maintain the process of hair growth cycle, the role of SHG stem cells is to initiate 
hair regeneration (Greco et al., 2009).    
 
Recently, Greco and colleagues (2009) identified Fgf7 and Fgf10 as potent 
activators of hair regeneration by predominately having an effect on SHG cells 
and not the bulge during telogen-anagen transition. They also showed levels of 
1.0 Introduction 
Exploring molecular mechanism controlling skin homeostasis and hair growth: MicroRNAs in 
Hair-cycle-Dependent Gene Regulation, Hair Growth and Associated Tissue Remodelling   
             P a g e  | 39 
Wnts transcripts and the level of β-catenin stabilisation elevated during late 
telogen/early anagen in the SHG cells (Greco et al., 2009). 
 
Cell proliferation in the germinative compartment of the telogen HF can also be 
activated by applying mechanical or chemical stimuli. An example of mechanical 
stimulation, which is currently used to induce and investigate the murine hair 
growth cycle, is plucking/removal of the hair shafts using warm wax on the back 
skin hair of a mouse. This would not only lead to the onset of a new hair growth 
cycle but also synchronising majority of HFs in this region. This allows the 
analysis of expression patterns of genes of interest at distinct hair cycle stages. 
However, there is the possibility of abnormal effects due to the wounding caused 
by plucking (Paus et al., 1999; Paus, 1998). 
 
1.13.2 Anagen 
The anagen phase of the hair cycle can be divided into six sub-stages.  The 
earliest changes observed during anagen initiation have been shown to occur in 
the cells of the DP and the SHG cells (Stenn and Paus, 2001). During mid-
anagen hair progenitor cells proliferate, surround the growing DP, move 
downwards into the subcutaneous tissue and begin to differentiate into the hair 
shaft and IRS. Melanocytes located in the hair matrix show pigment-producing 
activity (Slominksi et al., 2005), and the newly formed hair shaft begins to 
develop. Late anagen is characterised by the fully formed hair bulb, which 
engulfs the DP located deep in the subcutaneous tissue, and by emerging a 
pigmented hair shaft through the epidermis (Paus et al., 1999; Stenn and Paus, 
2001; Randall and Botchkareva, 2009; Vogt et al., 2009). 
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There are at least three crucial signalling pathways in mice, which are known to 
participate in driving HFs from telogen to anagen. These three pathways include 
Shh, the Wnt and BMP signalling pathways. In telogen stage of the hair cycle, 
stabilization of β-catenin, a recognized effector of active Wnt signalling and a 
transcriptional cofactor for Lef1/TCF proteins (Gat et al., 1998; Celso et al., 2004; 
Lowry et al., 2005; Van Mater et al., 2003) is required for onset of new hair 
growth. During telogen, active BMP signalling is required for maintaining bulge 
stem cells in a relatively quiescent state (Blanpain et al., 2004; Horsley et al., 
2008), and therefore preventing early anagen induction (Rendl et al., 2008).  
 
Induction of Shh target genes occurs in the anagen HF in response to expression 
of Shh. The Shh pathway is vital for maintaining the stem cell population, and 
regulating the development of HFs (Oro and Higgins, 2003; Athar et al., 1999). 
Overexpression of Shh in mice was shown to accelerate HFs transition from 
telogen to anagen (Sato et al., 1999). In addition, significance of Shh in telogen-
anagen transition was shown by a single topical application of synthetic agonists 
of the Shh pathway, which stimulated anagen induction (Paladini, et al., 2005). 
 
Onset of Wnt signalling activation promotes several transcriptional changes in 
the HF, particularly in the proliferating and differentiating keratinocytes of the hair 
bulb (Lowry et al., 2005).  This activation of Wnt signalling coincides with the 
decrease in BMP signalling, therefore, subdividing the telogen phase into a high 
BMP refractory phase and a low BMP competent phase for hair regeneration and 
anagen induction (Plikus et al., 2008). Initial evidence of the role of Wnt/β-catenin 
signalling in anagen induction came from a study using TOPgal transgenic mice 
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carrying a TCF/LEF optimal promoter upstream of a β-galactosidase gene. They 
showed an increase in β-galactosidase in the bulge region of the HFs at the 
onset of anagen (DasGupta and Fuchs, 1999). Also, the first anagen-like stage 
(postnatal day 12) was shown to not occur in mice in which β-catenin expression 
is progressively lost in the skin (Huelsken et al., 2001). Wnts 10a and 10b have 
been shown to be expressed in postnatal HFs at anagen onset, but not in resting 
follicles of telogen skin (Reddy et al., 2001). These data are consistent with the 
view that a Wnt signal activates β-catenin signalling in the bulge, thereby driving 
the resting follicle into active growth. These studies demonstrate a role for Wnt/β-
catenin signalling during initial development of HFs as well as required for 
anagen induction (Van Mater et al., 2003). 
 
Activation of Wnt and Shh signalling in early anagen HFs may be due to the 
down-regulation of BMP signalling, which antagonizes the Wnt and Shh 
pathways in HFs (Baker et al, 1999; Botchkarev et al, 2001). Interestingly, 
BMPR-IA expression is significantly reduced in SHG keratinocytes, which show 
the highest rates of proliferation in early anagen HFs, while expression of the 
BMP antagonist noggin is increased in the follicular epithelium and in the 
mesenchyme (Botchkarev et al, 2001). 
 
During anagen development, the hair matrix keratinocytes also express an array 
of growth modulatory molecules, growth factor receptors and transcriptional 
regulators that are required for normal hair growth, including, Shh, β-catenin /Lef-
1, c-kit, c-met, Fibroblast growth factor receptor 2 (FgfR2), KGF, IGF-I receptor. 
The corresponding ligands of the receptors found in the hair matrix, are 
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expressed in the DP, such as Wnt5a, SCF, HGF, Fgf7 and IGF-1. These 
signalling pathways are essential for HF cycling (Philpott et al., 1994; Paus and 
Cotsarelis, 1999; Botchkarev et al., 2003; Botchkarev et al., 1999; Danilenko et 
al., 1996; Botchkarev and Kishimoto, 2003; Randall and Botchkareva, 2009).   
 
Studies using mice that lack IGF-1 or their receptor revealed poorly developed 
HFs. IGF-1 has been shown to maintain and increase follicle growth in vitro 
(Philpott et al., 1994; Stenn et al., 1996). Mice that lack Fgf-7 have reasonably 
normal HFs, (Guo et al., 2006) but disruption of the receptor for Fgf-7, which is 
also the receptor for Fgf-2, causes markedly reduced and abnormal HF formation 
(Werner et al., 1994). 
  
The end of the anagen phase is believed to be controlled in part by Fgf5. Fgf5 is 
the most powerful molecule known so far to control anagen-catagen transition 
(Herbert et al., 1994; Pethö-Schramm et al., 1996). Fgf5 is highly expressed in 
the HFs just before the end of anagen stage (Rosenquist and Martin, 1996). 
Studies have shown that mice that lack Fgf5 have an extended anagen stage, 
leading in the ‘angora’ phenotype, with hair that is 50 percent longer than normal 
(Sunberg et al., 1997). Even in mice that lack this growth factor, the follicle still 
eventually enters the catagen stage, indicating that other signalling pathways are 
also important for the induction of catagen stage. The transition from anagen to 
catagen also involves EGF receptors, as mice without EGF receptors or with 
non-functional receptors had extended anagen stage (Hansen et al., 1997).  
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Members of the neurophin family, including brain-derived neurotrophic factor 
(BDNF), NT-3 and NT-4 have been also shown to be upregulated in the proximal 
HF epithelium just before the onset of catagen, whereas their high affinity 
receptors TrkB and TrkC are expressed in the DP during late anagen-early 
catagen (Botchkarev et al., 1998; Botchkarev et al., 1999). Transgenic mice, 
overexpressing either NT-3 or BDNF, under K14 promoter, showed premature 
catagen development. BDNF and NT-3 leads to downregulation of SCF and 
Vascular endothelial growth factor (VEGF) secretion by DP cells in vitro. This 
could partially explain neutrophin-induced anagen-catagen transition molecular 
mechanisms (Tobin et al., 1999; Botchkarev and Paus, 2003). 
 
1.13.3 Catagen 
The transition of actively growing HF into the stage of spontaneous involution 
(catagen) is a biological process, which varies in different body regions and 
determines the diversity of fur seen in animals and humans. This regression of 
the HF in catagen is characterized by 1) a cessation of proliferation and 
differentiation of hair matrix keratinocytes; 2) termination of melanogenesis, and 
3) activation of massive apoptosis in the hair matrix (Slominski et al., 1994; 
Lindner et al., 1997; Thody and Graham, 1998; Botchkareva et al., 2001). The 
onset of these apoptotic events seems to be predetermined and finely 
orchestrated (Paus, 1998). 
 
During catagen, the DP is transformed into a cluster of quiescent cells in close 
contact with the regressing HF epithelium, which moves from the subcutis to the 
dermis/subcutis boarder to contact the distal portion of the HF epithelium, 
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including the SHG (Botchkareva et al., 2006).  HF compartments involved in hair 
production are reduced in length by up to 70% during catagen. This allows the 
HF to regenerate in the next hair cycle after receiving the appropriate stimulation. 
Although catagen is often considered a regressive event, it is a delicately 
orchestrated, energy-requiring remodelling process, whose progression allows 
for renewal of a further generation of the HF. The close contact between DP and 
HF epithelium is essential for proper hair cycling. In the mice with hairless (hr) 
gene mutation, the disintegration of the DP and the HF epithelium during 
catagen leads to the loss of the capacity of the HF to re-enter anagen 
(Panteleyev et al., 1999).  
 
Apoptosis, a programmed cell death is indeed the most important characteristic 
feature of catagen, which is well-coordinated and occurs in the proximal part of 
the HF. Apoptosis is regulated differently in each HF compartment and distinct 
cell populations show different abilities to undergo apoptosis (Botchkareva et al., 
2006). The majority of the follicular epithelial cells and melanocytes are very 
susceptible to apoptosis, whereas DP fibroblasts, a population of keratinocytes 
and melanocytes selected for survival display a high resistance to apoptosis 
(Linder et al., 1997; Botchkareva et al., 2006). 
 
During catagen, apoptosis may be considered as a wave, which begins from 
melanogenic area (late anagen) (Tobin et al., 1999), and then later propagates to 
the hair matrix (early catagen) and then to the proximal/central outer and IRS’s 
and hair shaft (mid-and late catagen) (Botchkarev and Paus, 2003). These 
apoptotic cells are phagocytised by macrophages and by neighbouring epithelial 
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cells, which fill the space left by apoptotic cells (‘‘apoptotic force’’) (Stenn and 
Paus, 1998).  
 
Catagen may occur in HFs due to withdrawal of hair growth stimulators or 
signalling via death receptors. p53 is a transcription factor, identified as a 
possible mediator of apoptosis in the hair matrix keratinocytes during catagen. 
p53 knockout mice were shown to have reduced rates of catagen progression 
compared with control mice. Thus, p53 was identified as a pro-apoptotic protein 
in catagen (Botchkarev et al., 2001b). 
 
HFs also expresses distinct ‘death’ receptors during catagen stage of hair cycle 
including TNF receptor, Fas/CD95 and p75 NTR. This implicates involvement of 
‘death’ receptors and their ligands in active remodelling of HF compartments 
during catagen.  
TGF-β1 has been shown to promote premature catagen onset. The precise 
mechanism of TGF-β1 induced catagen is not know, however, it has been 
suggested that TGF-β1 may alter growth factors or their receptors, which 
promote cell proliferation and differentiation during late stages of anagen (Foitzik 
et al., 2003). TGF-β1 has been shown to inhibit expression of HGF in human DP 
in vitro (Shimaoka et al., 1994). 
 
During catagen in mice, expression of the Bcl-2 to Bax ratio in hair matrix 
keratinocytes is markedly decreased compared with anagen levels (Lindner et 
al., 1997; Botchkareva et al., 2006). Also in catagen, the regressing HF has 
shown to express caspase 3, 4 and 7 (Lindner et al., 1997; Botchkarev and 
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Paus, 2003), the enzymes, which participate in a cascade that is triggered in 
response to pro-apoptotic signals (Thornberry and Lazebnik, 1998). 
 
The hr transcription factor has been shown to be an important regulator of 
apoptosis in the HF. Apoptosis is strongly increased in the hair matrix 
keratinocytes of hr mutant mice, resulting in premature entry of HFs to catagen 
from anagen. This subsequently leads to disintegration of the DP from the 
follicular epithelium and permanent hair loss (Panteleyev et al., 1999). Vitamin D 
receptor (VDR) gene ablation in mice was shown to lead to hair loss and the 
phenotype resembled hair loss caused by mutations in the hr gene (Miller et al., 
2001), thereby suggesting a common signalling pathway for both hr and VDR. 
Subsequently it was shown that hr protein serves as a transcription co-repressor 
for the VDR (Hsieh et al., 2003; Potter et al., 2001).  This suggests that 
interactions between hr protein and VDR may contribute to apoptosis in HF 
matrix keratinocytes (Botchkareva et al., 2006). 
 
The balance between proliferation and apoptosis during catagen can also be 
regulated by survivin (Botchkareva et al., 2006). Survivin is a member of the 
apoptosis inhibitor protein (IAP) family, which has been identified as a possible 
regulator of cell proliferation as well as an inhibitor of apoptosis. Botchkareva 
and colleagues (2003) showed that survivin was expressed in the proliferating 
keratinocytes of the hair matrix and ORS of anagen HF but its expression 
disappeared with the onset of catagen. Pharmacological inhibition of survivin in 
the HF caused inhibition of HF length in organ culture model associated with 
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reduced levels of proliferative cell and increased TUNEL positive cells in HFs 
(Botchkareva et al., 2003).  
 
X-linked inhibitor of apoptosis protein (XIAP), which also belongs to the family of 
IAPs, is expressed in the hair matrix, ORS, and follicular papilla of early catagen 
HFs. During catagen, Eda A1 mRNA and Edar protein were shown to be 
expressed at high levels in the ORS and IRS. In downless mice lacking Edar, 
accelerated apoptosis in the ORS of the HF, along with decrease in expression 
of XIAP was found compared with control mice. It was suggested that Edar 
signalling is involved in regulating apoptosis in HF keratinocytes in part due to 
regulating XIAP expression in the HF epithelium during catagen (Fessing et al., 
2006). 
 
The survival of the distinct HF cell populations during catagen is essential for the 
ability of HFs to regenerate in the next hair cycle. These cell populations include 
fibroblasts of the DP, epithelial stem cells and some of the daughter (transient 
amplifying) cells, and undifferentiated melanocytes that are able to restore the 
hair pigmentation unit in the next hair cycle.  DP fibroblasts display very potent 
anti-apoptotic properties during the entire hair cycle. They are characterized by 
high levels of anti-apoptotic protein Bcl-2 and lack of the expression of apoptotic 
‘death’ receptors (Lindner et al., 1997). 
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1.13.4 Exogen 
The process of hair shedding (exogen) in mice is now considered as a distinct 
stage of the hair cycle.  Although the loss of club fibers occurs in the large 
majority of hairy mammals, very little is known about this cycle phase. This stage 
is the least studied aspects of HF activity. However, efforts have been made to 
understand and determine the significance of this stage. There are currently two 
theories on the process of hair shedding. The first is that hair shedding is a 
passive process. Passive process involves the removal of old hair shaft from 
previous HF cycle by mechanical force of the new growing hair shaft within the 
follicle (Milner et al., 2002; Higgins et al., 2009).  
 
However, increasing evidence suggests that exogen is an active process. 
Studies from desmoglein-3 knockout mice and Bcl-xL transgenic mice have 
shown increased club fiber retention in this stage. This demonstrated the 
importance and the involvement of adhesion molecules and programmed cell 
death in the retention and release of the club fiber in the epithelial sac (Koch et 
al., 1998; Pena et al., 1999). The importance of the exogen phase in the context 
of the HF biology is becoming more widely recognized, although more 
comprehensive investigation is required to understand the molecular 
mechanisms controlling this phase of the hair growth cycle (Higgins et al., 2009). 
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1.14 The importance of Wnt signalling and its implications in the skin 
and hair follicle 
1.14.1 Wnt/β-catenin signalling pathway 
The Wnt signalling pathway has a crucial role in the HF development and HF 
cycling, tissue regeneration and in several other processes. Any mutations or 
deregulated expression of components of the Wnt pathway can lead to 
developmental defects and excessive levels β-catenin have been implicated in 
the development of several human cancers (Miller et al., 1999; Klaus and 
Birchmeier, 2008). 
 
At the core of the Wnt signalling pathway is β-catenin, a multi-functional protein 
with independent roles in cadherin-mediated cell adhesion and Wnt signal 
transduction (Willert and Nusse, 1998). The end result of Wnt/β-catenin pathway 
is the activation and free, signalling pool of β-catenin proteins in the cell that 
enters the nucleus and forms a complex with members of the Lef-1/TCF family of 
transcription factors to regulate expression of target genes.  This can only be 
achieved by regulating the stability of β-catenin in the cell.  In the absence of 
active Wnt signalling, β-catenin is degraded by initial phosphorylation and 
subsequent ubiquitination by the proteasome pathway, keeping the levels of free 
β-catenin low.  In contrast, activation of the Wnt pathway prevents the 
phosphorylation and subsequent ubiquitination of β-catenin, which results in 
elevated levels of β-catenin in the cell (Miller et al., 1999) (Fig. 4).  
 
Phosphorylation and subsequent ubiquitination of β-catenin is a crucial process 
of regulating the levels of  β-catenin as deregulation of β-catenin can lead to 
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several forms of cancer including colonal cancer (He et al., 1998; Tetsu and 
McCormick, 1999), Familiar Adenomatous Polyposis (FAP) (Kinzler et al., 1991; 
Nishisho, 1991), HF specific tumours such as, trichofolliculoma (Celso et al., 
2004) and pilomatricomas of the skin, and may contribute to hematological 
malignancies such as leukemia (Chan et al., 1999; Jamieson et al., 2004). 
 
This crucial process of phosphorylation and subsequent ubiquitination of β-
catenin is carried out by ‘the destruction complex’ consisting of four proteins: 
GSK-3, Axin, APC, and β-TrCP/Slimb. This elaborate complex of proteins is only 
formed when there is in-active Wnt signal.  The function of this complex is to 
maintain low levels of β-catenin in the cell.  Axin and APC proteins serve as 
scaffolds, binding both β-catenin and GSK-3 and facilitating the phosphorylation 
of β-catenin by GSK-3.  Mutation or deletion of any of these proteins in the 
destruction complex have been shown to lead to highly stable forms of β-catenin 
that are constitutively active (Pai et al., 1997; Yost et al., 1996). These mutations 
are often found in a variety of human cancers (Miller et al., 1999). 
 
1.14.2 Wnt/β-Catenin signalling in skin and hair in health and disease 
Several studies have suggested that multiple steps in skin and HF 
development/cycling are dependent upon a change in the transcriptional status of 
genes that are regulated by Wnt signalling pathway.  Several Wnts and their 
Frizzled receptors have been shown to be expressed in the epidermis in a highly 
dynamic and complex pattern (Reddy et al., 2001). In postnatal skin, two 
members of the Lef/TCF family are expressed. Tcf3 is expressed in the bulge 
and ORS of the HF, while Lef-1 is expressed in the ORS and matrix cells 
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(DasGupta and Fuchs, 1999; Merrill et al., 2001). This suggests that Wnt/β-
catenin signalling is important in HF cycling. 
Subsequent studies in the skin have shown that selective ablation of Lef-1 gene 
in the epidermis inhibits HF development (van Genderen et al., 1994). In 
contrast, transgenic mice overexpressing Lef1 resulted in de novo HF formation 
in the skin. Similarly, transgenic overexpression of a constitutively stable 
(‘oncogenic’) form of β-catenin induces additional HFs (Alonso and Fuchs, 2003).  
By contrast, conditional ablation of β-catenin blocks HF formation altogether 
(Huelsken et al., 2001).  In mice expressing stabilised β-catenin to the ligand-
binding domain of a mutant oestrogen receptor (DeltaNβ-cateninER) induced 
resting HFs into anagen and promoted growth of existing follicles by topical 
application of synthetic 4-hydroxytamoxifen (4OHT) (Celso et al., 2004). 
However, excessive activation of β-catenin has been shown to result in the 
formation of HF-derived tumours resembling trichofolliculomas. Pilomatricomas, 
which is an age related development of skin tumours in mice, have been shown 
to have higher levels of β-catenin characterized by dead hair cells surrounded by 
rapidly proliferating matrix cells (Gat et al., 1998; Chan et al., 1999). This 
establishes the canonical Wnt signalling as a crucial pathway required for HF 
induction, development (van Genderen et al., 1994), and skin tumourigenesis 
(Chan et al., 1999; Van Mater et al., 2003; Celso et al., 2004).  
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Figure 4.  Schematic representation of the canonical Wnt signalling 
pathway.  A) When Wnt receptor complexes are not bound by ligand, the 
serine/threonine kinases, CKI-γ and GSK3β, phosphorylate β-catenin, which 
is facilitated by Axin and APC.  Phosphorylated β-catenin is recognized by β-
TrCP complex, a component of a dedicated E3 ubiquitin ligase complex. This 
results in the ubiquitination of β-catenin, which is targeted for rapid destruction 
by the proteasome.  In the nucleus, binding of Groucho to TCF/Lef1 
transcription factors inhibits the transcription of Wnt target genes.  B) In 
contrast, in the presence of Wnt signalling the Frizzled/LRP co-receptor 
complex activates the canonical signalling pathway.  Dishevelled (Dsh) and 
GBP/Frat1 inhibit phosphorylation of β-catenin by inducing phosphorylation of 
LRPs by GSK3β and CK1γ instead, thereby regulating the binding of Axin.  
The binding of Axin away from the destruction complex results in the 
stabilization of β-catenin.  In the nucleus, β-catenin displaces Groucho from 
TCF/Lef-1 transcription factors to promote the transcription of Wnt target 
genes. Abbreviations: TCF, T cell factor; Lef-1, lymphoid enhancing factor 1; 
CKI-γ, casein kinase I-γ; LRP, Lipoprotein receptor; U, ubiquitination; P, 
Phophorylated. (Adapted from Clevers, 2006). 
 
A 
1.0 Introduction 
Exploring molecular mechanism controlling skin homeostasis and hair growth: MicroRNAs in 
Hair-cycle-Dependent Gene Regulation, Hair Growth and Associated Tissue Remodelling   
             P a g e  | 53 
1.15 The importance of BMP signalling in the skin and its appendages 
Inductive processes during development and organogenesis are controlled by 
closely associated interactions between stimulators and inhibitors, the balance of 
which determines whether or not induction of HFs occurs. Epithelial-
mesenchymal derived appendages, such as the HF, tooth, or feather involve 
interactions between hair placode keratinocytes and fibroblasts of underlying 
mesenchymal condensations (Hardy, 1992; Oro et al., 1998; Philpott et al., 1998) 
and include potent inhibitors of induction, some of which belong to the BMP 
family (Lamb et al., 1993; Jung et al., 1998; Botchkarev et al., 1999).  BMPs 
belong to a large group of secreted polypeptide growth factors that form the 
TGF-β superfamily. BMP signalling plays essential roles during embryonic 
development, postnatal tissue remodelling and regeneration in numerous organs 
by regulation of cell proliferation, differentiation, and apoptosis (Botchkarev and 
Paus 2003; Li, et al. 2003; Massague 2003; Mishina 2003; Plikus et al., 2008). In 
the skin, BMP signalling has been shown to control crucial steps in HF 
development and cycling including inhibition of the initiation phase of the 
secondary HF morphogenesis (Botchkarev et al., 1999), inhibitory influence on 
stem cell population of the HF during the resting phase of the hair cycle and in 
later stages it is required for proper control of keratinocyte differentiation into HF-
specific cell lineages and hair pigmentation (Botchkarev et al., 2001; Kobielak et 
al., 2003; Andl et al., 2004; Kin Ming et al., 2004; Yuhki et al., 2004; Sharov et 
al., 2005). Recent studies have also demonstrated a strong anti-tumour activity 
of the BMP signalling pathway in the skin epithelium (Blessing et al., 1995; 
Zavadil et al., 2007; Sharov et al., 2009). 
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 1.16 Skin Carcinogenesis 
Skin cancer is one of the most common cancers in the world and rates of 
incidences continue to rise (Glick and Yuspa, 2005). During the last decade, 
there was a significant progress in the identification of molecular mechanisms 
underlying the development of the major cutaneous cancers, such as malignant 
melanoma, basal cell carcinoma, and squamous cell carcinoma (Li et al., 2006; 
Owens and Watt, 2003). In particular, it was shown that mechanisms controlling 
skin and HF development seem to be very similar to carcinogenesis, and key 
signalling pathways such as Wnt/β-catenin signalling, Shh, Notch and TGF-β, 
which regulate skin and HF development are also implicated in the pathobiology 
of cutaneous neoplasias (Sharov et al., 2009).  
 
The chemically induced skin carcinogenesis in mice model has been an 
important tool for researches in investigating the molecular mechanisms 
contributing to human epithelial cancer development (DiGiovanni, 1992; 
Hennings et al., 1993; Yuspa, 1994; Chan et al., 2004, Abel et al., 2009). Skin 
carcinogenesis in mice can be divided into three discrete steps: i) initiation, ii) 
promotion, and iii) malignant conversion (Hennings et al., 1983). Initiation of 
tumour development in the skin involves an irreversible genetic change induced 
by a subcarcinogenic dose of a carcinogen such as 7,12- 
dimethylbenz(a)anthracene (DMBA). Initiation with DMBA leads to mutations in 
the Ha-ras gene (Yuspa, 1994), and, this stage usually does not involve 
morphological changes in skin. The promotion of tumour development requires 
the constant application of tumour promoters such as, 12-tetradecanoil-phorbol-
13-acetate (TPA) to mouse skin. This leads to the tumour promotion, which is 
1.0 Introduction 
Exploring molecular mechanism controlling skin homeostasis and hair growth: MicroRNAs in 
Hair-cycle-Dependent Gene Regulation, Hair Growth and Associated Tissue Remodelling   
             P a g e  | 55 
characterized by a dramatic induction of epidermal cell proliferation and 
hyperplasia. The end result of the promotion stage is the development of 
premalignant clonal outgrowths known as papillomas (DiGiovanni, 1992; Yuspa, 
1994; Chan et al., 2004). For papillomas conversion into SCC, the accumulations 
of additional genetic changes are required (Hennings et al., 1993; Chan et al., 
2004), for example, p53 mutations (Ruggeri et al., 1991). p53 functions to induce 
growth arrest, promote apoptosis, block angiogenesis, or mediate DNA repair 
(Ko and Prives, 1996). The importance of p53 in preventing tumour formation 
was shown by the presence of mutations in the p53 pathway in nearly all cancers 
(Hollstein et al., 1991), including in the skin (Caulin et al., 2007). 
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1.17 MicroRNA- A New Layer of Gene Regulation  
1.17.1 The Importance and Function of MicroRNAs 
MicroRNAs (miRNA) are a large family of regulatory molecules found in all multi-
cellular organisms. MiRNAs are small non-coding RNAs of approximately 22 
nucleotides (nt) in length, which is created by enzymatic cleavage of 
endogenous primary transcript that contains a local hairpin structure (Bartel, 
2004; Lee and Ambros, 2001; Ambros et al., 2003; Gregory et al., 2004). Since 
the discovery of the first miRNA gene in Caenorhabditis elegans (lin-4) in 1993 
(Lee et al., 1993), approximately 800 miRNA genes have been identified in the 
human genome, which can exist either individually or form polycistronic clusters. 
Currently, it is estimated that miRNA genes make up about ~3% of the known 
genes and up to 30% of genes may be regulated by miRNAs in eukaryotes (Yu 
et al., 2007). Of these 800 miRNAs, over 200 miRNAs have been discovered 
experimentally, and additional ones have been identified via computational 
approaches (Lagos-Quintana et al., 2001; Lim, 2003; Lim et al., 2003; Cheng 
and Li, 2008). 
 
The function of miRNAs is just beginning to be understood, and it is evident that 
miRNAs have important regulatory roles in a variety of biological processes 
including control of developmental timing (Abbot et al., 2005), growth control, cell 
differentiation (Yi et al., 2008) and proliferation (Cheng et al., 2005), embryonic 
stem cells (Murchison et al., 2005) and in cancer development (Calin, 2004; 
Gregory and Shiekhattar, 2005). MicroRNAs regulate gene expression by base 
pairing with the 3’ untranslated regions (3’UTRs) of target messenger RNAs 
(mRNAs), thus representing post-transcriptional level of regulation of gene 
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expression known as Post-transcriptional gene silencing (PTGS) (Lewis et al., 
2003; Cullen, 2004; Lewis et al., 2005). MiRNAs and their mRNA targets appear 
to represent remarkably diverse regulatory networks as a single miRNA can bind 
to and regulate many different mRNA targets and/or conversely, several different 
miRNAs can bind to and cooperatively control a single mRNA target (Lewis et al, 
2003).  Thus, the discovery of miRNAs has added a new dimension to our 
understanding of complex gene regulatory networks. 
 
1.17.2 Structure and Biogenesis of MicroRNA 
MicroRNAs are transcribed by RNA polymerase II (Pol II) to generate a stem 
loop containing primary RNA transcript precursors known as pri-miRNA (Lee et 
al., 2002), which can range from hundreds to thousands of kilobases in size (Lee 
et al., 2004; Bushati and Cohen, 2007). Majority of genes encoding miRNAs are 
found within intergenic miRNA genes, while the rest of them are intragenic 
(Bohnsack et al., 2002). Pri-miRNAs precursors are characterised by the 
presence of loop and stem structures with imperfect complimentary region. The 
mature miRNAs are possibly present on either side of the stem. Interestingly, 
these pri-miRNAs show a 5’cap structure (7-methylguanosine), are 
polyadenylated at the 3’ end and have intronic and exonic regions similar to any 
other protein coding mRNA. Pri-miRNA is then processed into precursor-miRNA 
(pre-miRNA) by the nuclear RNase III enzyme Drosha (Kim, 2005a; Kim, 2005b; 
Bosjancic and Glavac, 2008). In the nucleus, Drosha interacts with essential co-
factor DiGeorge Syndrome Critical Region Gene 8 (DGCR8) protein, (Pasha in 
Drosophila/DiGCR8), a protein containing two double stranded RNA-binding 
domains. The Droha-DGCR8 complex cleaves pri-miRNA, to form the ~70nt long 
containing 2nt 3’-overhang pre-miRNA (Denli et al., 2004; Han et al., 2004; 
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Chen, 2005; Gregory et al., 2006; Yeom et al., 2006).  Knockdown of Drosha, 
using RNA interference (RNAi) technology, results in the strong accumulation of 
pri-miRNA, and the reduction of pre-miRNA and mature miRNA in vivo (Lee et 
al., 2003), suggesting that Drosha is absolutely essential for miRNA biogenesis. 
It was shown that RNA stem-loops with a large, unstructured terminal loop 
(above 10nt) are the preferred substrates for the cleavage of Drosha (Zeng et al., 
2005). However, the precise mechanisms that the Drosha uses to discriminate 
miRNA precursors are still unknown.  
 
It was shown that Drosha cleaves the pri-miRNA in an asymmetric manner near 
the base of the stem region and generates a double stranded 5’-phosphate and 
3’-end two nucleotide overhang structure (Chendrimada and Sheikhatter, 2007). 
The efficiency of Drosha-DiGCR8 processing on pri-miRNA precursors depends 
on the terminal loop size, the stem structure and the flanking sequence of the 
Drosha cleavage site, because shortening of the terminal loop, disturbance of 
complementarity within the stem and removal or mutation of sequences that 
flank the Drosha cleavage site significantly decrease, if not abolishes, the 
Drosha processing of pri-miRNAs (Lee et al., 2003; Zeng and Cullen, 2003).  
 
The 2-nt 3’-end overhang, which is characteristics of RNases III endonucleases 
mediated cleavage, is recognised by Exportin-5 (Exp5). Exp5 is bound with 
guanosine triphosphate (GTP), a member of the Ran-dependent nuclear 
transport receptor family (Lund et al., 2004). The depletion of nuclear GTP-
bound Ran (RanGTP) and cellular Exp5 has shown to impair the export of pre-
miRNA into the cytoplasm suggesting the crucial function of Exp5 in miRNA 
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biogenesis (Yi et al., 2003; Lund et al., 2004; Bohnsack et al., 2004). On arrival, 
exportin-5-Ran/GTP is hydrolysed to exportin-5-Ran/GDP, releases pre-miRNAs 
into the cytoplasm. Pre-miRNAs are further processed in the cytoplasm by 
another RNase III enzyme known as Dicer (Bernstein et al., 2001; Grishok et al., 
2001; Hutvagner et al., 2001; Ketting et al., 2001). Efficient Dicer cleavage also 
requires the presence of the 2nt 3’-overhang and a minimal stem length, 
suggesting a model in which the Dicer may recognize the end of the Drosha 
cleavage product, and therefore position the site of the second RNase-III 
cleavage on the stem of the miRNA precursors (Hutvagner et al., 2001).  
 
Dicer also associates with a double stranded binding protein, known as TRBP 
(the human immunodeficiency virus trans-activation response RNA-binding 
protein). This protein is required for Dicer processing of pre-miRNA in the 
cytoplasm. Studies investigating the role of Dicer-TRBP complex in miRNA 
biogenesis discovered that the knockdown of TRBP leads to Dicer destabilisation 
and consequentially loss of miRNA biogenesis (Chendrimada et al., 2005). 
Dicer-TRBP complex cleaves the pre-miRNA and produces double stranded 
miRNAs ~22nt long. Differences in size may be a result of the presence of 
bulges and mismatches on the pri-miRNA stem. These miRNAs are 
indistinguishable from a small-interfering RNA (siRNA), the mediator of RNAi. 
Cleavage of pre-miRNA produces short-lived miRNA duplex, where one strand is 
the duplex is degraded, while the other mature single stranded miRNA is then 
incorporated into an RNA Induced Silencing Complex (RISC) (Bartel, 2004).  It is 
not yet clear how the separation of the double stranded miRNA duplex occurs 
and how the mature strand is incorporated into the RISC complex.  
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Studies have suggested that separation of strands may be due to the low 
stability of the 5’-end of the mature strand and thus facilitate the 
mature/passenger strand separation. Other suggestions include: (i) the role of an 
unidentified helicase, which unwinds the duplex. The separated mature miRNA 
strand is then incorporated into the RISC, (ii) the double stranded miRNA duplex 
may be inserted into the RISC and the RISC then recognises and cleaves the 
passenger strand as a substrate, leaving the mature strand to bind to target 
mRNA (Bartel, 2004; Chendrimada and Sheikhatter, 2007). In addition, it has 
been postulated that TRBP is required for the recruitment of Dicer processed 
double stranded miRNA into the RISC complex for mature/passenger strand 
separation (Chendrimada et al., 2005). 
 
Comparable to Drosha, Dicer also contains two tandem RNase-III domains and 
also produces pre-miRNA by a single cleavage event. Currently, given the lack 
of knowledge regarding the exact structural elements that guide Dicer and 
Drosha cleavage, it is complicated to speculate about their precise biochemical 
mechanisms. However, it is highly possible that Drosha and Dicer share closely 
related mechanisms for the processing of miRNAs (Kim, 2005a). 
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1.17.3 Post-transcriptional Regulation by MicroRNAs 
Even though, all miRNA-mRNA interactions appear to downregulate gene 
expression post-transcriptionally, the level of regulation of target mRNA by 
miRNAs has been shown to vary substantially, from less than two-fold to greater 
than ten-fold, depending on the specific miRNA-mRNA target combinations. 
Although the crucial factors that define the different magnitudes of regulation 
remain unknown, mRNAs that are only modestly regulated must be translated. 
Whether the level of translation of target mRNAs is determined by the 
accessibility of the mRNA to miRNAs or by other factors is yet to be defined 
(Aukerman and Sakai, 2003; Maroney et al., 2006; Jackson and Standart, 2007).  
 
MiRNAs are believed to regulate gene expression post-transcriptionally by 
forming Watson-Crick base pairs between miRNA recognition element (MRE) in 
target mRNAs 3’ UTR and 5’-region of miRNA, called the seed region 
(Brennecke et al., 2005). In animals, most miRNAs are believed to base pair 
imperfectly with their target mRNA(s) and these interaction sites are enriched in 
3’-UTRs (Bartel, 2004). The amount of complementation between the miRNA 
and its target mRNA determines the fate of the bound target mRNA (Hutvagner 
and Zamore, 2002; Cheng and Li, 2008). Perfect pairing causes the target mRNA 
to be cleaved, as is the case in the majority of plant miRNAs (Dugas et al., 2004). 
Imperfect base pairing alternatively leads to the blockade of translation, as seen 
in the majority of animal miRNAs (Fig. 5) (Wightman et al., 1993; Reinhart et al., 
2000). 
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One of the first examples of the role of endogenously expressed miRNAs in 
down-regulating gene expression was lin-4, which negatively regulates its target, 
lin-14, by repressing its translation (Olsen and Ambros, 1999). Base pairing 
between lin-4 and lin-14 has been shown to be vital for their interaction in vivo, 
as mutations that affect their base pairing complementarity compromises or 
abolish this negative regulation (Lee et al., 2002). These genetic interactions 
between lin-4 and lin-14 stimulated a series of molecular and biochemical 
studies demonstrating that the direct, but imprecise, base pairing between lin-4 
and the lin-14 3′ UTR was crucial for the ability of lin-4 to control lin-14 
expression via the regulation of protein synthesis (Lee et al., 1993; Olsen and 
Ambros, 1999; Kim, 2005a). 
 
1.17.4 RNA Inducing Silencing Complex (RISC) 
Even though, currently the progress in identifying protein and RNA components 
of the RISC has advanced considerably, the biochemical mechanism by which 
this complex functions still remains largely unknown. Genetic screens combined 
with biochemical purification have shown that the RISC is composed of Piwi-
Argonaute-Zwille (PAZ) complex (Hammand et al., 2001). Dicer cleavage 
products are incorporated into PAZ-containing RISCs, which mediates mRNA 
degradation or translational suppression (Hannon, 2002; McManus and Sharp, 
2002; Tahbaz et al., 2004). Current structural analysis of PAZ complex has 
shown that it is able to interact at low-affinity with the 3′ end of single stranded 
RNAs (Bernstein and Caudy, 2001; Grishok et al., 2001; Zeng and Cullen, 2004). 
This alliance also permits the PAZ domain to interact with double stranded RNAs 
that present 2-nt 3′ end overhangs, such as those that result from Drosha 
cleavage (Bohnsack et al., 2004; Grishok et al., 2001; Zeng and Cullen, 2004).  
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Ago2 is the catalytic domain of the PAZ complex required for efficient cleavage 
of target mRNA. Ago2 is a member of the Argonaute protein family and the only 
member in humans that is associated with both siRNA and miRNA silencing 
pathways. It was shown that mutations within the Ago2 inactivate RISC, 
suggesting the importance of Ago2 in miRNA-induced mRNA silencing (Liu et al., 
2004; Rand et al., 2005).  
 
Early analyses of miRNA involvement in regulation of gene expression did not 
show changes in the target mRNA levels, whereas the amounts of proteins 
encoded by those mRNAs were significantly reduced. In addition, miRNAs 
targeted mRNAs were found on polysomes, suggesting that the block to 
translation occurred after initiation of protein synthesis. These studies have 
suggested that RISC containing miRNA (miRNP complex) may have direct 
effects on target mRNA by inhibition of initiation of translation, which results in 
prevention of ribosome association with the target mRNA (Olsen et al., 1999). 
 
Additional mechanism of regulation of miRNA may involve post-initiation 
repression of target mRNAs. This includes premature ‘ribosome drop off’, slowed 
or stalled elongation, and co-translational protein degradation. In addition to 
direct effects on translation, miRNPs can have effects on targeted mRNAs by 
promoting deadenylation (Giraldez et al., 2006), which might result in 
degradation of target mRNA. Both de-adenylation and degradation of target 
mRNA may take place in cytoplasmic P bodies, which are enriched with factors 
involved in mRNA degradation. It is possible that miRNA-targeted mRNAs could 
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be sequestered from the translational machinery and degraded or stored for 
subsequent use (Nilsen, 2007).  
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Figure 5: MicroRNA Biogenesis. Primary microRNA (pri-miRNA) is 
synthesized in the nucleus by RNA polymerase II (RNA Pol II). The RNA 
endonucleases Drosha and its cofactor DiGCR8 cleave pri-miRNA to produce 
precursor miRNA that is about 70 nucleotides long. This product is exported to 
the cytoplasm by Exportin 5 where it is cleaved again by the second RNA 
endonucleases Dicer to form the approximately 22nt-long mature miRNA. One 
of the double-stranded miRNA is incorporated to the RNA-induced silencing 
complex, where by imperfect base matching with the 3’UTR and the seed 
region of miRNA, it captures the target mRNA in the complex. This causes 
inhibition of translation by the ribosome. If perfect base pairing with the 3’ UTR 
and the seed region of miRNA, it captures the target mRNA in the complex 
resulting in mRNA degradation. Abbreviations: Pre-miRNA, Precursor 
microRNA; RISC, RNA induced silencing complex; mRNA, messenger RNA; 
DGCR8, DiGeorge Syndrome Critical Region Gene 8 (Adapted from Shilo et 
al., 2007). 
Post-transcriptional 
regulation 
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1.17.5 MicroRNA-mediated control in the Skin and Hair Follicle 
We are currently in the early stages of miRNA research and the role of these 
miRNAs in the body’s largest organ, the skin, is currently being intensely 
investigated. Recent significant findings about the possible roles of miRNAs in 
skin and HF development, which were uncovered initially by Andl and colleagues 
(2006) and Yi and colleagues (2006), may provide important insights that lays the 
foundation for research in areas closely associated with cutaneous biology, 
including wound healing, skin ageing, skin carcinogenesis, angiogenesis 
research, and HF development and cycling.  
 
Pioneering work initially carried out by Andl and colleagues (2006) and 
subsequently Yi and colleagues (2006) attempted to determine whether Dicer is 
essential for the development of HFs and/or epidermis. Dicer is one of the key 
enzymes in the processing of miRNA to functional mature miRNA. Ablation of 
Dicer arrests mechanisms triggered by mature miRNA.  It was first discovered by 
in situ hybridization of mouse embryos and mouse literates that Dicer is present 
in both epidermis and HF ORS. Keratinocyte-specific deletion of the Dicer gene 
was carried out in mice. Dicer mutant mice were at first indistinguishable from 
control mice group. However, by postnatal day 7, mice were characterised by 
stunted HFs, which lacked external hair growth. Evagination of the epidermis by 
HFs and replacement of HFs by cyst-like structures of epithelial cells within the 
dermis was observed in Dicer mutant mice. In addition, expression of the 
progenitor cell marker Keratin 15 was absent in the skin of newborn Dicer mutant 
(Andl et al., 2006; Yi et al., 2006). 
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In contrast to decreased proliferation in the HF, Dicer mutant mice showed 
hyperproliferative epidermis, with abnormal expression of basal and suprabasal 
specific keratins (i.e, Krt14) compared with control mice. Dicer mutant mice also 
showed reduced expression of Shh and Notch1, which were previously identified 
as important regulators of HF development. Shh was shown to regulate follicular 
proliferation and down growth of HFs. Notch1, regulates the maintenance of IRS 
precursors and epidermal proliferation (Nicolas et al., 2003; Pan et al., 2004) and 
inactivation of Notch1 in the skin was shown to lead to almost complete hair loss 
followed by cyst formation (Vauclair et al., 2005). 
 
To identify HF-specific miRNAs, global analysis of miRNAs expression was 
performed in transgenic mice overexpressing Dkk1, a potent inhibitor of the Wnt 
signalling pathway. Dkk1 transgenic mice are characterised by altered HF 
development (Andl et al., 2006), therefore this model was chosen for the 
identification of miRNAs, which could possibly be involved in the control of HF 
development.  Expression of several miRNAs, in particular, miR-200b and miR-
196a, have emerged in the skin of Dkk1 transgenic mice suggesting their 
importance for HF development (Andl et al., 2006).  
 
Research work carried out by Yi and colleagues (2006) further explored the role 
of miRNA in mouse skin during HF development. They discovered that many 
miRNAs are differentially expressed by epidermal and HF keratinocytes. These 
findings support the current belief that target mRNAs in the skin are efficiently 
regulated by miRNAs (Andl et al., 2006; Yi et al., 2006).  
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Following studies of Dicer knockout mice, Yi and colleagues (2009) knocked out 
the essential co-factor DGCR8 of the miRNA processing machinery. Similar to 
Dicer-deficient mice, DGCR8 knockout animals showed elevated apoptosis in 
skin epithelium and evaginated HFs. Severe defects in epidermal differentiation 
and barrier formation leading to dehydration and neonatal death (Yi et al., 2009). 
These studies demonstrate that miRNAs play a critical role in skin 
morphogenesis and HF development. 
 
Recently, miR-203 was identified as a keratinocyte-specific miRNA in the skin (Yi 
et al., 2008; Lena et al., 2008). These studies showed miR-203 by targeting p63 
restricts epidermal proliferation and induces epidermal differentiation and 
therefore, miR-203 defines a molecular boundary between proliferation and 
differentiation in epidermal suprabasal cells. 
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1.17.6 MicroRNAs and skin disorders  
1.17.6.1 MiRNAs and skin cancer 
Many miRNAs have been implicated in targeting mRNAs, which are involved in 
cell proliferation, differentiation and apoptosis (Bartel et al., 2004; Gregory and 
Shiekhattar, 2005). These biological processes are commonly altered during the 
development of skin disorders including skin cancer. To identify a potential role of 
global miRNAs in skin tumourigenesis, Kumar and colleagues (2007), inhibited 
maturation of all miRNAs by targeting three essential miRNA processing 
regulators: the two endonucleases (Dicer and Dorsha) and Drosha processing 
partner DiGCR8 in cancer cell lines. They found that abrogation of global miRNA 
processing machinery leads to transformed cell phenotype and more invasive 
tumours compared with controls (Kumar et al., 2007). This study has further 
enhanced our understanding of the global impact of elimination of miRNAs and 
its possible anti-invasive and anti-metastasis abilities in several cancer cell lines. 
However, the role of miRNAs in skin disorders and skin tumourigenesis is still in 
its infancy (Kumar et al., 2007). Particularly, a role of individual miRNAs in skin 
pathobiology remains unknown. 
 
MiRNA-21 is one of the most upregulated miRNAs in a number of cancer 
profiling experiments and has been shown to be upregulated in majority of 
cancer cell lines tested to date (Tong and Nemunaitis, 2008). In the skin, miR-21 
has been shown to be also upregulated in some inflammatory skin disorders 
such as psoriasis and atopic eczema (Sonkoly et al., 2007; Friedland, et al., 
2009; Zibert et al., 2010). Furthermore, miR-21 was shown to be overexpressed 
in several tumours, including melanoma (Lu et al., 2008) and has been 
implicated in squamous cell carcinoma (SCC). SCC is an extremely common 
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skin cancer (Glick et al., 2005) and even though increased understanding and 
improved prevention strategies are currently being employed, SCC still continues 
to rise worldwide. Dziunycz and colleagues (2010) showed elevated expression 
of miR-21 in SSC suggesting that miR-21 may regulate SCC formation, 
contribute to development and/or progression of SCC (Dziunycz et al., 2010). 
 
Recently, miR-21 has been identified as a crucial functional target of several anti-
tumourigenic pathways. For example, BMP-6 exerts its anti-metastasis effect by 
a mechanism involving transcriptional repression of miR-21 in breast cancer (Du 
et al., 2009). MiR-21 regulation was demonstrated in response to BMP signalling 
initially during normal development and homeostasis of the vasculature (Davis et 
al., 2008). In addition, miR-21 has been identified as a direct regulator of BMPRII 
expression and deregulation of BMPRII, leads to prostate cancer progression (Ye 
et al., 2007; Qin et al., 2009).  
 
1.17.6.1 MiRNAs and skin inflammatory diseases 
Psoriasis is a common chronic inflammatory skin condition characterized by 
accelerated keratinocyte proliferation, reduced apoptosis and epidermal 
infiltration of inflammatory cells that leads to the formation of skin plaques. TNF-α 
is a pro-inflammatory cytokine shown to play an important role in the 
pathogenesis of psoriasis (Ettehadi et al., 1994). Recent studies have shown a 
possible involvement of miRNAs in the pathogenesis of chronic inflammatory skin 
diseases such as psoriasis and atopic eczema. Three miRNAs have been 
implicated so far in these skin disorders, including: miR-203, miR-146a and miR-
125b. MiR-203 was the first miRNA to be implicated in the pathogenesis of 
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psoriasis by regulating inflammation, proliferation and morphogenesis-associated 
processes in the skin (Chen et al., 2004; Sonkoly et al., 2007). Activator of 
transcription 3 (STAT3) has been shown to be constitutively activated in 
epidermal keratinocytes of human psoriatic lesions (Sano et al., 2005). Following 
genome-wide analysis of miRNA expression, upregulation of miR-203 was 
shown to lead to downregulation of suppressor of cytokine signalling-3 (SOCS-3) 
expression in psoriatic skin. SOCS-3 is an inhibitor of the signal transducer and 
STAT3 pathways (Sonkoly et al., 2008). Therefore, targeting of miR-203 may 
lead to inhibition of STAT3 and potentially improving clinical prognoses in 
psoriatic patients (Sano et al., 2008).  
 
In addition to miR-203, miR-146a has also been shown to be overexpressed in 
many psoriatic skin lesions (Sonkoly et al., 2008). MiR-146a was shown to target 
the TNF receptor-associated factor 6 (TRAF6) and IL-1R-associated kinase 
(IRAK), all of which are all involved in the TNF-α pathway, which contributes to 
psoriatic skin inflammation. It was discovered the expression of miR-146a was 
NFkappaβ-dependent (Taganov et al., 2006). In addition, it was shown that 
NFkappaβ activation resulted in the inhibition of TNF-α-induced apoptosis, which 
may be regulated by miR146a overexpression, potentially contributing to the 
pathogenesis of psoriasis (Tang et al., 2001). MiR-125b expression has been 
shown to be down-regulated in psoriasis (Sonkoly et al., 2008). MiR-125b is 
involved in post-transcriptional repression of TNF-α. MiR-125b downregulation 
reduced inhibitory effect on TNF-α (Sand et al., 2009). Furthermore, several 
other miRNAs have been implicated in human melanoma (Philippidou et al., 
2010) and atopic dermatitis (Sonkoly et al., 2010). Recent global microarray 
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profiling revealed that miR-155 was upregulated in human melanoma and atopic 
dermatitis compared with relatively low expression detected in normal skin 
(Philippidou et al., 2010; Sonkoly et al., 2010).  
 
Taken together, miRNAs are important players involved in the control of skin and 
HF development and deregulation of the expression of miRNAs in skin leads to 
the development of skin and HF disorders. 
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Aims 
HF development and growth involves all the important physiological processes 
found in the human body. These include interactions between different cell types, 
proliferation, migration, controlled cell growth, cell differentiation and cell death. 
As a consequence, the importance and value of the HF as a model for scientific 
research is way beyond its scope for cutaneous biology or dermatology alone 
(Tobin, 2005).  
 
MiRNA research in the area of dermatology is relatively new.  MiRNAs have 
been investigated intensely in dermatological research areas recently, leading to 
many intriguing discoveries (Yi and Fuchs, 2009). The elucidation of the 
molecular mechanisms that regulate skin and HFs homeostasis may provide 
new insights into the management and effective treatment of several skin and HF 
disorders and cancers. 
 
This project investigates the role of miRNAs using HF as a model and examines 
the expression levels and location of certain miRNA during HF morphogenesis, 
HF growth/cycling, and tumourigenesis in murine skin.  This will be relevant to 
researchers investigating the fundamentals principles of organogenesis, 
oncogenesis, growth and regeneration of skin and HFs.   
 
Therefore, the aims of this study were i) to define changes in the miRNA profiles 
in skin during hair cycle-associated tissue remodelling, ii) to determine the role of 
individual miRNAs in regulating gene expression programs that drive HF growth, 
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involution and quiescence, iii) and to explore the role of miRNAs in mediating the 
effects of BMP signalling in the skin. 
 
 
  
 
 
 
Chapter II 
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2.0 Materials and Methods 
2.1 Animals 
All animal work was performed under the project license of Professor Vladimir 
Botchkarev and carried out by Dr Andrei Mardaryev (University of Bradford, UK). 
Mice had free access to food (standard rodent diet) and tap water. The animal 
room was maintained under continuous 12-hour light and dark cycles with 
temperature and humidity at 21±1oC and 40-60%, respectively.   
 
C57BL/6 mouse model was used for all animal experiments, under several 
different experimental conditions. Each control and experimental groups 
contained at least five mice per treatment/time point, which were harvested 
according to accepted practises (Paus et al., 1999). Skin samples were collected 
from mice at postnatal days 12-23 (P12-P23). To induce hair cycle, depilation of 
the back skin was performed by applying very briefly a hot wax/rosin mixture on 
the dorsal skin of 7-week old mice followed by plucking of hair shafts by 
wax/rosin mixture, which induces homogeneous anagen development over the 
entire depilated back of the mouse.  After the induction of  full anagen in 
depilated back skin, the consecutive stages (catagen and telogen) spontaneously 
occur, in a fairly homogeneous manner (Muller-Rover, et al., 2001). In depilated 
induced cycle: skin were harvested at the telogen stage of the hair cycle 
(unmanipulated skin), as well as at anagen II [3 days post depilation (dpd)], 
anagen IV (5 dpd), anagen VI (8-12dpd), and catagen (16,19 dpd), using ≥5 
mice/time point. 
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Harvested skins were covered in embedding OCT-mounting medium (Tissue-
Tek®, CA USA) and then frozen by adding to liquid nitrogen (Paus et al., 1999). 
 
Transgenic mice overexpressing BMP antagonist noggin (under K14 promoter) 
were generated on FVB background by a construct containing mouse noggin 
cDNA (kindly provided by R. Harland) and human growth hormone poly-A 
sequence as it was described previously (Sharov et al., 2009). 
 
2.1.1 Chemically induced skin carcinogenesis in mouse skin: 
The mouse skin model represents one of the best-established in vivo models for 
the study of the sequential and stepwise development of tumours. Scientists 
have been able to use this model for multi-stage chemical skin carcinogenesis to 
evaluate both novel skin cancer prevention strategies, and genetic manipulation 
on tumour initiation, promotion and progression in the skin (DiGiovanni, 1992; 
Abel et al., 2009). Here we have used a two-stage protocol for mouse skin 
tumourigenesis. FVB 8-week-old mice were exposed to a single dose of 
subcarcinogenic of DMBA (250µg/ml) (Sigma, Sigma, St. Louis, MO, USA), 
followed by the applications of TPA (40μg/ml) (Sigma, Sigma, St. Louis, MO, 
USA) twice a week for up to 15 weeks. FVB mice were chosen as these mice 
were shown to be more sensitive to chemical induction of SCC of the skin 
(Hennings et al., 1993).  Skins were collected at day 0 (untreated), 15 and 28 
weeks after the beginning of the experiment.  
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2.1.2 Pharmacological experiments and morphometric analyses: 
Synthetic miR-31 inhibitor (anti-miR-31) or inhibitor negative control (Dharmacon 
Inc, USA) was administered subcutaneously to back skin of 8-week-old C57BL/6 
mice in concentration 20 µM using AteloGene kit (Koken Co, Japan), a system 
which provides local sustained, slow-releasing oligonucleotide delivery 
(Minakuchi,et al., 2004;Takeshita et al., 2005). In the first experiment, anti-miR-
31 treatment was performed on 1, 2, 3, and 4 dpd (days of post depilation), and 
skin samples were collected on 5 dpd. In the second experiment, anti-miR-31 
was administrated on 4, 5, 6, and 7 dpd, and skin was harvested on 8 dpd. In 
each experiment, ≥4 or 5 mice/time point were used for analyses in both 
experimental and control groups. Collected samples were processed for 
morphometric, histological, and biochemical analyses. In control and anti-miR-31 
treated skin, HF morphology and staging was carried out by examining at least 
50 different HFs per mouse. Alkaline phophatase detection method was used, 
because it allows precisely the identification of the defined stages of HF cycling 
by staining the DP (Handjiski et al., 1994).  
 
2.2 Cell culture 
2.2.1 Culturing of Primary mouse epidermal keratinocytes: 
Primary mouse epidermal keratinocytes (PMEKs) were prepared from newborn 
mice at P1-3, as described elsewhere (Lichti et al., 2008). PMEKs were grown in 
Eagle's minimum essential medium (EMEM) calcium-free medium (Lonza, 
Slough, UK) supplemented with 0.05mM calcium, at 33°C, 8% CO2 (Scientific 
Laboratory Suppliers, Hessle, UK) until 60–70% confluent.  
2.0 Methods and Materials 
Exploring molecular mechanism controlling skin homeostasis and hair growth: MicroRNAs in 
Hair-cycle-Dependent Gene Regulation, Hair Growth and Associated Tissue Remodelling   
  
P a g e  | 79 
 
2.2.2 Culturing of HaCaT cells: 
HaCaT cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) 
(Lonza, Slough, UK) supplemented with heat-inactivated 10% FBS (Sigma, St. 
Louis, MO, USA), 5% L-glutamine (Sigma, St. Louis, MO, USA) and 10mg/ml of 
antibiotics (Sigma, St. Louis, MO, USA) at 37°C, 5% CO2 (Scientific Laboratory 
Suppliers, Hessle, UK) until 60–70% confluent. 
 
2.2.3 Experimental transfection and treatment of primary mouse epidermal 
keratinocytes: 
To define the effects of the loss or gain of selected miRNAs activity on the 
keratinocytes, PMEKs were transfected with 200nM synthetic miR-31 inhibitor 
(anti-miR-31), miR-31 mimic (pro-miR-31), miR-21 mimic (pro-miR-21), miR-214 
mimic (pro-miR-214) or miRNA negative controls (Dharmacon Inc, USA), 
respectively, using Lipofectamine RNAiMax (Invitrogen, UK). Lipofectamine 
RNAiMAX and synthetic miRNAs mixture were incubated for 20mins at room 
temperature in a ratio of 2:1 and subsequently added to PMEKs and incubated 
for 4 hours at 33°C, 8% CO2. Cells were harvested 24 hours after transfection 
and used for further analyses.  
 
2.2.3.1 Lithium chloride (LiCl) treatment of keratinocytes: 
To activate Wnt signalling in the keratinocytes, 10mM LiCl was added for 2 hours 
(Klein and Melton, 1996), followed by transfection of cells with 200nM pro-miR-
214 as described above (step 2.2.3) for 4 hours at 33°C, 8% CO2. Cells were 
then harvested 24 hours after transfection. 
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2.2.3.2 BMP4 treatment of keratinocytes: 
PMEKs were treated with 100ng/ml of BMP4 (R&D system, UK) for 4 and 12 
hours and collected for further analysis as described previously (Fessing et al., 
2010).  To explore the regulatory effects of miR-21 on BMP-induced gene 
expression, PMEKs were transfected with 200nM synthetic pro-miR-21 or miRNA 
negative controls as described above (step 2.2.3) for 4 hours. Next, after quick 
wash in PBS, cells were treated with 100ng/ml of BMP4 for 4 hours at 33°C, 8% 
CO2. This was followed by their harvesting for total RNA isolation 
 
2.3 RNA Isolation and Microarray analysis 
2.3.1 Isolation from the skin: 
Total RNA was isolated from snap frozen experimental samples by using 
miRNeasy kit (Qiagen, Crawley, UK).  One ml of Qiazol RNA isolation reagent 
(Sigma, St Louis, MO, USA) was added to 50mg of tissue for lysis, and RNA was 
isolated following manufacturer’s instructions.  For miRNA microarray analysis in 
the skin, 5µg of RNA was used. Total RNA was isolated from the skin of neonatal 
mice at postnatal days 12-15 (P12-P15), i.e. when HFs complete morphogenesis 
and actively produce hair (anagen-like stage), as well as at P16-P17 and P20-
P23 (i.e., during catagen and telogen stages, respectively) (Paus et al., 1999).  
MiRNA microarray analysis was performed by LC Sciences, (Houstan, Texas, 
USA). 
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2.3.2 Isolation from cultured keratinocytes: 
Total RNA was isolated from PMEKs by using miRNeasy kit.  One ml of Qiazol 
RNA isolation reagent was added to 1 x107cells for lyses, and RNA was isolated 
following manufacturer’s instructions. MiRNA microarray analysis was performed 
by LC Sciences. mRNA microarray analysis was performed by Mogene Co. (St. 
Louis, MO, USA) using 41K Whole Mouse Genome 60-mer oligo-microarray 
(manufactured by Agilent Technologies). 
 
2.4 Real Time PCR 
2.4.1 Principles 
Real-time PCR allows the possibility of detecting and measuring the amplified 
product as the reaction is progressing, that is in “Real Time”. This is in contrast to 
conventional PCR, where the amplified product is only possibly detected by an 
end-point analysis by running amplified DNA on an agarose gel, until after the 
reaction has finished. There are a number of fluorescence molecules that can be 
used for real time PCR to measure DNA product levels. These include: DNA-
binding dyes such as, SYBR GREEN® and fluorescently labelled sequence 
specific primers, TaqMan Assay®. Each Real-Time PCR machine is equipped 
with specialized thermal cyclers with fluorescence detection modules, which are 
capable of monitoring the fluorescence signal as amplification occurs. The 
measured fluorescence is proportional to the amount of amplified product in each 
cycle.  At first, the fluorescence signal is not detected even though the product of 
interest is accumulating exponentially but eventually enough amplified product 
will be produced to produce a detectable signal. This is known as threshold cycle 
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(Ct).  Ct is measured during the exponential phase and is determined by the 
amount of template at the start of the amplification phase (McPherson and 
Møller, 2006). Ct was used to determine the relative expression of target genes in 
experimental samples. 
 
2.5 Analysis of miRNA expression 
2.5.1TaqMan Real Time PCR 
2.5.1.1 Principle: 
cDNA synthesis of miRNA requires a specialised novel stem loop Reverse 
Transcription (RT) primer during reverse transcriptase reaction. This stem loop 
RT primer overcomes the fundamental problem of miRNA being very short 
(approx. 22nt long). The TaqMan® Assay kit (Applied Biosystems, Foster city, 
CA, USA) overcomes this problem by extending the 3’ end of the mature miRNA, 
via binding of RT primer, therefore, providing a longer reverse transcription 
product suitable for real time PCR (Chen and Guegler, 2007; Schmittgen et al., 
2008). 
 
 
2.5.1.2 TaqMan complementary DNA (cDNA) Synthesis: 
RNA was isolated from cells or tissue samples using Qiazol lysis reagent 
(Qiagen, Crawley, UK) as described above (step 2.3) followed by DNase I 
treatment and purification on RNeasy columns, as following the manufacturer’s 
instructions. cDNA was synthesised using TaqMan® Assay Kit (Applied 
Biosystems, Foster City, CA, USA) following manufacturer’s instructions. The 
following master mix was made up for each reverse transcription reaction: 
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100mM of dNTPs, 1µl of multiscribe reverse transcriptase, 1.5µl 10x reverse 
transcriptase buffer, 0.19µl RNase inhibitor (20units/μl) and 4.6µl water. 7μl of 
this master mix was combined with 5ng of total RNA. This was mixed gently and 
3μl of RT primer (Applied Biosystems, Foster City, CA, USA) assay was added to 
reaction mix followed by brief centrifugation. cDNA was synthesised using a 
Master Cycler gradient machine (Eppendorph, Cambridge, UK) under the 
following cycling conditions: 16°C for 30 minutes, followed by 42°C for 30 
minutes and 85°C for 5 minutes. 
 
2.5.1.3 TaqMan real-time PCR procedure for detection miRNA expression: 
Real-time PCR was performed using TaqMan® Real Time PCR Assay kit 
(Applied Biosystems, Foster City, CA, USA) and MyiQ single-colour real-time 
PCR detection system (Bio-Rad Corp, UK). Each TaqMan® qRT-PCR consisted 
of 1µl TaqMan Real Time PCR Assay (Applied Biosystems, Foster City, CA, 
USA), 10µl TaqMan 2X Universal PCR Master Mix (Applied Biosystems, Foster 
City, CA, USA), 1.33µl of cDNA template and 7.67µl of water. Real-time PCR 
was performed under the following cycling conditions:  95°C for 10 minutes, 
followed by 40 cycles of 95°C for 15 sec and 60°C for 1 minute. QRT-PCR was 
performed in triplicates.  Differences between samples and controls were 
calculated using the Genex database software (Bio-Rad Corp, UK) based on the 
Ct (∆∆Ct) Livak equitation method and normalized to the corresponding Small 
nucleolar RNA 202 values (SnoRNA). SnoRNAs are constitutively expressed 
across all tissues; the use of same assay chemistry and RNA isolation protocols 
makes snoRNAs ideal candidates for normalization of miRNA expression (Chen 
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and Guegler, 2007). Data were pooled, mean ± SEM was calculated, and 
statistical analysis was performed using unpaired Student's t test.  
 
2.6 Analysis of mRNA expression 
2.6.1 First-strand qRT-PCR: 
RNA was isolated from the cells or tissue as described above (step 2.3). For RT-
PCR, 1µg of each RNA sample was used as a template for cDNA synthesis 
using Superscript III first-strand synthesis system (Invitrogen, Paisley, UK), 50ng 
of random hexamers and 1µl of water. The mixture was incubated in a thermal 
cycler at 65°C for 5 minutes, and then immediately place on ice for at least 1 
minute. The following was added to the mixture (on ice): 10μl of 2X First-Strand 
Reaction Mix and then 2μl of Superscript™ III/RNaseOUT™ Enzyme Mix. The 
following cycling conditions were used: 25°C for 10mins, followed by 50°C for 50 
minutes, and termination at 85°C for minutes.  
 
2.6.2 Real-Time PCR: 
QRT-PCR was performed with iQ SYBR Green Supermix (Bio-Rad Corp, UK), 
using 10ng cDNA and 1uM primers. PCR primers were designed with Beacon 
Designer software (Premier Biosoft International; Table 1). Amplification was 
performed at the following conditions: 95°C for 5 min, followed by 40 cycles of 
denaturation (95oC for 15 sec), annealing (30 sec at temperature experimentally 
determined for each primer pairs) and elongation (72o C for 15 sec). For each 
gene of interest, qRT-PCR was performed in triplicates. Differences between 
samples and controls were calculated using the Genex database software (Bio-
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Rad Corp, UK) based on the Ct (∆∆Ct) equitation method and normalized to the 
corresponding Glyceraldehyde 3 phosphate dehydrogenase (GAPDH). Data 
analysis was performed as described above. Data were pooled, mean ± SEM 
was calculated, and statistical analysis was performed using unpaired Student's t 
test.  
 
Table 1: List of primer sequences for qRT-PCR 
Accession 
Number 
Sequence Definition Sense/Anti-sense Primers 
 
NM_015732 
 Axin2 
CACCTCTCCTCTGTTACCTTC 
GTCAACGCTCTGCCCTAC 
 
NM_026505 
BMP and activin 
membrane-bound 
inhibitor (BAMBI) 
TCCTGTATCTGTTTCCTTCCTGAG 
ACTGATGGTGGTGACTGTGTAG 
NM_010055 Distal-less homeobox 3 (Dlx3)  
CCAAATCCACTCCTCTCTG 
GTCTTGCCTGGTCTATCTC 
NM_001165902 
 
Catenin (cadherin 
associated protein), 
beta 1 (Ctnnb1) 
GCCACCAAACAGATACATAC 
CCTCTCAGCAACTCTACAG 
 
NM_0076331 CCND1 (Cyclin D1) TTGGGAGAAGGAGAG CCTGGGAGTCATCGGTAG 
NM_008002 Fibroblast growth factor 10 (FGF10) 
CCACCATGCTGAAGTGTGTTAG 
TTTGAGGATTAGGAGGAGGGAAG 
 
NM_008084 
Glyceraldehyde 3 
phosphate 
dehydrogenase 
(GAPDH) 
CAGTGAGCTTCCGGTTCA 
CTGCACCCAGAAG 
NM_010495 
 
Inhibitor of DNA 
binding 1 (Id1) 
GCATCTTGTGTCGCTGAG 
AGGCTGAAAGGTGGAGAG 
 
NM_010496 
 
Inhibitor of DNA 
binding 2 (Id2) 
GCCATTTCACCAGGAGAAC 
AATAACGGTATCACAGTCCAG 
 
NM_008321 Inhibitor of DNA binding 3 (Id3) 
GCATGGATGAGCTTCGATCTTAAC 
CTTCTCTCGGGCTCCAGGTC 
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NM_016958 Keratin 14 (Krt1-14) CCACCTTTCATCTTCCCAATTCTC GTGCGGATCTGGCGGTTG 
NM_008470 Keratin 1-16 (Krt1-16) AATATCCACTCCTCCTCAC GTTGAACCTTGCTCCTTG 
NM_010663 Keratin 1-17 (Krt1-17) ACCTGACTCAGTACAAGCC CCTTAACGGGTGGTCTGG 
NM_001042660 
 
MAD homolog 7 
(Drosophila) (Smad7) 
CGTGTGTCCCGCTTGTCTTG 
ACTCTCGTTTCCTGTCTTCGTATATG 
 
NM_013601 
 Msh-like 2 (Msx2) 
CGCCTGTTGGACTCTATG 
TCGCTTAGGGTGACAATG 
 
NM_010849 
 
Myelocytomatosis 
oncogene (Myc) 
TGTACCTCGTCCGATTCC 
TCTCCTCATGCAGCACTAG 
 
NM_008960 
 
Phosphatase and 
tensin homolog (Pten) 
ATTGTTGGTGTGAGGATGGTAGG 
AGGTAGGTACGCATTTGCTGAG 
 
 
AJ459711 Precusor-miR-21 
TGTACCACCTTGTCGGATAG 
GATACCAAAATGTCAGACAGC 
AY699265 
 Primary-miR-21 
TCCTAGAATTGGCATTAAGCCCCAG 
ATGTCACGACCACGACAGGG 
NM_001168491 
 
Programmed cell 
death 4 (Pdcd4) 
CCACACTCATACTCTGTTCTTG 
GCCTCCATCTCCTTCACTTAC 
 
NM_024449 Sclerostin (Sost) CGGACCTATACAGGACAAG TAGCCCAACATCACACTC 
NM_011595 
 
Tissue inhibitor of 
metalloproteinase 3 
(Timp3) 
TCGGCTGTTTGGGTTGAG 
CTCTGGCTGGTGTCTCTTC 
 
NM_024427 
 Tropomyosin 1 (Tpm1) 
AGCATTGATGACTTAGAAGAG 
GACTTGGAATCTCAGAAGAC 
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2.7 In Situ Hybridization 
2.7.1 Principle: 
In Situ hybridization (ISH) is a technique, which is applied to localize gene 
expression at the histological level (Dagerlind et al., 1992). Since the first ISH 
generally radioactive nucleotides have been used to synthesize probes. One of 
their major advantages is that radio-labelled probes have the ability to detect very 
low levels of transcripts. However, their major limitations are relatively poor 
resolution, safety hazards associated with ionising radiation and long 
autoradiography exposure times of up to 30 days (Morris et al., 1990). All of 
these disadvantages are dependent on the radioisotope used in the ISH. 
Furthermore, the photographic emulsion showing the hybridization signals is not 
at the same focus as the tissue section, which impairs resolution and microscopic 
observation (Braissant and Wahli, 1998). The recently use of non-radioactively 
labelled nucleotides has significantly improved ISH by shortening the amount of 
time needed for development and provides excellent histological resolution 
(Morris et al., 1990). 
 
Locked Nucleic Acid (LNA) based detection is currently the most applicable for 
rare transcripts. These LNA based detection probes have improved significantly 
the sensitivity to specific miRNA transcripts by increasing the melting 
temperature of the probes, which provides the bases of stringency required for 
ISH procedure (Obernosterer et al., 2007). Obernosterer and colleagues (2007) 
and Silahtaroglu and colleagues (2007),  describe optimised methods/conditions 
for sensitive and specific histological detection of miRNAs by ISH, which were 
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incorporated into our protocol.  These methods were combined with the unique 
miRNA recognition properties of LNA-modified oligonucleotide probes. The 
inclusion of LNAs in oligonucleotides dramatically increases the affinity for their 
RNA targets and enhances mismatch-discrimination capability (Exiqon, 
Copenhagen, Denmark). LNAs, which are bi-cyclic RNA analogs that allow a 
significant, increase in the hybridization temperature and thereby an enhanced 
stringency. Enhanced stringency allowed the use of short probes, which 
previously could not be used due to reduced stringency and thus limiting their 
use in ISH (Obernosterer et al., 2007). 
 
2.7.2 In situ hybridization procedure: 
For miRNA detection on tissue sections, cryosections (10µm) were fixed in 4% 
paraformaldehyde for 10 min at room temperature. After acetylation in 
triethanolamine buffer (4.5 mM triethanolamine, 6 M HCl, and 3 mM acetic 
anhydride) for 10 min and premobilization (1% Triton X-100/1xDEPC treated 
phosphate buffer-saline) for 30 min, slides were hybridized specifically with DIG-
labelled miR-31, miR-21 and miR-214 probes in concentration of 2.5pmol, 
12.5pmol and 2.5pmol, respectively, (Exiqon, Copenhagen, Denmark) diluted in 
hybridization buffer (50% formamide DI, 2xSCC, 1% dextran sulfate, and 0.4 
mg/ml t-RNA) for 16-18h at 50°C overnight. Slides subsequently were washed in 
2x SCC (10 min, 4 times, 67°C), 0.1x SCC (60 min, 67°C), 0.2x SCC (10 min, 
RT). Immunodetection of miRNAs was performed with sheep alkaline 
phosphatase conjugated anti-DIG antibody (1:5000; Roche, Mannheim, 
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Germany) followed by a staining reaction with NBT/BCIP solution (Roche, 
Mannheim, Germany) for 16-18h at room temperature. 
 
2.8 Immunohistochemistry 
For immunohistochemical analyses, formalin-fixed cryostat sections (10µm) of 
mouse back skin were used. The cryosections were incubated with primary 
antisera against Keratin 16 (Abcam, Cambridge, UK; diluted 1:5000), Keratin 17 
(Abcam, Cambridge, UK; diluted 1:5000), and Dlx3 (Santa Cruz, CA, USA; 
diluted 1:100) overnight at +4°C, followed by application of corresponding Alexa-
Cy3 labelled antibody (Invitrogen, UK; diluted 1:200) for 1hr at 37°C.  Incubation 
steps were interspersed by four washes with phosphate buffer-saline (PBS, 5 
min each). Image preparation and analysis were performed using a fluorescent 
microscope (Nikon, Tokyo, Japan) in combination with DS-C1 digital camera and 
ACT-2U image analysis software (Nikon, Tokyo, Japan). 
 
2.9 Immunocytochemistry 
For immunocytochemistry analyses, PMEKs were washed in cold PBS and fixed 
in methanol (at -20°C for 10mins). These cells were incubated with primary anti-
sera against rabbit β-catenin (Abcam, Cambridge, UK; diluted 1:2000), overnight 
at +4°C, followed by application of anti-rabbit Alexa-Cy3-labelled antibody 
(Invitrogen, UK; diluted 1:200) for 1 hour at 37°C. Keratinocytes were counter 
stained with DAPI (4', 6-diamidino-2-phenylindole). Incubation steps were 
interspersed by four washes with PBS (5 min each). Image preparation and 
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analysis were performed using a fluorescent microscope in combination with DS-
C1 digital camera and ACT-2U image analysis software. 
 
2.10 Multicolour fluorescence 
2.10.1 Fluorescent in situ hybridization (FISH) and β-catenin 
immunofluorescence: 
For miR-214 detection on tissue sections (E13-P2.5), cryosections (10µm) were 
fixed in 4% paraformaldehyde for 10 min at room temperature. After acetylation 
in triethanolamine buffer (4.5 mM triethanolamine, 6 M HCl, and 3 mM acetic 
anhydride) for 10 min and premobilization (1% Triton X-100/1xDEPC treated 
PBS) for 30 min, slides were hybridized with 2.5 pmol DIG-labelled miR-214 
probe (Exiqon, Copenhagen, Denmark) diluted in hybridization buffer (50% 
formamide DI, 2xSCC, 1% dextran sulfate, and 0.4 mg/ml t-RNA) for 16-18h at 
50°C overnight. Slides subsequently were washed in 2x SCC (10 min, 4 times, 
67°C), 0.1x SCC (60 min, 67°C), 0.2x SCC (10 min, RT). Next, sections were 
incubated with primary anti-sera against rabbit β-catenin (Abcam, Cambridge, 
UK; diluted 1:2000) and sheep anti-DIG-conjugated-TRITC antibody (1:50; 
Roche, Mannheim, Germany) overnight at +4°C, followed by application of anti-
rabbit Alexa488-labelled antibody to detect β-catenin (Invitrogen, UK; diluted 
1:200) for 1 hour at 37°C. All incubation steps were interspersed by four washes 
with PBS (5 min each). Image preparation and analysis were performed using a 
fluorescent microscope in combination with DS-C1 digital camera and ACT-2U 
image analysis software. 
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2.11 Flow cytometry analysis 
PMEKs were transfected with 200nM anti-miR-31, pro-miR-31, or miRNA 
negative controls (Dharmacon Inc, USA) as described above (step 2.2.3). After 
24 hours of transfection, the medium was removed, and cells were washed twice 
with PBS, and then trypsinized. Pellets were then fixed in 70% ethanol in PBS (at 
-20°C for 30 min). The cell suspension was centrifuged at 2000 rpm and 
resuspended in PBS containing propidium iodide (400µg/ml; Sigma, St. Louis, 
MO, USA) and RNase A (10 mg/ml; Invitrogen, UK) at 37°C for 30 min. Vials 
were placed on ice before analysis. Flow cytometry analyses were performed 
using a FACS-Calibur flow cytometer (BD Biosciences; San Jose, CA, USA). 
Data obtained were analyzed using the CellQuest software (BD Biosciences; San 
Jose, CA, USA). 
 
2.12 Alkaline Phosphatase staining 
Alkaline phosphatase staining was performed on 10μm cryosections fixed in 
acetone (at -20°C for 10 mins). The sections were incubated in developing 
solution (100 mM NaCl pH 8.3, 100 mM Tris, pH 9.5 and 20 mM HCL, 0.05% 
Naphtol ASBI phosphate, 0.5% DMF, 25 mM Na-Nitrite, and 5% New fuchsin) for 
15 mins at room temperature. Sections were then counterstained with 
haematoxylin for 20s at room temperature, followed by washing with running 
water.  
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2.13 Western blot analysis 
Proteins were extracted from snap-frozen skin samples or cultured cells using 
RIPA lysis buffer (Appendixes B). Proteins were processed for Western blot 
analysis by adding 100µl of RIPA lysis buffer to either 1 x 107 cells and/or 50mg 
of tissue. This was followed by homogenisation of mixture by vortexing and 
spinning down at 1000rpm for 5min at +4°C. The supernatant was removed and 
Bradford assay was performed to determine protein concentration. Five 
micrograms of protein were separated on Sodium dodecyl sulphate 
polyacrylamide (SDS-PAGE) gel electrophoresis at 100 volts for 1hr 30mins. This 
was followed by transferring proteins (transblotting) to nitrocellulose membrane 
(Bio-Rad Corp, UK) for 20min at 400mAmps (for buffers and reagents see 
Appendixes B). Proteins were incubated with primary antibodies (Table 2) 
overnight at +4°C. Corresponding horseradish peroxidase-tagged IgG antibodies 
were used as secondary antibody (1:5000; Thermo Scientific, UK). Antibody 
binding was visualized with an enhanced chemiluminescence’s system 
(SuperSignal West Pico Kit; Thermo Scientific, UK) and autoradiographed with X-
ray film (CL-Xposure Film, Thermo Scientific, UK). Densitometric analysis was 
performed by measuring the intensity of staining of β-actin and target proteins, 
which in turn correlates with the amount of the protein detected. This was carried 
out using Total Lab v1.10 software (Biogenetic Services, Brookings, SD, USA). 
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2.14 Luciferase reporter assay 
HaCaT cells were grown in DMEM supplemented with heat-inactivated 10% fetal 
bovine serum in an atmosphere of 5% CO2 at 37°C, until 60-70% confluent. 
3’UTR fragments containing miRNA specific putative binding sites (Table 3) were 
amplified from mouse genomic DNA using forward and reverse primers 
containing XhoI and NotI restriction sequences, respectively. The following 
primers were used:  
 
 
 
 
 
Antigen Host Dilution Manufacturer 
Actin Mouse  monoclonal 
1:2000 Abcam, 
Cambridge, UK 
FGF10 Goat  polyclonal 1:2000 Abcam, Cambridge, UK 
K14 Mouse  monoclonal 
1:3000 Biomeda, Foster 
City, CA, USA 
K16 Rabbit   polyclonal 1:3000 Abcam, Cambridge, UK 
K17 Rabbit   polyclonal 1:3000 Abcam, Cambridge, UK 
Scelrostin Rabbit  polyclonal 1:50 Abcam, Cambridge, UK 
β-catenin Rabbit   polyclonal 1:2000 Abcam, Cambridge, UK 
 Table 2: List of primary antibodies used in Western blot  
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These amplified fragments were cloned at XhoI and NotI sites downstream of 
CV40 promoter-driven Renilla luciferase cassette in psiCHECK2 (Promega, 
Madison, WI, USA). For dual luciferase assay, these constructs (200ng) were co-
transfected with 200nM pro-miR-31, pro-miR-21, pro-miR-214 or control 
oligonucleotide (Dharmacon Inc, USA) into HaCaT cells using 0.5 µl 
Lipofectamine 2000 (Invitrogen, UK) in 96-well plates. As an additional negative 
control, HaCaT cells were transfected with miRNAs, which did not contain 
Target Sequence  Sense/Anti-sense Primers 
Keratin 14 3’UTR GGGCTCGAGAGATCCGCACCAAGGTCAT TTTGCGGCCGCGCAACTCAGAAAAAGAAGC 
Keratin 16 3’UTR GGGCTCGAGGTCCATCCTCAAGGAGCAAG TTTGCGGCCGCCCAAAAAGCTTTATTAGCCTACC 
Keratin 17 3’UTR GGGCTCGAGGCTGCAGAGAGGCAGCTTCCCT TTTGCGGCCGCCGACGTCTCTCCGTCGAAGGGA 
FGF10 3’UTR GGGCTCGAGTGACGATCCAAACATAGAAG TTTGCGGCCGCGCTTTCCAGTAAATGCTTG 
Dlx3  3’UTR AATCTCCCTCCCCTTGCTTA ACACTCTGGCTCCCATTTTG 
Sclerostin 3’UTR GGGCTCGAGTTTCTACACAACAGTTTAAGG TTTGCGGCCGCATTAACAATGCCTCTGGTC. 
β-catenin 3’UTR 
(binding site 1) 
CGAGGAGTAACAATACAAATGG 
TGTTATGTTCTAGTGAACCTG 
β-catenin 3’UTR 
(binding site 2) 
GCGGTAGGGTAAATCAGTAAGAG 
CGCATCTGTTGAAGCATTGTATC 
 
Smad7 3’UTR 
(binding site 1) 
AGTCACAGTATTGCTACC 
AAGAACAGTGTCAAAGTATC 
 
Smad7 3’UTR 
(binding site 2) 
TGACACTGTTCTTAGCTCAATGAG 
GTCCTTTCCTCTCTCAAAGCAC 
 
Table 3: Primer sequences of amplified fragments for reporter gene assays 
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putative binding sites for gene of interest; such as pro-miR-31 was used with 
psiCHECK2 plasmids containing Smad7 3’UTR binding site, while pro-miR-21 
was used to test the specificity of miR-214 binding to the  β-catenin 3’UTR. At 24 
hours after transfection, the relative luciferase activities were determined using 
Dual-Glo® Luciferase Assay System (Promega, Madison, WI, USA) on the Infinite 
2000 micro-plate reader (Tecan, Reading, UK). 
 
The effects miR-214 on Wnt/β-catenin mediated transcriptional activation of 
TCF/Lef  binding sites in HaCaT cells was done as described previously 
(Veeman et al., 2003), using TOPflash plasmid (Addgene, Cambridge, MA, USA; 
Addgene plasmid 12456). For dual luciferase assay, PMEKS were co-transfected 
with TOPflash plasmid (200ng) and with 200nM pro-miR-214 or control 
oligonucleotide (Dharmacon Inc, USA) into HaCaT cells using 0.5 µl 
Lipofectamine 2000 (Invitrogen, Paisley, UK) in 96-well plates. Four experimental 
groups were used: 1) untreated cells (control), 2) transfection with control 
oligonucleotide, 3) treatment with 10mM of LiCl, and 4) combination of 
transfection with pro-miR-214 and 10mM LiCl treatment. At 24 hours after the 
beginning of the experiment, the relative luciferase activities were determined 
using Dual-Glo-luciferase assay system on the Infinite 2000 micro-plate reader. 
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3.1. Hair cycle-associated changes in the miRNA signature in the skin 
 
3.1.1 MicroRNA microarray profiling  
 
To identify the changes in the miRNA expression in the skin and hair follicle (HF) 
during distinct stages of the hair cycle in mice (i.e., during anagen or period of 
active growth and hair production, catagen or stage of apoptosis-driven involution, 
telogen or period of relative resting), global microarray analysis of miRNAs was 
performed as described previously (Singh et al., 2008). Total RNA was isolated 
from the skin of neonatal mice at postnatal days 12-15 (P12-P15), i.e. when HFs 
complete morphogenesis and actively produce hair (anagen-like stage), as well as 
at P16-P19 and P20-P23 (i.e., during catagen and telogen stages, respectively) 
(Paus et al., 1999).   
 
Global miRNA expression profiling revealed the substantial hair cycle-associated 
changes in the expression of a large number of miRNAs in the skin (Fig. 6A). In 
particular, expression of 219 out of 568 miRNAs analyzed showed significant 
(p<0.01) differences between the distinct hair cycle stages (Appendixes A). Among 
these miRNAs, a largest proportion showed significant changes in expression 
between the anagen and telogen skin, while relatively lower number of miRNAs 
displayed differences in expression between anagen and catagen, as well as 
between the catagen and telogen stages of the hair cycle (Fig. 6B).  
Anagen Catagen Telogen
P12    P14     P15       P16       P17    P20      P21      P22 Days
A B
C
Changes in miRNA expression between different hair cycle stages
Significant                  Insignificant
Figure 6. Global miRNA expression profile in mouse skin at distinct hair
cycle stages. A) Heat map represents differentially expressed miRNAs
between distinct stages of the hair cycle. Colour map was used to visualize
the difference in expression. B) Differences in the expression of miRNAs
between distinct hair cycle stages. C) Heat map represents a cluster of
miRNAs with significantly (P<0.01) up-regulated expression in anagen,
compared to catagen and telogen skin. Red colour represents elevated
expression of miRNAs. Green represents decreased expression of miRNAs.
P <0.01. Unpaired student’s t- test and ANOVA tests.
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3.1.2 A role of microRNA-31 in the skin and hair follicle 
For further analyses of the roles of miRNAs in the control of hair cycle-associated 
gene expression programs in the skin, miR-31 was selected, as its expression 
showed the most remarkable changes between the anagen and catagen/telogen 
stages of the hair cycle (Fig. 6C, Appendixes, A). Microarray data was validated 
by qRT-PCR. QRT-PCR showed very high levels of miR-31 transcripts in neonatal 
skin during the anagen-like stage at P12, while during catagen (P17-P19) its 
expression progressively decreased (p<0.02) and remained at low levels during 
telogen (p<0.02) (P20-P23; Fig. 7A).  
Similar changes in the miR-31 levels were observed in adult skin during the 
depilation-induced hair cycle. MiR-31 expression progressively increased during HF 
transition from telogen to anagen and reached maximum at late anagen stage (day 
12 post depilation) (p<0.02), followed by rapid decrease during catagen stage (days 
16-19 post depilation) (p<0.02) (Fig. 7B).  
Consistent with microarray and qRT-PCR data, in situ hybridization for miR-31 
showed lack of its expression in telogen skin (Fig.7C). MiR-31 expression appeared 
first in the epidermis and in the growing hair bulb of mid-anagen HF on day 5 post 
depilation (Fig. 7D). In late anagen HFs (day 12 post depilation), miR-31 was 
prominently expressed in the hair matrix, as well as in the ORS and IRS, while 
relatively lower expression was seen in the DP and lack of expression was seen in 
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the dermis (Fig. 7E). During catagen, miR-31 expression progressively decreased 
(mid-catagen; Fig. 7F).  
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Figure 7. Spatiotemporal expression of miR-31 during hair cycle. A)
Detection of miR-31 in neonatal skin by qRT-PCR: it is expressed maximally
during the anagen-like stage (P12), while its expression progressively decreased
during catagen (P17–P19) and remained at very low levels during telogen (P20–
P23). B) Detection of miR-31 in the skin during depilation-induced hair cycle: miR-
31 expression progressively increased during HF transition from telogen to
anagen and reached a maximum at late anagen stage (d12 after depilation),
followed by rapid decrease during catagen (d16–19 after depilation). C-F)
Representative microphotographs of in situ hybridization for miR-31 in HF at
different hair cycle stages. C) Lack of miR-31 expression in telogen. D) miR-31
expression in the epidermis (large arrow) and in the growing hair bulb of mid-
anagen HF (small arrow). E) Prominent miR-31 expression in the hair matrix
(arrowhead), outer and inner root sheaths (small and large arrows), and its lower
expression in the dermal papilla in late anagen HFs (asterisk). F) Low miR-31
expression in the epithelium of catagen HF (arrow). **P <0.02. Unpaired student’s
t- test. n= 3. Scale bar 100µm. Abbreviations: Ep, epidermis; derm, dermis; shg,
secondary hair germ.
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shg
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3.1.3 Inhibition of miR-31 activity in the skin accelerates anagen development 
and alters hair shaft formation 
To explore the role of miR-31 in the control of hair cycle, synthetic inhibitor 
designed to specifically bind to and block the miR-31 activity was administered into 
the back skin of 7-week-old mice at different time-points of the hair cycle (Fig. 8A, 
Fig 9A). According to the experimental approaches established previously (Zhu et 
al., 2008), the efficiency of anti-miR-31 in inhibiting the miR-31 activity was 
assessed by analyzing the expression of miR-31 in the treated and control samples 
using TaqMan® miRNA assay and qRT-PCR. These experiments showed 
significant decrease of the miR-31 expression in the skin treated with miR-31 
inhibitor (p<0.05) versus the control (Fig. 8B) 
In the first experiment, anti-miR-31 was administered daily into mouse back skin 
during the early anagen (days 1-4 of the depilation-induced hair cycle), and skin 
was harvested at day 5 after the beginning of the experiment (Fig. 8A). Inhibition of 
miR-31 activity during early anagen resulted in acceleration of anagen progression 
compared to the control (Fig. 8C,D).  In mice treated with anti-miR-31, significantly 
more HFs were found in anagen IV stage (p<0.05), characterizing by larger and 
more pigmented hair bulbs, whereas the majority of HFs in the control skin reached 
only anagen III phase of the hair cycle (Fig. 8C-E).  Acceleration of anagen 
development in mice treated with anti-miR-31 versus the controls was also 
associated with significant (p<0.05), morphologically recognizable increase in the 
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skin thickness (Fig. 8F), used as an additional well-established parameter of the 
hair cycle progression in mice (Handjiski et al., 1994). 
In the second experiment, mice were treated with anti-miR-31 during the mid-
anagen phase of the hair cycle (days 4-7 post depilation), and skin samples were 
collected on day 8 of the experiment (Fig. 9A). The efficiency of miR-31 inhibition in 
skin was assessed by analyzing the expression of miR-31 using TaqMan® miRNA 
assay and qRT-PCR in the treated and control samples. These experiments 
showed significant decrease (p<0.05) of the miR-31 expression levels in the skin 
treated with miR-31 inhibitors against the control (Fig. 9B).  Administration of anti-
miR-31 during mid-anagen did not cause any significant changes in the rate of hair 
cycle progression, and HFs in both experimental and control skin reached anagen 
VI stage. However, HFs treated with anti-miR-31 were characterized by larger hair 
bulbs, altered hair shaft structure with irregular distribution of melanin, and 
hyperplastic and deformed ORS, compared to the control (Fig. 9C,D).  
anti-mir-31
1      2     3      4      5
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harvestingdepilation
0
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C D
Control anti-miR-31
Epi
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day 5 day 5
E F* * *
Control anti-miR-31
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Figure 8. Inhibition of miR-31 accelerates early anagen development. A-E)
Hair cycle was induced by depilation in the back skin of 8-week-old C57BL/6 mice;
anti-miR-31 or vehicle control were administered daily subcutaneously at dpd 1-4.
Skin was harvested at dpd 5 (A). B) Inhibition of miR-31 activity was assessed by
TaqMan real-time PCR: a significant reduction in miR-31 levels was detected in
treated skin compared with control. C-D) Representative skin examples of control
(C) and anti-miR-31-treated mice at day 5 (D); sections were stained for the
detection of endogenous alkaline phosphatase activity to visualize the morphology
of dermal papilla as an important indicator of the defined stages in HF cycle.
Percentage of HFs in defined stages of anagen was evaluated in cryostat sections
of the skin of control or anti-miR-31-treated mice by quantitative
histomorphometry using established morphological criteria (Muller-Rover et al.,
2001); there was a significant increase in the percentage of HFs in anagen IV
stage in anti-miR-31-treated skin, compared with the control (E). F) Skin thickness
after anti-miR-31 treatment is significantly enhanced, compared to the control. *P
< 0.05. Unpaired student’s t- test. n= 3. Scale bar 100µm. Abbreviations: Epi,
epidermis; derm, dermis.
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Figure 9. Inhibition of miR-31 during mid-anagen phase alters hair follicle
morphology. Hair cycle was induced by depilation in the back skin of 8-week-old
C57BL/6 mice; anti-miR-31 or vehicle control were administered daily
subcutaneously at dpd 4–7. Skin was harvested at dpd 8 (A). B) Inhibition of miR-
31 activity was assessed by TaqMan real-time PCR: a significant reduction miR-
31 levels was detected in treated skin compared with control. Representative skin
examples of control and anti-miR-31-treated mice (C,D) at day 8. C)
Representative skin example of control skin showing HFs with anagen VI
morphology. D) Microphotographs of HFs that received anti-miR-31 treatment,
depicting hair shaft deformation (large arrows), hyperplastic and deformed outer
root sheath (arrowheads) of the HF after anti-miR-31 treatment. **P <0.02.
Unpaired student’s t- test. n= 3. Scale bar 100µm.
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3.1.4 Does modulation of the miR-31 activity lead to changes in cell cycle 
progression in keratinocytes? 
To further explore mechanisms underlying the effects of miR-31 on hair cycle, 
primary mouse epidermal keratinocytes (PMEKs) were transfected either with anti-
miR-31 or with miR-31 mimic (pro-miR-31) to inhibit or enhance miR-31 activity, 
respectively.  Transfection efficiency was assessed by qRT-PCR, which revealed 
significant decreased (p<0.05) and increased (p<0.02) in the miR-31 levels in the 
keratinocytes after treatment with anti-miR-31 or pro-miR-31, respectively, versus 
the controls (Figure 10A,B).  
To assess whether miR-31 shows any effects on cell proliferation, PMEKs were 
stained by propidium iodide and flow cytometry analysis was performed. FACS 
quantification did not reveal any significant changes in cell cycle progression as a 
result of either miR-31 inhibition or its activation (Fig. 10C).  This data suggest miR-
31 activity is not involved in the regulation of keratinocyte proliferation. 
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Figure 10. FACS analysis of miR-31 effects on cell cycle
progression. (A,B) qRT-PCR analysis revealed significant increase
and decrease in expression levels of miR-31 in keratinocytes treated
with anti-miR-31 or pro-miR-31, respectively, compared with the
controls. C) No changes in cell cycle progression through the different
phase of cell cycles as a result of either miR-31 inhibition or activation
was detected by FACS analysis. *P < 0.05, **P < 0.02. Unpaired
student’s t- test. n= 3.
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3.1.5 Modulation of miR-31 activity induces complex changes in gene 
expression program in primary mouse epidermal keratinocytes 
To identify putative target genes for miR-31, PMEKs transfected with anti-miR-31, 
were processed for microarray analysis, using Whole Mouse Genome 60-mer oligo-
microarray (manufactured by Agilent Technologies). Global gene expression 
analysis in keratinocytes treated with anti-miR-31 or control cells revealed that miR-
31 inhibition resulted in two-fold or higher changes in expression of 419 genes that 
encode distinct adhesion molecules, components of the cytoskeleton, metabolic 
enzymes and growth factors/receptors/signalling molecules involved in the control 
of cell fate decision and differentiation (Fig. 11, for complete list of genes see 
Appendixes C). Functional assignments of the genes, which expression was 
altered in keratinocytes after anti-miR-31 treatment revealed that 53% of them 
represent distinct signalling and growth regulatory molecules or transcription 
factors, thus suggesting a potential involvement of miR-31 in the control of 
keratinocyte responsiveness to growth factor stimulation/inhibition during anagen 
development and hair cycle-associated tissue remodelling.  
Gene Symbol Increased in fold expression
Transcription factors
Distal-less homeobox 3 Dlx3 2.4
Distal-less homeobox 1 DLx1 2.1
T-box 15 Tbx15 2
Peroxisome proliferative activated receptor alpha PPARa 2.7
Peroxisome proliferative activated receptor gamma PPARg 2.5
Signalling
Sclerostin Sost 3.3
Fibroblast growh factor 14 Fgf14 2.5
Mitogen-activated protein kinase 15 Mapk15 2.5
Mitogen-activated protein kinase kinase kinase 2 Map3k2 2.4
Mitogen-activated membrane bound inhibitor Bambi 2.2
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Fibroblast growh factor 10 Fgf10 2.0
Adhesion
FAT tumour suppressor homolog 3 Fat3 2.2
Neural cell adhesion molecule 1 Ncam 2.0
Cadherin 17 Cdh17 2.0
Structural Proteins
Keratin 14 Krt 14 3.0
Keratin 16 krt 16 2.4
Keratin 17 krt 17 3.4
Keratin 5 krt 5 2.5
Keratin 6a krt 6a 2.6
Table 4. Selection of over expressed genes in mice skin
treated with sequence specific antagonist of microRNA-31.
Analysis of the microarray data was used to select genes, which
showed two-fold or higher changes in expression after miR-31
inhibition in keratinocytes. These genes are known key
regulators in hair follicle development, maintenance and
regeneration.
Figure 11. Functional annotation of the genes differently
expressed in primary mouse epidermal keratinocytes treated with
sequence specific antagonist of miR-31. Analysis of the microarray
data demonstrated two-fold or higher changes in expression of >400
genes encoding for adhesion/extracellular matrix molecules, cell
differentiation, metabolism, signalling, transcription, cell
cycle/apoptosis and cytoskeleton markers.
Page    111
3.0 Results 
Exploring molecular mechanism controlling skin homeostasis and hair growth: MicroRNAs in Hair-
cycle-Dependent Gene Regulation, Hair Growth and Associated Tissue Remodelling   
  
                                                         P a g e  | 112 
3.1.6 MicroRNA-31 controls the expression of keratin 14, 16 and 17 in the hair 
follicle 
In addition to the changes in expression of genes that encode signalling/regulatory 
molecules and transcription factors implicated in hair cycle control, microarray 
analysis revealed that expression of several keratin genes has been affected after 
inhibition of the miR-31 activity (Table 4).  Transcripts for keratins 14, 16 and 17 
(Krt14, Krt16, and Krt17, respectively) were increased in the keratinocytes treated 
with anti-miR-31, compared to the controls (Fig. 12A). Treatment of the 
keratinocytes with anti-miR-31 also resulted in increase in the levels of keratins 14, 
16, but not keratin 17 proteins (K14, K16, K17, respectively) (Fig. 12B). Moreover, 
administration of anti-miR-31 into mouse back skin also resulted in upregulation of 
Krt14, Krt16, and Krt17 expression. Elevated levels of Krt14, Krt16, and Krt17 
transcripts and corresponding proteins were detected in the extracts of the full-
thickness skin treated with anti-miR-31 versus the controls, as determined by qRT-
PCR and Western blotting, respectively (Fig. 12D,E).  
K16 and K17 expression by immunofluorescence showed marked alterations in the 
HFs treated with anti-miR-31 versus the control (Fig. 12G-J). Consistent with data 
reported previously (Panteleyev et al., 1997), K17 immuno-reactivity was detected 
in the unilateral cluster of hair matrix cells, as well as in the ORS and in the medulla 
of the hair shaft of control HFs (Fig. 12G). However, anti-miR-31 administration 
resulted in the increase of K17 expression in the unilateral cluster of matrix cells 
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and in the opposite side of the hair matrix, as well as in the hair shaft and thickened 
ORS versus the controls (Fig. 12H). K16 expression also increased in the ORS and 
companion layer of the HF after anti-miR-31 treatment compared to the controls 
(Fig. 12I,J).  
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Figure 12. MiR-31 regulates expression of keratins in the
primary mouse epidermal keratinocytes and in mouse skin.
Keratin (K)14, K16, and K17 expression in the primary
keratinocytes transfected with either anti-miR-31 or control
oligonucleotides: qRT-PCR analysis showing a significant
upregulation of K14, K16, and K17 mRNA levels in the
keratinocytes transfected with anti-miR-31 (A); Western blot
analysis demonstrating increased levels of K14, K16, but not
K17 proteins after transfection with anti-miR-31(B) confirmed by
the densitometric analysis (C). Expression of K14, K16, and
K17 in skin treated either with anti-miR-31 or with vehicle
control: a significant up-regulation of K14, K16, and K17 mRNA
in skin that received anti-miR-31 treatment compared with
control was detected by qRT-PCR (D). Western blot analysis
shows elevated K14, K16, and K17 protein levels after anti-miR-
31 treatment (E), confirmed by the densitometric analysis (F).
G,H) K17 detection by immunofluorescence in the control and
anti-miR-31 treated skin, respectively. Increase in K17
expression in the unilateral disk (small arrow) and in the
opposite side of the hair matrix (large arrow) in the treatment
compared with the control. Prominent K17 expression was also
seen in the hair shaft (arrowhead) and in the thickened outer
root sheath (asterisk) in anti-miR-31 treated skin (H) compared
to the hair shaft (arrowhead) and outer root sheath (asterisk) in
the control (G). I, J) K16 immunofluorescence in the HF:
increased immunoreactivity of K16 in the outer root sheath and
companion layer of the HF after anti-miR-31 treatment (J),
(small arrows and large arrow, respectively), compared to the
controls (small arrows) (I). *P >0.05; **P >0.02. Unpaired
student’s t- test. n= 3. Scale bar 100µm.
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3.1.7 MicroRNA-31 regulates expression of the distinct components of the 
FGF, BMP signalling pathways and the Dlx3 transcription factor in the skin 
Expression of the selected genes whose expression in keratinocytes was changed 
after anti-miR-31 treatment (Table 4) and which are implicated in the control of hair 
cycle and keratinocyte differentiation (fibroblast growth factor 10 (Fgf10), bone 
morphogenetic protein, and activin membrane bound inhibitor (Bambi), Sclerostin 
(Sost), and distal-less homeobox 3 (Dlx3) (Stenn  and Paus, 2001; Botchkarev, et 
al., 2003; Alonso and Fuchs, 2006) was further examined in mouse back skin 
treated with anti-miR-31. Consistent with microarray data, the anti-miR-31 treatment 
resulted in increased expression of transcripts for Fgf10, BMP pathway inhibitor 
Bambi, Wnt, and BMP signalling antagonist Sost (Fig. 13A). Western blot analysis 
of the full-thickness skin samples obtained after anti-miR-31 treatment in vivo also 
showed that Fgf10 and Sost protein levels were increased compared to the controls 
(Fig. 13B). Expression of the Dlx3 transcription factor was also increased in primary 
keratinocytes treated with anti-miR-31 (Fig. 13D). By immunofluorescence analysis of 
the skin treated with anti-miR-31, ectopic Dlx3 expression in the HF ORS and 
increase of the Dlx3 expression in the hair matrix, IRS, and hair shaft were seen 
(Fig. 13F) compared with the controls (Fig. 13E). These data suggest that the 
effects of the anti-miR- 31 on anagen progression and hair shaft formation (Fig. 8, 
Fig. 9) were executed, at least in part, via modulation of the activity of the Fgf, BMP, 
and Wnt pathways and Dlx3 transcription factor in the HFs.  
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Figure 13. Changes in gene expression of FGF10, BAMBI, Sost and Dlx3 in
the skin due to miR-31 inhibition. A) Elevated expression of FGF10, BAMBI,
and SOST transcripts in anti-miR-31-treated skin compared with the controls was
detected in the extracts of the full-thickness skin by qRT-PCR. B) Western
blotting assay of the extracts of the full-thickness skin either treated with anti-
miR-31 or with vehicle control to detect FGF10 and Sost proteins: up-regulation
of FGF10 and Sost proteins was detected in anti-miR-31-treated samples
compared with the controls confirmed by densitometric analysis (C). D) Detection
of Dlx3 transcripts by qRT-PCR showed its up-regulation in anti-miR-31-treated
skin compared with the control. E,F) Analysis of Dlx3 protein expression by
immunofluorescence. In the control, Dlx3 is expressed in the hair matrix (large
arrow), inner root sheath (small arrow), and in the hair shaft (asterisk) (E); In
anti-miR-31 skin, elevated expression was observed in the hair matrix (large
arrow), inner root sheath (small arrow), and in the hair shaft (asterisk), Dlx3 is
present in the outer root sheath (arrowhead) (F). *P <0.05; **P <0.02. Unpaired
student’s t- test. n= 3. Scale bar 50µm.
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3.1.8 Keratin 16, Keratin 17, FGF10 and Dlx3 are direct targets of miR-31 
Bioinformatic analysis using RNA22 algorithm revealed that Dlx3, Fgf10, Sost, 
Krt14, Krt16, and Krt17 carry several putative miR-31 binding sites (Fig 14A). To 
validate whether miR-31 directly regulates expression of these genes, the effects of 
miR-31 on the 3’UTR (un-translated region) target mRNA were tested using a 
luciferase reporter assay. We judged the repression of average luciferase activity 
by 30% or more as a significant effect of miRNA on gene expression (Miranda et 
al., 2006). 
Co-transfection of HaCaT cells with pro-miR-31 and the Krt16 3’UTR reporter 
construct caused 50% reduction in luciferase activity, compared to the 
corresponding control (Fig. 14B). A putative binding site within the 3’ UTR of K17 
introduced into reporter construct co-transfected with pro-miR-31, decreased 
luciferase activity by 60%, which contained a single-mismatched hexamer found 
within the 3’UTR (Fig. 14B). Greater than 60% suppression of the luciferase activity 
was also observed after co-transfection of the cells with pro-miR-31 and Dlx3 
3’UTR reporter construct, compared to the control (Fig. 14B). A putative binding 
site within the 3’UTR of Fgf10 mRNA introduced into the luciferase reporter 
construct also demonstrated sensitivity to miR-31 in the co-transfection assay by 
reducing luciferase activity greater than 30% (Fig. 14B).  
However, the reporter constructs containing segments of the 3’UTRs of Krt14 and 
Sost did not demonstrate significant sensitivity to miR-31 in the co-transfection 
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experiments (Fig. 14B). Collectively, these data indicate that Krt16, Krt17, Dlx3, 
and Fgf10, but not Krt14 and Sost transcripts might represent genuine targets of 
miR-31. 
Summary 
MiR-31 is predominantly expressed in the HF during its active growth phase. 
Inhibition of miR-31 leads to: the accelerated development of early anagen, 
hyperplastic changes in the ORS and hair shaft defect during mid-anagen phase. 
MiR-31 regulates HF differentiation and cycling by i) involvement in the cross-talk 
between the BMP and Wnt signalling pathways ii) modulating FGF10 pathway iii) 
regulation of expression of structural genes Krt16 and Krt17. By targeting a number 
of growth regulatory molecules, transcription factors and cytoskeletal proteins, miR-
31 is involved in the control of hair cycling and hair fiber formation. 
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Figure 14. Krt16, Krt17, Dlx3 and FGF10 are primary targets of miR-31. A)
Predicted interactions between miR-31 and Krt14, Krt16, Krt17, Dlx3, Sost, and
Fgf10 mRNA. Alignment of mouse sequences in the 3’-UTR of Krt14, Krt16,
Krt17, Dlx3, Sost and Fgf10 mRNA. The seed region is shown in red.
Representation is limited to the region around the miR-31 complementary site.
B) Cotransfection of HaCaT cells with pro-miR-31 and the Krt16 3’UTR, Krt17
3’UTR, Dlx3 3’UTR construct encompassing putative binding sites caused more
than 40% reduction in luciferase activity, compared to the corresponding
controls. About 30% suppression in the luciferase activity has also been
observed after co-transfection of the cells with pro-miR-31 and Fgf10 3’UTR
reporter construct, compared to the control. Pro-miR-31 did not cause significant
reporter inhibition with constructs containing segments of the 3’UTR of Krt14 and
Sost mRNA. *P < 0.05, **P < 0.02. Unpaired student’s t- test. n= 3.
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3.2 Exploring the role of microRNA-214 in skin biology 
Based on miRNA microarray profiling, we also selected miR-214 for further 
investigation, because its expression levels showed significant changes between 
the growth phase (anagen) and catagen/telogen transitional stages of the hair 
cycle. 
To validate microarray data qRT-PCR was performed and showed very high levels 
of miR-214 transcripts in neonatal skin during the anagen-like stage at P12, while 
during catagen (P17-P19) its expression significantly decreased (p<0.02), and 
during telogen stage expression remained at low levels (p<0.02) (P20-P23; Fig. 
15). 
To determine miR-214 localisation during adolescent HF cycle, in situ hybridization 
was employed. In telogen skin, miR-214 expression was observed in the epidermis, 
HF infundibulum, SHG and the bulge (Fig. 16A). During mid-anagen (day 5 post 
depilation), miR-214 expression remained in the epidermis and HF bulge, as well as 
appeared in the HF bulb, ORS and DP (Fig. 16B). In late anagen HFs (day 12 post 
depilation), miR-214 was prominently expressed in the hair matrix, IRS and ORS, 
while relatively lower expression was detected in the DP (Fig. 16C). During catagen 
(day 18 post depilation), prominent expression of miR-214 was still seen in the 
regressing hair matrix, while its expression decreased in the epithelial sheaths and 
in the epidermis (Fig.  16D).  
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Figure 15. QRT-PCR analysis of miR-214 expression
levels in mouse neonatal skin. MiR-214 is expressed
maximally during the anagen-like stage (P12), while during
catagen (P17-P19) its expression progressively decreased
and remained at low levels during telogen (P20-P23). **P <
0.02. Unpaired student’s t- test. n= 3.
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Figure 16. Spatio-temporal expression of microRNA-214
during the hair cycle. A-D) Representative
microphotographs of in situ hybridization for miR-214 in the
HF at different hair cycle stages. A) Expression of miR-214
was detected in the epidermis (arrowhead), the bulge and
secondary hair germ. B) Expression of miR-214 was detected
in the epidermis (large arrowhead), hair matrix (arrow) and no
expression was detected in the pre-cortex of the HF (small
arrowhead) and dermal papilla (asterisk) in mid-anagen HFs.
C) Prominent expression of miR-214 was seen in the hair
matrix (arrow heads), with lower expression was observed in
the outer and inner root sheaths (small and large arrows,
respectively) and dermal papilla, in late-anagen HFs. D)
During catagen, weaker expression of miR-214 was seen in
the epidermis (arrowhead) and epithelial sheaths, while
expression remained elevated in the hair matrix (arrow),
which included the dermal papilla. Scale bar 100µm.
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3.2.1 Involvement of miR-214 in the regulation of the activity of canonical Wnt 
signalling pathway.  
Bioinformatic analysis using RNA22 algorithm, a method for identifying miRNA 
binding sites and their corresponding heteroduplexes (Miranda et al., 2006) 
revealed that β-catenin carries two putative miR-214 binding sites in its 3’ UTR 
region. Moreover, all the miR-214 seed regions (2-8nt position) and corresponding 
pairing sites make perfect and/or near perfect complementarity with 3’UTR of target 
mRNA (Fig. 18D,E), which is a common accepted principle in miRNA target 
prediction (Brennecke et al., 2005).  
 
β-catenin is an important component of the Wnt signalling pathway. In the course of 
Wnt signalling, cytoplasmic β-catenin becomes translocated into the nucleus, where 
it binds to Lef/TCF transcription factors, which leads to activation of Wnt target gene 
transcription (Miller et al., 1999). β-catenin is a multifunctional protein that plays an 
important role during skin and HF morphogenesis and cycling (Huelsken  et al., 
2001; Miller, 2002) and regulates stem cell  differentiation (Huelsken  et al., 2001). 
Therefore, delineating the relationship and regulatory mechanisms between miR-
214 and β-catenin will shed some light on the role of miR-214 in the control of 
normal skin and HF development and HF growth and cycling. 
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3.2.2 Expression of microRNA-214 and β-catenin during hair follicle 
morphogenesis 
Fluorescent in situ hybridization was used to analyze the expression patterns and 
possible co-localisation of miR-214 and β-catenin during HF morphogenesis. 
Examination of expression of β-catenin and miR-214 in early embryonic skins (E13) 
mice revealed β-catenin presence throughout the epithelium surface, whereas miR-
214 expression was not detected during this stage (Fig. 17A,B). At E17.5, the 
epidermis and hair placodes were β-catenin positive (stage 1, large arrow and 
asterisk Fig. 17E,F). In contrast, low expression of miR-214 was detected in the 
epidermis and hair placodes (stage 1, small arrows).  In the HFs at stages 3-4 of 
HF development, miR-214 expression was detected, while β-catenin expression 
was absent from these HFs (arrowheads, Fig.17D,F). During the next phase of 
follicle development (stage 5), β-catenin expression was detected in the central 
stalk of the developing HF, whilst its expression was more prominent in the 
epidermis (Fig. 17H,I). In contrast, miR-214 expression was seen in the peripheral 
regions of these developing HF (Fig. 17G,I). In more advanced stages of HF 
development (stage 6), β-catenin expression increased in the stalk of the 
developing HFs (Fig. 17K,L), which coincided with a dramatic reduction miR-214 
expression in these HFs (Fig. 17J). 
This data suggests that miR-214 may govern the expression patterns and levels of 
β-catenin during HF induction and development. 
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Figure 17. Expression of miR-214 and β-catenin during
HF morphogenesis. A-L) Representative microphotographs
of fluorescent in situ hybridization for miR-214 and β-catenin
immunofluorescence during hair follicle development. A-C)
miR-214 was not detected in E13 skin in the epidermis (A,C).
β-catenin expression was detected in the uniform basal
keratinocyte layer of the epidermis (arrows) (B,C). Low
expression of miR-214 was detected in early stages of HF
development (stage 1, small arrows), while higher expression
of miR-214 was detected in HFs in more advanced stages
(stages 3-4, arrowheads) (D,F). β-catenin expression was
detected in the epidermis (large arrows) and in hair placodes
(stage 1, asterisks) (E-F). With further progression of HF
morphogenesis, β-catenin was expressed in differentiating
keratinocytes of the developing HFs (stage 5, arrowheads),
while expression remained elevated in the epidermis (large
arrows) (H,I). MiR-214 expression reduced in the epidermis
and increased in the peripheral regions of the developing HFs
(small arrows), with relative low expression detected in the
central parts of the HF (G,I). β-catenin expression increased
in the central differentiating keratinocytes of the developing
HFs (stage 6, arrowheads), with relatively lower expression
detected in the epidermis (K-L). No expression of miR-214
was detected in these developing HFs (stage 6) (J,L). Scale
bar 100µm.
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3.2.3 MicroRNA-214 regulates β-catenin expression in primary mouse 
epidermal keratinocytes  
To define if miR-214 is involved in the regulation of β-catenin expression, PMEKs 
were transfected with miR-214 mimic (pro-miR-214) to enhance miR-214 activity. 
Transfection efficiency was assessed by qRT-PCR, which revealed significantly 
increased (p<0.01) levels of miR-214 transcripts in the PMEKs treated with pro-
miR-214 versus the control (Fig. 18A).   
QRT-PCR and Western blot analysis were employed to detect the changes in β-
catenin expression in the keratinocytes in response to elevated miR-214 activity. 
This resulted in the level of β-catenin transcript being significantly reduced (p<0.05) 
after pro-miR-214 transfection compared with the control (Fig. 18B). Western blot 
analysis of the PMEKs samples obtained after pro-miR-214 transfection showed β-
catenin protein levels were also decreased compared to the control keratinocytes 
(Fig. 18C).  
To validate whether miR-214 directly regulates expression of β-catenin, the effects 
of miR-214 on β-catenin 3’UTR was tested using a luciferase reporter assay. We 
judged the repression of average luciferase activity by 30% or more as a significant 
effect of miRNA on gene expression (Miranda et al., 2006). Two predicted putative 
binding sites within the 3’UTR of β-catenin mRNA were separately introduced into a 
luciferase reporter gene and caused different effects on luciferase activity (Fig. 
18D,E). The first putative binding site within the 3’UTR of β-catenin mRNA 
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introduced into the luciferase reporter construct showed no effect on luciferase 
activity (Fig. 18D). In contrast, co-transfection of HaCaT cells with the β-catenin 
3’UTR construct encompassing the second putative binding site, showed more than 
60% reduction in luciferase activity (Fig. 18E). To assess whether this reduction of 
luminescence was specific, transfection of β-catenin 3’UTR construct (binding site 
2) was carried out with alternative miRNA, which does not have any putative 
binding sites for β-catenin, such as miR-21. Co-transfection of HaCaT cells with 
miR-21 mimic and the β-catenin 3’UTR construct had no effect on luciferase activity 
(Fig. 18E). These data suggest that β-catenin carry one functional binding site for 
miR-214, therefore it serves as a direct target of miR-214. 
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Figure 18. MiR-214 regulates expression of β-catenin in
keratinocytes. A) MicroRNA-214 levels was assessed by
qRT-PCR: significant increase in the miR-214 levels in the
keratinocytes after treatment with pro-miR-214 compared with
the controls. B) qRT PCR: β-catenin transcripts were
significantly reduced in keratinocytes treated with pro-miR-
214 compared with control. C) Western blotting assay of the
extracts of keratinocytes treated with pro-miR-214 or with
vehicle control: a decrease in β-catenin protein was detected
in pro-miR-214-treated cells compared with the control
confirmed by densitometric analysis. D,E) Predicted
interaction between miR-214 and β-catenin mRNA. The seed
region is shown in red. The first putative binding site within
the 3’UTR of β-catenin mRNA introduced into the luciferase
reporter construct showed no effect on luciferase activity (D),
while co-transfection of HaCaT cells with the β-catenin 3’UTR
construct encompassing the second putative binding site,
showed more than 60% reduction in luciferase activity (E),
compared to controls and miR-21. P *<0.05, **P <0.02, ***P <
0.01. Unpaired student’s t- test. n= 3.
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3.2.4 Effect of miR-214 on the Wnt/β-catenin signalling pathway 
To further explore if miR-214 expression is involved in regulating Wnt-mediated 
effects, PMEKs were treated with lithium chloride for the activation of Wnt 
signalling. Lithium chloride acts as a potent inhibitor of GSK-3 protein. GSK-3 
protein is part of the ‘destruction complex’ required for the degradation of 
cytoplasmic β-catenin (Klein and Melton, 1995). The consequence of the activation 
of the canonical Wnt/β-catenin pathway is the activation and free, signalling pool of 
stable β-catenin protein in the cell that enters the nucleus and forms a complex with 
members of the Lef/TCF family of transcription factors, resulting in increased 
expression of target genes (Miller et al., 1999; Persad et al., 2001; Stambolic, 
2002). This can only be achieved by regulating the stability of β-catenin in the cell 
(Miller et al., 1999).  
Immunocytochemistry was used to analyze the effects of miR-214 on β-catenin 
intracellular localisation in the keratinocytes. By immunocytochemistry, β-catenin 
was localised predominantly in the cytoplasm of the untreated keratinocytes (Fig. 
19C). In contrast, lithium chloride treatment resulted in translocation of β-catenin 
into the nucleus of keratinocytes (Fig. 19D). However, transfection of keratinocytes 
with pro-miR-214 prevented lithium chloride-induced translocation of β-catenin into 
the nucleus (Fig. 19E).  
As the next approach, we analyzed expression of Axin2 as an additional indicator of 
Wnt signalling activity (Jho et al., 2002, Lui et al., 2000). In our experiments we 
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observed that the transcript levels of Axin2 were significantly higher (p<0.05) in 
lithium chloride treated cells compared to the control (untreated) cells. However, 
transfection of keratinocytes with pro-miR-214 abrogated the lithium chloride-
induced upregulation of Axin2 transcripts (p<0.02) (Fig. 19A). 
Next, the effects of miR-214 on Lef/TCF-activity was analysed by using luciferase 
reporter plasmid, TOPflash. Transfection of HaCaT cells with TOPflash and their 
subsequent stimulation with lithium chloride resulted in significant increase in the 
luciferase activity, compared to the controls, including untreated cells (p<0.05) and 
cells transfected with control oligonucleotides (p<0.02). However, elevated 
TOPflash reporter activity after lithium chloride treatment was abrogated by co-
transfecteion with pro-miR-214 (p<0.01) (Fig. 19F).  
In addition, we analyzed the effect of miR-214 on genes that are downstream 
targets of Wnt/β-catenin signalling. We selected Cyclin D1, c-myc and Pten genes. 
Interestingly, Pten has already been proven to be target of miR-214 (Yang et al., 
2008). Treatment of the keratinocytes with pro-miR-214, resulted in the marked 
decrease in mRNA levels for c-myc, cyclin D1 and Pten (p<0.01, p<0.01, p<0.05, 
respectively) versus controls (Fig. 19B).  
These results indicate that miR-214 may indeed negatively regulate Wnt signalling 
pathway activity in the keratinocytes by targeting β-catenin. 
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Summary 
MiR-214 is predominantly expressed in the anagen HFs during the HF cycle. MiR-
214 is a negative regulator of Wnt signalling. MiR-214 and β-catenin are mutually 
exclusively expressed during HF morphogenesis and β-catenin was confirmed as a 
direct target of miR-214. Therefore, miR-214 may regulate Wnt mediated effects in 
HF morphogenesis, HF growth and cycling. 
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Figure 19. MiR-214 regulates Wnt signalling activity in
the primary mouse epidermal keratinocytes. A) Activation
of Wnt signaling in keratinocytes was carried out using lithium
chloride (LiCl) at 10mM concentration. qRT PCR revealed
significant increase in the Axin2 levels in keratinocytes
treated with LiCl. However, transfection of keratinocytes with
pro-miR-214 abrogated the LiCl-induced upregulation of
Axin2 transcripts. B) miR-214 decreases expression of c-
myc, cyclin D1 and Pten transcripts in keratinocytes
compared with controls. C-E) Immunocytochemistry was
used to analyze the effects of miR-214 on β-catenin
intracellular localisation in the keratinocytes. In untreated
cells, β-catenin was primarily localsied in the cytoplasm of
cells (arrows), with some cells showing translocation of β-
catenin into cell nucleus (arrowhead) (C). Keratinocytes
treated with LiCl showed localization of β-catenin in the
nucleus (arrowhead) (D). Keratinocytes treated with LiCl plus
pro-miR-214 showed a dramatic reduction in β-catenin
localization in the nucleus of cells (arrowhead) (E). F) The
effects of miR-214 on Lef/TCF-activity was analysed by using
luciferase reporter plasmid, TOPflash. Transfection of HaCaT
cells with TOPflash and their subsequent stimulation with LiCl
resulted in significant increase in the luciferase activity, while
TOPflash reporter activity after LiCl treatment was abrogated
by co-transfection in keratinocytes with pro-miR-214. *P <
0.05, P **< 0.02, ***P < 0.01. Unpaired student’s t- test. n= 3.
Scale bar 100µm.
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3.3 BMP4-induced changes in the expression of miRNAs in keratinocytes 
It is widely accepted that miRNAs regulate their targets via interaction and binding 
to the 3’UTR of target genes. However, little is known about the mechanism 
regulating miRNAs expression.  
BMP signalling plays essential roles during skin development, postnatal tissue 
remodelling, and tumourigenesis (Li et al., 2006). BMP signalling inhibits the 
initiation of the HF development, as well as operates as tumour suppressor in adult 
skin (Botchkarev et al., 1999; Sharov et al., 2009). The goal of this study was to 
explore if some of the inhibitory effects of BMP signalling are mediated by miRNAs. 
To identify the changes in the miRNA expression in response to the activation by 
BMP4, global microarray analysis of miRNAs was performed as described 
previously (Singh et al., 2008).  Total RNA was isolated from the PMEKs treated 
with BMP4 for 4 hours.  Global miRNA expression profiling revealed that 42 out of 
226 miRNAs analyzed showed significant (p<0.01) changes in their expression in 
response to BMP4 treatment (Fig. 20).  However, only 13 from those 42 miRNAs 
showed changes in ≥2 fold or higher (Table 5). We selected miR-21, whose 
expression was significantly decreased after exposure to BMP4, compared to the 
control for further analysis. 
 
Table 5. Changes in microRNA gene expression program in
primary keratinocytes due to BMP4 treatment. Microarray
analysis of the global microRNA expression profiling in
keratinocytes; ≥2-fold or higher changes in expression of miRNAs
after BMP4 treatment.
MicroRNA BMP4 0h BMP4 4h Fold 
change 
p-value 
miR-1196 500 1,252 2.5 3.00E-04 
miR-1944 340 706 2.1 7.89E-05 
miR-744 230 471 2.0 2.17E-04 
miR-674 323 631 2.0 4.48E-06 
miR-28 222 411 1.9 2.10E-05 
miR-30a 520 294 -1.8 4.15E-04 
miR-1894-3p 706 334 -2.1 2.62E-03 
miR-21 23,698 9,392 -2.5 4.40E-06 
miR-705 1,684 648 -2.6 1.86E-05 
miR-689 2,378 829 -2.9 1.46E-04 
miR-1892 473 163 -2.9 5.38E-04 
miR-26b 303 90 -3.4 8.55E-04 
miR-20b 1,079 253 -4.3 2.06E-04 
 
Figure 20. Global miRNA expression profile in primary mouse
epidermal keratinocytes after BMP-4 treatment. Heat map
represents substantial changes in expression of miRNAs in control
keratinocytes compared with keratinocytes treated with BMP4.
Colour map was used to visualize the difference in miRNA
expression. Red colour represents elevated expression of miRNAs.
Green represents decreased expression of miRNAs. P <0.01.
Unpaired student’s t- test and ANOVA tests.
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3.3.1 BMP4 inhibits expression of miR-21 in primary mouse epidermal 
keratinocytes 
To validate microarray data and explore further if BMP4 inhibits miR-21 expression 
and interferes with its transcription, we analysed expression of primary precursor-
miR-21 (pri-miR-21), stem-loop precursor-miR-21(pre-miR-21), and mature form of 
miR-21 by real-time PCR analysis. 
Levels of pri-miR-21 and pre-miR-21 in the keratinocytes remained unchanged after 
either 4 or 12 hours of BMP4 treatment (Fig. 21A).  However, dramatic decrease in 
the expression of mature miR-21 form was detected in response to BMP4 
exposure, compared to the control (Fig. 21B).  This data suggest that BMP4 
negatively regulates expression of miR-21 post-transcriptionally, involving only in 
the final step of its biogenesis, cytoplasmic processing of pre-miR-21 into mature 
miR-21 form.  
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Figure 21. BMP4 inhibits expression of mature miR-21. A)
By qRT-PCR transcript levels of primary-miR-21 and
precursor-miR-21 after BMP4 treatment were unchanged. B)
BMP4 treatment significantly reduces expression of mature
form of miR-21 overtime. *P < 0.05, **P < 0.02. Unpaired
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3.3.2 MicroRNA-21 differentially regulates BMP target genes in primary mouse 
epidermal keratinocytes 
To delineate the relationship between BMP-4 and miR-21 regulation of genes 
expression, PMEKs were treated with BMP4 and miR-21 mimic (pro-miR-21), and 
total RNA was analysed for changes in the expression of the genes that are i) 
known to mediate the effects of BMP, and ii) were experimentally proven to be a 
direct targets of miR-21. Id1, Id2 Id3, Smad7 and Msx2 genes were selected as 
known BMP target genes (Ogata et al., 1993; Hussein et al., 2003). Based on 
previous publications, TPM1, Pdcd4, TIMP3 and Pten were chosen as the direct 
targets of miR-21 (Zhu et al., 2007; Asangani et al., 2008; Zhang et al., 2008; Song 
et al., 2010). 
Treatment of the keratinocytes with BMP4 for 4 and 12 hours, resulted in the 
marked increase in mRNA levels of target genes of both BMP and miR-21, 
compared to the control cells (Fig. 22A,C). In contrast, the expression of these 
genes was differently regulated in the keratinocytes by over-expressing miR-21. 
The levels of transcripts of BMP signalling target genes (Id1, Id2 Id3, and Msx2) 
remained unchanged in the keratinocytes transfected with pro-miR-21 (Fig. 22B). 
However, the treatment with pro-miR-21 resulted in downregulation of the 
expression of Pten, Pdcd4, TPM1, and TIMP3, compared to the control cells (Fig. 
22D). The next step was to analyse, if miR-21 overexpression would abrogate 
BMP4-induced gene expression. To answer this question, keratinocytes were first 
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transfected with pro-miR-21 and then treated with BMP4. Pre-treatment of the 
keratinocytes with pro-miR-21 prevented the increase in mRNA levels of Pten, 
Pdcd4, TPM1, and TIMP3 caused by BMP4 (Fig. 23A). 
In addition, the effect of miR-21 on Smad7 expression in keratinocytes was 
analysed. Smad7 is an inhibitory Smad protein, which antagonises TGF-β and BMP 
signalling (Hanyu et al., 2001). Bioinformatic analysis of TargetScan and RNA22 
revealed Smad7 carries two putative miR-21 binding sites (Fig. 23B). In our 
experiments, BMP4 treatment significantly (p<0.01) increased the expression of 
Smad7 transcripts in the keratinocytes versus the control. However, Smad7 
expression was significantly (p<0.05) reduced in the cells transfected with pro-miR-
21 versus the control (Fig. 22C,D). In addition, pre-treatment of the keratinocytes 
with pro-miR-21 prevented BMP4-induced Smad7 expression (Fig. 23A). To 
validate whether miR-21 directly regulates expression of Smad7, the effects of miR-
21 on Smad7 3’UTR was tested using a luciferase reporter assay.  
Two predicted putative binding sites within the 3’UTR of Smad7 mRNA were 
separately introduced into a luciferase reporter gene caused different effects on 
luciferase activity (Fig. 23C,D). The first putative binding site within the 3’UTR of 
Smad7 mRNA introduced into the luciferase reporter construct transfected with pro-
miR-21, showed no effect on luciferase activity (Fig. 23C). In contrast, co-
transfection of HaCaT cells with the Smad7 3’UTR construct encompassing the 
second putative binding site, showed more than 60% reduction in luciferase activity 
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(Fig. 23D). To assess whether this reduction of luminescence was specific, 
transfection of Smad7 3’UTR construct (binding site 2) was carried out with 
alternative miRNA, miR-31, which does not have any putative binding sites for 
Smad7. No effect on luciferase reporter activity was observed by miR-31 (Fig. 
23D).  Thus, Smad7 is a genuine target of miR-21.  
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Figure 22. Correlation in the regulation of gene
expression between BMP4 and miR-21 using qRT-PCR.
A) BMP4 treatment in keratinocytes resulted in significant
increase in expression of Id1-3 and Msx2 compared to
untreated cells. B) The expression of Id1-3 were not effected
by miR-21 transfection compared with controls. C)
Expression of Smad7, TIMP3, Pdcd4, TPM1 and Pten were
upregulated after BMP4 treatment, with the most significant
elevation in expression being detected after 4 hours. D)
Expression of Smad7, TIMP3, Pdcd4, TPM1 and Pten in
keratinocytes was reduced by miR-21 transfection compared
with the controls. *P < 0.05, **P < 0.02, ***P < 0.01. Unpaired
student’s t-test . n= 3.
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Figure 23. Correlation in the regulation of gene
expression between BMP4 and miR-21. A) Expression of
Smad7, TIMP3, Pdcd4, TPM1 and Pten was upregulated
after BMP4 treatment, while transfection with pro-miR-21
prior to BMP4 exposure leads to dramatic reduction in the
expression of Smad7, TIMP3, Pdcd4, TPM1 and Pten. B)
Predicted interactions between miR-21 and Smad7 mRNA.
Alignment of mouse sequences in the 3’-UTR of Smad7
mRNA. The seed region is shown in red. The representation
is limited to the region around the miR-21 complementary
site. C) The first putative binding site within the 3’UTR of
Smad7 mRNA introduced into the luciferase reporter
construct showed no effect on luciferase activity. In contrast,
co-transfection of HaCaT cells with the Smad7 3’UTR
construct encompassing the second putative binding site
showed more than 50% reduction in luciferase activity,
compared to the corresponding control and miR-31. E) A
schematic representation of the possible mechanism involved
in the regulation of inhibitory Smad7 by BMPs via miR-21 in
keratinocytes. *P < 0.05, **P < 0.02, ***P < 0.01. Unpaired
student’s t-test . n= 3.
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3.3.3 MicroRNA-21 expression is elevated in the skin tumours of mice over-
expressing BMP inhibitor noggin 
Recent reports have identified that miR-21 is a unique miRNA consistently 
overexpressed in tumours, including SCC of the skin (Si et al., 2007; Selcuklu et al., 
2009; Dziunycz et al., 2010). However, spatiotemporal expression of miR-21 in the 
skin has not yet been elucidated. Expression analysis of miR-21 was carried out in 
the skin of transgenic (TG) mice overexpressing the BMP antagonist noggin (under 
K14 promoter). These mice are characterized by spontaneous development of HF-
derived tumours, which resemble human trichofolliculoma (Sharov et al, 2009). 
 
K14-noggin mice showed significantly (p<0.02) higher levels of miR-21 transcripts, 
compared to the corresponding wild type mice (Fig. 24A).  By in situ hybridisation, 
weak miR-21 expression was observed in the epidermis and HF epithelium in 
anagen skin of control mice (Fig. 24B). In K14-noggin mice, prominent miR-21 
expression was seen in the tumours, preferentially in the peripheral portions (Fig. 
24C). It was previously shown the peripheral portions of the tumours in K14-noggin 
TG mice contain proliferating cells (Sharov et al., 2009), which suggest that miR-21 
can be involved in sustaining of the population of proliferative cells in the tumours. 
 
Next, we assessed if expression of miR-21 target genes was changed in K14-
noggin mice by qRT-PCR. Expression of Pten, Pdcd4, TPM1, Smad7, and TIMP3 
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transcripts were significantly decreased (p<0.01, p<0.01, p<0.01, p<0.02 and 
p<0.02, respectively) in K14-noggin mice, compared to wild type mice (Fig. 24D-F).  
Therefore, these data demonstrates concurrent expression of miR-21 and its 
targets in the skin with inactive BMP signalling. 
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Figure 24. Increased expression of miR-21 in the skin of K14-Noggin mice.
A) Detection of miR-21 in the skin of wild type and K14-noggin mice was carried
out by qRT-PCR: miR-21 expression was elevated in the skin of K14-noggin
mice compared with wild type. B,C) Representative microphotographs of in situ
hybridization for miR-21 expression in skin of wild type and K14-noggin mice. B)
Weak miR-21 expression was observed in the epidermis (small arrow) and HF
epithelium (large arrow) in mouse anagen VI skin. C) In the skin of K14-noggin
mice, prominent miR-21 expression was seen in the peripheral portion of the
tumours (arrows). D-F) Analysis of miR-21-target genes by qRT-PCR: significant
reduction in expression was observed for Pdcd4, TIMP3, Pten, Smad7 and
TPM1 in the skin of K14-noggin mice compared to wild type mice. **P < 0.02,
***P < 0.01. Unpaired student’s t-test. n= 3. Scale bar 100µm.
R
e
la
tiv
e
 
e
xp
re
s
s
io
n
R
e
la
tiv
e
 
e
xp
re
s
s
io
n
R
e
la
ti
ve
 e
xp
re
ss
io
n
0
1
2
3
4
5
6
7
8
9
Wild type noggin TG
R
e
la
ti
v
e
 e
xp
re
ss
io
n
 o
f 
m
iR
-2
1
**
A
B
m
iR
-2
1
 r
e
la
ti
v
e
 e
x
p
re
s
s
io
n
Page    150
3.0 Results 
Exploring molecular mechanism controlling skin homeostasis and hair growth: MicroRNAs in Hair-
cycle-Dependent Gene Regulation, Hair Growth and Associated Tissue Remodelling   
  
                                                         P a g e  | 151 
3.3.4 MicroRNA-21 expression is elevated during chemically-induced 
carcinogenesis in murine skin 
To define spatio-temporal expression of miR-21 at different stages of chemically-
induced carcinogenesis, we utilized a two-stage chemical carcinogenesis procedure 
on mouse back skin involving DMBA/TPA treatments (DiGiovanni, 1992, Fig. 25A). 
Real-time PCR analysis revealed that in the skin treated with TPA for 15 weeks, 
miR-21 expression was significantly increased (p<0.05), compared to control mice 
(zero weeks of treatment). In the skin collected 28 weeks after the beginning of the 
experiment showed a further significant increase in the levels of miR-21 transcripts, 
compared to control (untreated) skin and in the skin treated with TPA for 15 weeks 
(p<0.01 and p<0.02, respectively) (Fig. 25B).    
By in situ hybridisation, very weak miR-21 expression was seen in the epidermis 
and HF epithelium in the control skin (untreated) (Fig. 25C). In the skin treated with 
TPA for 15 weeks, more prominent miR-21 expression was seen in the hyperplastic 
epidermis compared with control skin (Fig. 25D). In the skin collected 28 week after 
the start of the experiment, abundant miR-21 expression was seen in the 
hyperplastic epidermis and peripheral portion of the tumours containing low 
differentiated, proliferative cells, in “finger like” premalignant papillomas (Fig. 25E). 
These data suggest that miR-21 is potentially involved in promoting and mataining 
of tumour development in the skin. 
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Summary 
BMP signalling negatively regulates miR-21 expression in epidermal keratinocytes. 
There are two groups of BMP target genes, which expression is differentially 
regulated by miR-21. BMP mediates the effects on distinct groups of its targets in a 
miR-21-dependent and miR-21-independent manner. MiR-21 may operate as a pro-
oncogene in the epidermis and promote neoplastic transformation of epidermal 
keratinocytes and cancer progression via the targeting of distinct tumour-
suppressor genes and signalling pathways. 
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Figure 25. Expression of miR-21 in skin during
chemically induced carcinogenesis. A) A diagram showing
DMBA/TPA protocol to induce multi-stage carcinogenesis in
mouse back skin. Twice weekly applications of tumour
promoter TPA was applied to mouse back skin for a total of
15 weeks. Carcinogenesis in mice can be divided into three
discrete steps: i) initiation, ii) promotion (papillomas
formation) and iii) malignant conversion (SCC). Skin samples
were collected at 15 weeks and 28 weeks after the beginning
of the experiment. B) Detection of miR-21 expression in the
skin during chemically induced carcinogenesis was carried
out by qRT-PCR: in the skin treated with TPA for 15 weeks,
miR-21 expression was upregulated compared with control
(untreated skin). In skin sample collected 28 weeks after the
beginning of the experiment, miR-21 expression increased
further compared with samples collected 15 weeks after
treatment and control (untreated skin). C-E) Representative
microphotographs of in situ hybridization for miR-21 in skin
during chemically induced carcinogenesis. C) In control skin,
very weak miR-21 expression was detected in the HF
epithelium (small arrow) and epidermis (large arrow) D) In
skin treated with TPA for 15 weeks, miR-21 expression was
detected in the hyperplastic epidermis (arrows). E) In skin
collected 28 weeks after the beginning of the experiment,
abundant miR-21 expression was detected in the peripheral
portion of the tumours (arrows). *P <0.05, **P <0.02, ***P
<0.01. Unpaired student’s t-test. n= 3. Scale bar 100µm.
Abbreviations: DMBA, dimethylbenz[a]antracen; TPA, 12-
tetradecanoil-phorbol-13-acetate.
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4.1 Complex changes in miRNA expression during distinct stages of hair 
follicle cycle 
HF cycling is a unique biological phenomenon that is accompanied by the profound 
changes in the skin and HF microanatomy and in pigmentation, as well as by the 
remodelling of the cutaneous vascular and nervous apparatus (Botchkarev et al., 
1999; Mecklenburg et al., 2000; Peters et al., 2001; Stenn and Paus, 2001; 
Slominski et al., 2004; Slominski et al., 2005). This study revealed that each stage of 
the hair cycle is characterized by the distinct patterns of the miRNA profiles in the 
skin (Fig. 6), thus suggesting miRNAs as an important regulatory layer in the 
complex program controlling hair cycle-associated changes of gene expression in 
the skin and the HF. 
Remarkable fluctuations in the expression levels of distinct miRNAs during hair cycle 
suggest that these miRNAs may be involved in at least 3 distinct mechanisms of the 
control of gene expression proposed for miRNAs previously: 1) silencing of the 
distinct gene expression programs during the HF transition between hair cycle 
stages (i.e., switch between the telogen associated growth inhibitory programs and 
hair growth promoting programs during the telogen-anagen transition or between the 
hair growth-associated programs to pro-apoptotic programs during transition of the 
HFs from anagen to catagen); 2) establishing the optimal levels of the transcripts to 
prevent their overexpression, thus modulating a balance of activity of distinct 
signalling pathways (i.e., limiting an excessive activation of pro-carcinogenic 
signalling pathways, such as Wnt or Shh, during active HF growth and hair 
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production; and 3) control of the expression of the other miRNAs to limit their 
inhibitory effects on the levels of the target transcripts (i.e., similar to the antagonistic 
interactions between the miR-184 and miR-205 described previously (Yu et al., 
2008). 
4.1.1 MicroRNA-31 in complex regulation of the gene expression programs 
that control anagen progression and hair shaft formation in the HF 
Although the function of the distinct miRNAs or their clusters in the control of HF 
cycling remains to be further defined, here evidence is provided that miR-31 plays 
an important role in the control of anagen-associated gene expression programs in 
the HF.  
MiR-31 expression is markedly increased in the skin during anagen phase of the hair 
cycle, and its expression is seen in both the epidermal and follicular epithelial skin 
compartments, as well as in the DP (Fig. 7). Furthermore, inhibition of the miR-31 
activity in the skin results in anagen acceleration and in alterations in the hair shaft 
formation and ORS morphology (Fig. 8, Fig. 9). 
However, changes in miR-31 expression levels were observed using either anti-miR-
31 or miR-31 mimic did not affect proliferation in vitro (Fig. 10). These findings are 
consistent with recently reported data showing that overexpression of miR-31 in 
aggressive breast cancer cells does not affect their proliferation when compared to 
normal mammary epithelial cells (Valastyan et al., 2009). This suggests that 
elevated expression of miR-31 in cells with high proliferative activity is possibly 
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required to prevent alterations in growth factor signalling leading to tumour initiation 
or progression. 
In addition, these data show the inhibitory effects of miR-31 on anagen development 
are likely to be realized, at least in part, via modulation of the activity of the Fgf, Wnt, 
and BMP signalling pathways. By analyzing the global gene expression changes in 
primary keratinocytes treated with anti-miR-31, demonstrated that miR-31 is involved 
in regulating the expression of the several components of these pathways, such as 
the FGF receptor ligand Fgf10, the Wnt and BMP inhibitor Sost, and the BMP 
antagonist Bambi (Table 4). 
Moreover, Fgf10 might serve as one of the direct targets of miR-31 (Fig. 14). Fgf 
and Wnt pathways promote the HF telogen-anagen transition via providing the 
stimulatory signals to the HF stem cells and/or their progenies residing in the HF 
bulge and SHG, while BMP signalling operates as an anagen inhibitor antagonizing 
the activity of the Fgf and Wnt pathways during telogen (Botchkarev et al., 2001a; 
Van Mater et al., 2003; Plikus et al., 2008; Greco et al., 2009). Sost is capable of 
antagonizing the Wnt and BMP pathways in osteoblasts and adipocytes; however, it 
can also directly bind noggin, a potent BMP antagonist, stimulator of telogen-anagen 
transition and modulator of hair shaft pigmentation (Sharov et al., 2005; Winkler et 
al., 2004). Thus, by regulating the expression of the Fgf10, Bambi, and Sost miR-31 
may be involved in the fine tuning the activity of the Fgf, Wnt, and BMP pathways in 
distinct subpopulations of hair progenitor cells and in modulating the effects of these 
pathways on anagen progression and hair shaft pigmentation associated with it. 
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However, in addition to the effects of miR-31 on early stages of anagen 
development, inhibition of the miR-31 activity during mid-/late anagen results in 
alterations in the hair shaft formation accompanied by its thickening, irregular 
distribution of the pigment, as well as by the hyperplasia of the ORS (Fig. 9). Fgf, 
Wnt, and BMP signalling pathways are closely involved in the control of keratinocyte 
differentiation and hair shaft formation, and genetic alterations in the activity of these 
pathways results in the distinct abnormalities of the hair shaft formation and 
pigmentation (Schneider et al., 2001; Alonso and Fuchs, 2006; Sharov et al., 2006). 
Evidence is provided here that, in addition, to the modulatory effects on the activity 
of the Fgf, Wnt, and BMP pathways, miR-31 is also involved in the control of hair 
shaft formation, at least in part, via regulating the expression of the Dlx3 
transcription factor. Expression of the Dlx3 in the skin samples treated with anti-miR-
31 was significantly upregulated and, in addition to the expression in the hair matrix, 
IRS and hair shaft, Dlx3 is ectopically expressed in the ORS (Fig. 13). The 
luciferase reporter assay confirmed that expression of Dlx3 is directly regulated by 
miR-31 (Fig. 14B).  
Dlx3 transcription factor plays an important role in the control of the hair matrix 
keratinocyte differentiation toward the hair shaft and IRS cell lineages. Genetic Dlx3 
ablation in mice results in failure of proper formation of the hair shaft and IRS 
leading to complete alopecia (Hwang et al., 2008). Dlx3 also serves as a 
downstream target of the Wnt and BMP signalling pathways and as an upstream 
regulator of the Hoxc13 and GATA-3 transcription factors that are essential 
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components of the transcription programs controlling the formation of the hair shaft 
and IRS, respectively (Jave-Suarez et al., 2002; Kaufman et al., 2003; Kurek et al., 
2007).  
Thus, elevated Dlx3 expression and its ectopic appearance in the ORS in response 
to miR-31 inhibition (Fig. 13E,F) could contribute to the abnormalities in the hair 
shaft and ORS morphology seen in this study (Fig. 9). In addition to the changes 
observed in the expression of distinct signalling molecules, we demonstrate here 
that miR-31 regulates the expression of the K14, K16, and K17, the essential 
components of the keratinocyte cytoskeleton. Alterations in the levels of miR-31 
induced by miR-31 synthetic inhibitor resulted in up-regulation of the expression of 
these keratins both in vitro and in vivo (Fig. 12). Moreover, luciferase reporter assay 
revealed that expression of K16 and K17 are directly regulated by miR-31 through 
their 3’UTR, whereas K14 are most likely an indirect target of miR-31 (Fig. 14). 
Alterations of the hair shaft structure and ORS hyperplasia were found after 
inhibition of the miR-31 activity in the skin are accompanied by up-regulation of the 
expression of K17 in the hair matrix keratinocytes, hair shaft medulla, and ORS, as 
well as by increase of the K16 expression in the companion layer of the ORS (Fig. 
12G-J). In addition to the maintenance of keratinocyte cytoskeleton, K17 is capable 
of influencing keratinocyte growth and size by regulating protein synthesis (Kim et 
al., 2006). This suggests that K17 may contribute, at least in part, to the acceleration 
of anagen development and hyperplastic changes in the ORS in the HF treated by 
miR-31. 
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K16 and K17 are expressed in the medulla of the central portion of the hair shaft 
(McGowen et al., 1998; Bernot et al., 2002). K16 overexpression under control of the 
K14 promoter leads to the formation of curly hairs and hyperplasia of the ORS 
(Paladini and Coulombe, 1998). Genetic ablation of the keratin 17 results in hair 
shaft fragility and strain-dependent alopecia (McGowen et al., 2002), while 
intradermal administration of K17 oligonucleotides leads to marked alterations of the 
hair shaft morphology and shape (Fan and Yoon, 2003). These data suggest that 
the elevated levels of the K16 and K17 may, at least in part, contribute to the 
alterations in the hair shaft structure seen after anti-miR-31 treatment. 
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4.2 A role of microRNA-214 in regulating the hair follicle cycle 
Knowledge of the biological mechanisms regulating mammalian development is 
highly important for better understanding of the changes occurring in health and 
disease.  This is evident from the fact that many signalling pathways that control 
organ development such as: Wnt/β-catenin signalling, Shh, TGF-β/BMPs, Notch, 
FGFs and so on, are also involved in postnatal organ growth and regeneration 
(Fuchs, 1998; Schmidt-Ullrich and Paus, 2005).  Moreover, deregulation of any of 
these signalling pathways can lead to alteration in cell proliferation, differentiation, 
and apoptosis in many tissues, including the skin, resulting in impaired tissue repair 
and cancer development (Gat et al., 1998; Makrantonaki and Zouboulis, 2007; 
Nicolas et al., 2003; Farage et al., 2009; Mimeault and Batra, 2009).  
 
The role of miRNAs in regulating cellular processes such as cell proliferation, 
differentiation and programmed cell death has been shown in many tissues including 
the skin. MiR-214 expression was analysed in cancer stem cell differentiation, where 
it was shown miR-214 along with miR-199a could regulate cell differentiation of 
epithelial ovarian cancer stem cells (Yin et al., 2010).  In addition, in zebra fish, miR-
214 was shown to have negative effects on Shh signalling (Flynt et al., 2007). The 
regulatory effects of miR-214 on Shh signalling in zebra fish could be of evolutionary 
importance and potentially conserved in mammals. This regulatory mechanism 
maybe involved in regulating skin homeostasis. However, in mammals Shh has not 
been predicted as a target of miR-214. In contrast, β-catenin was bioinformatically 
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identified in this study as an evolutionary conserved target for miR-214. β-catenin is 
one the key components of Wnt signalling pathway, which is one of the most crucial 
signalling pathways in mammalian development. In the skin, it has been shown to be 
vital in the formation of hair placodes, hair shaft differentiation, and maintenance of 
skin stem cells (Gat et al., 1998; Huelsken et al., 2001). Deregulation in Wnt 
signalling pathway can lead to skin disorder such as, psoriasis (Hampton et al., 
2007) and some epithelial tumours (Kinzler et al., 1991; Nishisho et al., 1991; Chan 
et al., 1999; Gat et al., 1998; Tetsu and McCormick, 1999; Jamieson et al., 2004; 
Celso et al., 2004). This project attempted to elucidate the role of miR-214 and its 
regulatory role on Wnt/β-catenin in HF development.  
 
Global miRNA expression profiling validated by qRT-PCR, showed elevated levels of 
miR-214 transcripts in neonatal skin during the anagen-like stage at P12, compared 
with low expression in catagen and telogen stages (Fig. 15). In situ hybridization 
showed that miR-214 is predominantly expressed in the HF SHG and bulge regions 
in telogen skin (Fig. 16A).  The importance of Wnt/β-catenin signalling in telogen-
anagen transition was indentified from several studies. Data obtained from TOPgal 
transgenic mice carrying a Lef/TCF-responsive-element controlled reporter gene 
LacZ, showed an increase in β-galactosidase in the bulge region of the HFs at the 
onset of anagen (DasGupta and Fuchs, 1999). Furthermore, Wnt transcripts and the 
level of nuclear β-catenin accumulation have been shown to be elevated during late 
telogen/early anagen (Greco et al., 2008), suggesting that the stabilization of β-
catenin, a transcriptional cofactor for Lef1/TCF proteins is required for the activation 
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of stem cells in bulge region leading to the onset of new hair growth cycle (Gat et al., 
1998; Celso et al., 2004; Lowry et al., 2005; Van Mater et al., 2003). Contrasting 
patterns in miR-214 expression and Wnt-dependent β-catenin stabilization suggests 
that the latter maybe in part regulated by miR-214. 
 
Telogen stage is governed by a balance of growth activators and inhibitors. 
Alterations in this balance results in either initiation or prevention of active growth 
phase. In this context, the expression of miR-214 in the bulge region of the resting 
HFs may be involved in regulating the onset of anagen during the HF cycle through 
the regulation of β-catenin. Moreover, miR-214 may provide an additional regulatory 
mechanism in maintaining stem cell quiescence during telogen.  
During mid-anagen, miR-214 expression remained in the epidermis and HF bulge, 
as well as appeared in the HF bulb, ORS and DP (Fig. 16B). However, expression 
was absent from the pre-cortex region of the HF.  The absence of miR-214 
expression in the pre-cortex correlates with the study, showing elevated Lef-1 and 
nuclear β-catenin expression during pre-cortex formation in matrix cells (DasGupta 
and Fuchs, 1999). Elevated Lef-1 expression in the matrix cells has shown to be 
essential for commitment of keratinocytes to hair shaft differentiation (DasGupta and 
Fuchs, 1999).  Furthermore, Lef-1 knockout mice show arrest of HF development 
prior to the beginning of hair shaft formation (Van Genderen et al., 1994; DasGupta 
and Fuchs, 1999). This suggests that miR-214 may regulate Wnt/β-catenin/Lef-1 
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signalling involvement in the conversion of proliferating keratinocytes to hair shaft 
forming cells. 
In late anagen HFs, miR-214 was prominently expressed in the hair matrix, IRS and 
ORS (Fig. 16C), while in catagen, its expression gradually decreased, being mainly 
restricted to regressing HF matrix (Fig. 16D). In contrast, it was shown previously 
that no Wnt activity was detected in catagen and telogen stages (DasGupta and 
Fuchs, 1999).  
Taken together, analysis of miR-214 expression suggests that its expression might 
be tightly associated with Wnt activity during distinct stages of the HF cycle, and 
contributes to Wnt/β-catenin signalling dependent changes in cell fate and 
differentiation commitments which take place. This study highlights miR-214 as a 
potential regulator of maintaining the balance of Wnt/β-catenin pathway activity by 
preventing its excessive activation in the keratinocytes at different stages of 
postnatal HF remodelling. 
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4.2.1 A role for microRNA-214 in regulating Wnt signalling pathway during hair 
follicle morphogenesis  
As the next approach to validate our hypothesis that miR-214 is involved in the 
control of Wnt-β-catenin signalling, analysis of the expression and potential co-
localisation of miR-214 and β-catenin during HF morphogenesis was performed. Our 
data revealed mutual exclusive expression of miR-214 and β-catenin during HF 
development (Fig. 17). The Wnt/β-catenin/Lef-1 signalling pathway was shown to be 
one of the crucial pathways involved in initiating HF development. Overexpression of 
a Wnt-antagonist, Dkk-1, in murine epidermis was shown to lead in the abrogation of 
induction of all HFs (Andl et al., 2002), while overexpression of β-catenin results in 
de novo HF formation (Gat et al., 1998). The presence of miR-214 at sites of Wnt/β-
catenin activity suggests that miR-214 may determine HF induction by regulating 
Wnt activity in the skin. In HFs at advanced stages of HF morphogenesis, miR-214 
expression was initially detected in the peripheral regions of the HF (stage 5), while 
expression of β-catenin was observed in the central differentiating keratinocytes of 
the growing HFs. MiR-214 expression reduced in more advanced HFs (stage 6), 
while β-catenin expression reduced in the epidermis but increased in the stalk of 
these HFs.  β-catenin expression in the epidermis and HF correlates with current 
knowledge that Lef1 mRNA expression is weaker in the basal layer of epidermis, but 
increases in the hair bulb, in epithelial cells destined to express HF-specific keratins 
genes during HF morphogenesis (Zhou et al., 1995; Gat et al., 1998; DasGupta and 
Fuchs, 1999). This mutual exclusive expression pattern of miR-214 and β-catenin 
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suggests miR-214 as a possible negative regulator of Wnt signalling via targeting β-
catenin during HF development. This negative regulation maybe involved in 
maintaining balance of hair keratinocyte proliferation/differentiation and thus may 
regulate skin and HF morphogenesis. 
4.2.2 MicroRNA-214 regulates the activity of the Wnt/β-catenin signalling 
pathway in keratinocytes 
To test whether the spatiotemporal expression pattern of miR-214 has indeed a 
functional link with Wnt/β-catenin pathway, the effects of miR-214 on the activity of 
β-catenin in keratinocytes was analysed. Transfection of keratinocytes with synthetic 
miR-214 mimic resulted in reduced levels of β-catenin transcripts and protein (Fig. 
18A-C). Furthermore, miR-214 prevented translocation of β-catenin into the nucleus 
in response to the treatment with an activator of the Wnt signalling pathway lithium 
chloride, and abrogated the lithium chloride-induced increase of the expression of 
the Wnt target gene Axin2. In addition, analysis of the effects of miR-214 on 
TOPflash plasmid construct showed that activation of the Wnt-responsive element 
abrogated by miR-214. Moreover, the luciferase reporter assay confirmed that 
expression of β-catenin is directly regulated by miR-214 (Fig. 18E) and therefore, β-
catenin is indeed a genuine target of miR-214. Thus, these data demonstrate that 
miR-214 can be involved in the regulation of the activity of the Wnt/β-catenin 
signalling pathway in the keratinocytes.    
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These findings implicate miR-214 as a novel regulator of the Wnt/β-catenin 
signalling pathway and therefore, provides an additional regulatory mechanism of 
involvement of Wnt/β-catenin signalling in HF induction, stem cell 
activation/maintenance and hair shaft differentiation (Gat et al., 1998; Huelsken et 
al., 2001). 
  
In addition, miR-214 negatively regulates Wnt targets such as c-myc and cyclin D1. 
The c-myc proto-oncogene encodes the c-myc transcription factor, and is broadly 
expressed during skin embryogenesis and in tissue compartments that possess high 
proliferative capacity (i.e., the basal layer of the epidermis). Sustained activation of 
c-myc in the skin has been shown to result in epidermal hyperplasia with areas of 
focal dysplasia leading to papillomatous lesions that resemble the human 
premalignant skin lesions known as actinic keratosis, a precursor of SCC 
(Pelengaris et al., 2002). Most in vitro and in vivo studies have indicated that the 
predominant role of deregulated c-myc is to initiate/progress tumours via 
uncontrolled cell proliferation, reduced cell apoptosis and a loss of terminal 
differentiation in keratinocytes. In the HF, c-myc is expressed in the cells of anagen 
follicles, located in the IRS and ORS (Rumio et al., 2000; Bull et al., 2005).  
Activation of c-myc was shown to lead to elevated epithelial cell proliferation of ORS 
with reduced levels of apoptosis. Moreover, overexpression of c-myc resulted in 
marked desynchronization of the murine hair growth cycle, uncoupling of hair cycle-
related skin thickness and hyperplasia of the ORS (Bull et al., 2005).  
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Furthermore, cyclin D1 was detected in the bulge region in the telogen HF, which 
elevated during anagen onset and in anagen HFs it was detected in the ORS (Xu et 
al., 2003). Constitutive activation of Wnt/β-catenin/Lef-1/cyclin-D1 signalling leads to 
uncontrolled progression of cell cycle, a characteristic of cancer development 
(Shtutman et al., 1999; Xia et al., 2001). These expression patterns of c-myc and 
cyclin D1, coincides with miR-214 expression in corresponding HF stages. This 
suggests miR-214 may regulate cell proliferation and differentiation of epithelial cells 
and prevent the development of epithelial tumours by negative regulation of β-
catenin target genes in the skin and HF. 
The data presented here suggests also that miR-214 negatively regulates 
expression of Pten. Interestingly, Pten is a known target of miR-214 as it was shown 
in human ovarian cancer cells (Yang et al., 2008). In the HF, Pten is expressed in 
the bulge region and in the ORS of anagen HFs (Tsao et al., 2003; Zhang et al., 
2006). Keratinocytes-specific mutations of Pten in mice have shown to lead to 
accelerated HF morphogenesis (Suzuki et al., 2003). MiRNAs have been shown to 
have crucial regulatory roles in cell differentiation and proliferation and maintenance 
of skin stem cells. Therefore, miR-214 may represent a unique miRNA, which 
potentially can regulate skin and HF development and cycling, by targeting β-catenin 
and negatively regulating c-myc, cyclin D1, Axin2 and Pten, which are crucial 
players in skin and HF development, stem cell differentiation and carcinogenesis. 
These data suggest that the role of miR-214 in the skin and HF may be first and 
foremost to prevent highly stable forms of β-catenin becoming constitutively active; 
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thus by regulating a crucial pathway such as the canonical Wnt pathway, it can 
potentially regulate a diverse range of cellular processes involved in skin and HF 
development and HF cycling and tumourigenesis. 
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4.3 BMP signalling mediate its effects in the skin in part through post-
transcriptional regulation of miR-21 
BMPs are multifunctional growth factors that induce biological effects through the 
BMP receptor complex followed by activation of the BMP-Smad or BMP-MAPK 
signal transduction pathways (Botchkarev, 2003). BMP signalling plays a pivotal role 
in regulating of many developmental programs and regeneration in numerous 
organs including the skin, by regulation of cell proliferation, differentiation, and 
apoptosis (Botchkarev and Paus 2003; Li, Greco et al., 2003; Massague 2003; 
Mishina 2003; Plikus et al., 2008). 
BMPs have been shown to inhibit the initiation phase of the HF morphogenesis 
(Botchkarev et al., 1999). In adult skin, BMP signalling acts as an inhibitor in telogen 
phase for hair cycle induction (Botchkarev, et al 2001), while at later stages it is 
required for proper control of keratinocyte differentiation into HF-specific cell 
lineages (Kobielak et al., 2003; Andl et al., 2004; Kin Ming et al., 2004; Yuhki et al., 
2004). BMP signalling also controls hair pigmentation by interaction with the 
melanocortin receptor-1 signalling to modulate the balance between 
pheomelanogenesis and eumelanogenesis during hair growth (Sharov et al, 2005).  
Skin cancer including squamous and basal cell carcinoma, represent the most 
frequent type of malignancy in the Caucasian population and its incidence continues 
to grow in the UK and worldwide (Glick and Yuspa, 2005). Several studies have 
shown BMP signalling is important in regulating skin tumorigenesis. Overexpression 
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of BMP4/6 in murine epidermis was shown to lead to increased resistance to 
chemically induced carcinogenesis, while conditional ablation of the BMPR-IA in 
keratinocytes results in formation of HF-derived tumours (Ming-Kwan et al., 2004). 
Anti-tumour activities of BMP signalling have been shown to be suppressed by 
extracellular BMP inhibitors such as gremlin 1 and noggin. Gremlin 1 expression 
was shown to be increased in basal cell carcinomas, in which gremlin promotes cell 
proliferation, in contrast to BMPs (Sneddon et al., 2006). Recently, BMP antagonist 
noggin was shown to promote skin tumorigenesis via stimulation of the Wnt and Shh 
signalling pathways (Sharov et al., 2009). 
However, recent findings have suggested BMP tumour suppressive effects may be 
mediated by miRNAs (Reinke and Carthew, 2008). Increasing evidence suggests 
that miRNAs are important regulators of the oncogenic processes, and the 
expression of many miRNAs are deregulated in cancers (Deng et al., 2008). By 
targeting multiple signalling pathways miRNAs can either potentially prevent cancer 
development or contribute to cancer initiation and progression (Selcuklu et al., 2009; 
Inui et al., 2010). In this project, analysis of the spatio-temporal expression of miR-
21, which possesses oncogenic activity, was carried out in K14-noggin mice, to 
investigate whether some of these inhibitory effects of the BMP signalling are 
mediated in part by miRNAs. 
Microarray and real-time PCR analyses revealed substantial BMP4-dependent 
changes in the expression of distinct miRNAs (Fig. 20). Among them, miR-21 
expression was markedly decreased in keratinocytes after BMP4 treatment (Table 
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5). This was followed by analysis of the effects of BMP4 on miR-21 biogenesis, 
which showed BMP4 only negatively regulated mature form of miR-21. This 
suggests that BMP4 negatively regulates expression of miR-21 post-
transcriptionally, involving only in the final step of its biogenesis (Fig. 21). In 
contrast, in the skin of TG mice overexpressing noggin, expression of miR-21 was 
increased compared to wild-type mice (Fig. 24). These data are also consistent with 
recent findings that BMPs can downregulate miR-21 in breast cancer. BMP-6-
induced inhibition of miR-21 was suggested as a possible anti-metastasis factor by a 
mechanism involving post-transcriptional repression of miR-21 in breast cancer (Du 
et al., 2009). Therefore, negative regulation of miR-21 by BMP signalling identified in 
this study might suggest a novel molecular mechanism for BMP-induced tumour 
suppressive effects in the skin.  
Furthermore, we identified the existence of two groups of the BMP target genes, 
which are differentially regulated by miR-21. BMP-dependent tumour-suppressor 
genes such as Pdcd4, Pten, TPM1, and Smad7, are negatively regulated by miR-21, 
In fact, the downregulation of Pten, Pdcd4, TPM1, TIMP3 expression in the 
keratinocytes due to their transfection with  miR-21 mimic was anticipated, because 
these genes were experimentally proven to be the targets of miR-21 and have been 
shown to be either mutated or downregulated in many tumours (Zhu et al., 2007; 
Asangani et al., 2007; Li et al., 2009; Zhang et al., 2008; Song et al., 2010). 
Therefore, this suggests further that the anti-tumour effects of BMP signalling in 
keratinocytes can indeed be mediated by miR-21. BMP signalling may acquire its 
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miR-21
Cell Differentiation                 Tumour Suppression
Id1-3, Msx2                                       PTEN, PDCD4, TPM1, TIMP1
anti-tumour functions in the skin in part by down-regulating miR-21 expression, 
which will in turn abrogate negative effects of miR-21 on tumour suppressor genes. 
However, we identified that the expression of genes, which mediate BMP-induced 
cell differentiation effects, such as Id1-3, and Msx2, is not affected by miR-21. This 
suggests that BMP signalling pathway in keratinocytes mediates its diverse functions 
in miR-21-dependent and miR-21-independent manner (Fig. 26). 
 
 
 
 
 
 
 
 
 
 
In addition, this study revealed that Smad7 is a direct target of miR-21 (Fig. 23). 
Smad7 is an inhibitory protein, which mediates negative feedback loop to BMP 
signalling. It has been shown that inhibitory Smad7 not only antagonizes BMP 
signalling, but its expression is also induced by BMP signalling (Denissova et al., 
2000). The negative regulation of Smad7 via miR-21 adds another dimension to 
Figure 26. Illustrative representation of the complex regulatory 
pathways involved in BMP signalling in the skin.  BMP signalling 
negatively regulates miR-21 expression in epidermal keratinocytes.  There 
are two groups of BMP target genes, which expression is differentially 
regulated by miR-21. 
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BMP-Smad "canonical" pathway, and therefore, the novel regulatory mechanisms 
involved in maintaining/balancing signalling pathways in skin homeostasis.  
 
Despite the recent progress in understanding the role of miR-21 in disease and its 
regulation by BMPs, its roles and functional significance in the skin and HF in health 
and disease should be investigated further. 
 
4.3.1 MicroRNA-21 involvement in the control of gene expression in the skin 
during chemically induced carcinogenesis  
The great majority of malignant tumours arise from the epithelial part of the skin. 
Despite the fact that the epidermis is one the tissues most widely used in 
experimental cancer research (Marks, 1976; Hennings et al., 1993), our knowledge 
of the molecular processes that underlie epithelial proliferation and differentiation 
associated with the potential role of miRNAs in tumour development is still limited. 
Therefore, we analyzed the expression pattern of miR-21 in the skin during 
chemically induced carcinogenesis in FVB mice. 
It was observed that expression of miR-21 increased in the hyperplastic epidermis at 
the earliest stages of tumour initiation, while it was very abundant in premalignant 
papillomas of the skin. These data are correlated with recent reports that miR-21 is 
an active oncogenic miRNA. It was recently reported that miR-21 is upregulated in 
premalignant moderately differentiated papillomas of the skin and SCC. Recently, 
Dziunycz and colleagues (2010) showed expression of miRNAs was altered in SCC, 
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and one of the miRNAs, which showed the most dramatic increases in its expression 
was miR-21(Dziunycz et al., 2010). Furthermore, miR-21 has been shown to be 
overexpressed in various tumour types.  MiR-21 has been implicated in the 
promotion of tumour growth in breast cancer (Si et al., 2007), cell proliferation in 
pancreatic cancer (Roldo et al., 2006) and exert anti-apoptotic effects in human 
glioblastoma cells (Du et al., 2009; Qin et al., 2009). Si and colleagues (2007) 
demonstrated that inhibition of miR-21 activity in tumour cells resulted in the 
regression of tumour growth (Si et al., 2007). Therefore, this suggests a pro-
oncogenic role for miR-21 in promoting development and maintaining SCC in part by 
affecting important processes such as cell differentiation, proliferation and apoptosis 
in the skin.  
In addition, miR-21 may facilitate the promotion and maintenance of tumour 
development in the skin by targeting tumour suppressor genes, such as Pten and 
Pdcd4 (Meng et al., 2007; Asangani et al., 2008). The importance of Pdcd4 as a 
tumour suppressor was shown in the skin using mouse skin during chemical 
induction of skin carcinogenesis. Cmarik and colleagues (1999) analysed the effects 
of overexpressing Pdcd4 (under K14 promoter) on tumour formation in the mouse 
skin. It was shown that these TG mice showed significant reduction in papilloma 
formation, carcinoma incidence, and papilloma-to-carcinoma conversion frequency 
compared with wild-type mice (Cmarik et al., 1999). Furthermore, Pdcd4 was shown 
to inhibit neoplastic transformation in epidermal keratinocytes (Jansen et al., 2005). 
Pten is another tumour suppressor directly targeted by miR-21. Pten was shown to 
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be mutated and/or underexpressed in basal cell carcinoma, SCC and melanoma of 
the skin, influencing cellular processes such as cell proliferation, differentiation, and 
programmed cell death (Endersby and Baker, 2008). Loss of Pten functions has 
been linked to basal cell carcinoma, through the activation of Shh (Reifenberger, 
2007). Furthermore, suppression of Pten in the skin has been shown to lead to the 
development of SCC in humans and in mice (Ming and He, 2009). Moreover, either 
deletion or mutation of Pten leads to increased susceptible to tumour induction 
(Suzuki et al., 1998). These data demonstrate that Pdcd4 and Pten have crucial 
roles in skin cancer development. Therefore, our data suggests that the oncogenic 
features of miR-21 in promoting tumour development might include the 
downregulation of tumour suppressors in the skin, which can lead to increased cell 
proliferation and apoptotic resistance.  
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Conclusion 
MiRNAs are relatively new class of small non-coding RNAs that can regulate post-
transcriptionally their mRNA targets. Since skin serves as an excellent model system 
for studying the biology of organ development and regeneration, delineation of the 
roles of miRNAs in the skin is highly important for better understanding fundamental 
mechanisms that govern normal development and/or which can lead to the 
development of skin disorders. Our study identified the role of two miRNAs in skin 
and HF development and cycling (miR-31 and miR-214), and a potential role for one 
miRNA in skin tumourigenesis (miR-21). From the data presented here the following 
conclusions can be made: 
1. MiR-31 plays the important role in complex regulation of the gene expression 
programmes that control anagen progression and hair shaft formation in the 
HF. By targeting a number of growth regulatory molecules, transcription 
factors and cytoskeletal proteins, miR-31 is involved in establishing an 
optimal balance of gene expression in the HF required for its proper growth 
and hair fiber formation. Although many aspects of the miR-31-dependent 
effects on the HF cycling remain to be clarified, these data will help in further 
establishing molecular signalling networks that control organ regeneration 
and raise the possibility of exploring the role of miR-31 in pathobiology of 
distinct clinical conditions with impaired skin regeneration and hair growth. 
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2. MiR-214 is a novel regulator of the Wnt/β-catenin signalling pathway in 
keratinocytes. As a result, the importance and value of miR-214 as a 
regulator of Wnt/β-catenin signalling is way beyond cutaneous biology, and 
can be extended to other physiological processes, which have a canonical 
Wnt signalling pathway at its ‘core’. Therefore, this makes miR-214 a potential 
therapeutic target in various fields such as cutaneous biology, oncology and 
stem cell biology. Understanding the role of miR-214 as a novel regulator that 
controls skin morphogenesis and regeneration will help to develop new 
approaches for treatment of skin disorders by targeting the activity of miR-
214. 
 
3. This study establishes a novel mechanism involved in the realisation of the 
BMP effects in the skin and suggests miRNAs as important regulators 
modulating the effects of growth factor signalling pathways on skin 
development and tumourigenesis. Understanding the regulatory mechanisms 
in skin and HF tumour development and the role of BMPs and miR-21 in skin 
tumourigenesis may facilitate the clinical treatment and prevention of skin and 
HF derived tumours.  
 
In summary, miRNAs are potent regulators of multiple signalling pathways playing a 
crucial role in maintaining tissue homeostasis and pathogenesis of many diseases. 
The accomplishment of this project produced new information about miRNA 
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involvement in skin homeostasis and skin tumourigenesis. Better understanding of 
the roles of miRNAs will help to develop new approaches for treatment of skin 
disorders by targeting the activity of specific miRNAs. 
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Future Work 
The following experimental studies will be of help to further elucidate, 1) the 
mechanism underlying the functions of miR-31 in the skin and HF, 2) the underlying 
mechanisms involved in miR-214 in the control of the canonical Wnt signalling in the 
skin and HF and 3) the oncogenic functions of miR-21 in the skin epithelium by: 
1. Examining the role of miR-31 in human skin and HF by pharmacological 
modulation of miR-31 levels by using its mimics or inhibitors in organ 
culture 
2. By targeting cytoskeletal proteins such as keratins 16 and 17, which are 
important in wound healing processes it will be of interest to investigate if 
miR-31 can regulate certain aspects of wound healing, and age-
associated impaired skin repair. 
3. To define the effects of the gain and loss miR-214 activity on skin 
development and postnatal HF growth by generating transgenic mice 
overexpressing miR-214 or by pharmacological modulation of miR-214 
levels by using its mimics or inhibitors. 
4. To identify additional targets of miR-214 in keratinocytes 
5. To determine the effects of miR-21 inhibition on the distinctive stages of 
epidermal tumour formation during chemically induced multistage skin 
carcinogenesis. 
6. To identify miR-21 targets in epidermal mouse keratinocytes implicated in 
epidermal carcinogenesis. 
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Anagen Catagen Telogen P-value 
 
mmu-let-7a  
34,080 37,282 28,616 4.99E-05 
mmu-let-7b  26,775 28,245 21,593 3.97E-03 
mmu-let-7c  30,679 34,524 25,817 1.35E-04 
mmu-let-7d  26,886 26,308 21,365 2.89E-03 
mmu-let-7e  12,254 7,611 6,136 2.32E-03 
mmu-let-7f  29,618 27,453 22,636 5.85E-04 
mmu-let-7g  6,762 8,690 10,316 1.03E-04 
mmu-let-7i  8,921 12,732 12,953 1.04E-06 
mmu-miR-1  10,182 16,405 28,682 2.09E-08 
mmu-miR-100  226 259 633 1.11E-16 
mmu-miR-103  2,484 2,053 884 8.74E-09 
mmu-miR-106a  308 322 193 1.88E-02 
mmu-miR-107  2,235 1,703 793 1.40E-08 
mmu-miR-10a  643 450 313 2.66E-04 
mmu-miR-10b  1,871 1,807 2,449 1.29E-03 
mmu-miR-125a-5p  2,408 2,538 3,562 2.22E-05 
mmu-miR-125b-5p  9,991 12,985 16,895 1.02E-10 
mmu-miR-126-3p  2,239 5,403 7,564 8.03E-13 
mmu-miR-127  1,386 1,974 2,282 1.02E-03 
mmu-miR-128a  275 287 453 1.02E-08 
mmu-miR-130a  180 282 171 1.17E-06 
mmu-miR-133a  1,450 2,493 4,025 1.11E-16 
mmu-miR-133b  1,214 2,089 3,611 0.00E+00 
mmu-miR-140*  669 341 205 2.78E-15 
mmu-miR-143  941 2,705 3,587 4.02E-13 
mmu-miR-145  5,257 3,950 3,341 1.18E-07 
mmu-miR-146a  78 169 678 4.44E-16 
mmu-miR-148a  250 854 2,796 2.48E-12 
mmu-miR-150  159 215 581 1.66E-10 
mmu-miR-151-5p  1,382 970 924 2.87E-06 
mmu-miR-152  873 1,359 3,092 0.00E+00 
mmu-miR-155  618 45 25 0.00E+00 
mmu-miR-15a  875 649 989 6.91E-04 
mmu-miR-15b  6,140 2,928 2,384 2.81E-09 
mmu-miR-16  14,023 11,139 9,687 2.58E-02 
mmu-miR-17  1,780 2,100 877 2.34E-04 
mmu-miR-181a  1,253 2,207 1,267 4.99E-07 
mmu-miR-182  942 666 501 1.07E-06 
mmu-miR-183  1,855 935 482 2.32E-13 
mmu-miR-191  3,454 3,012 1,780 2.00E-15 
mmu-miR-195  4,159 3,828 6,763 0.00E+00 
mmu-miR-199a-3p  2,141 6,754 14,750 0.00E+00 
mmu-miR-199a-5p  207 363 641 1.55E-13 
mmu-miR-19b  195 296 117 5.05E-06 
mmu-miR-200a  144 842 809 4.34E-13 
mmu-miR-200b  8,130 4,745 2,703 1.73E-10 
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List of differentially expressed miRNAs in distinct hair cycle stages 
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mmu-miR-200c  11,342 7,148 3,421 0.00E+00 
mmu-miR-203  57,573 59,271 32,593 4.44E-16 
mmu-miR-205  13,774 21,404 14,430 3.63E-04 
mmu-miR-20a  2,290 2,601 1,246 3.66E-04 
mmu-miR-21  4,219 4,299 9,121 1.72E-06 
mmu-miR-214  4,088 2,542 4,671 1.15E-04 
mmu-miR-22  231 484 535 4.38E-05 
mmu-miR-221  297 411 317 8.37E-06 
mmu-miR-222  442 435 297 1.55E-04 
mmu-miR-223  473 25 166 4.29E-09 
mmu-miR-24  4,791 9,292 10,421 3.17E-07 
mmu-miR-25  3,795 2,616 1,680 3.85E-14 
mmu-miR-26a  17,633 26,562 26,411 1.30E-07 
mmu-miR-26b  3,627 3,544 6,210 7.88E-05 
mmu-miR-27a  1,744 5,366 7,887 1.13E-11 
mmu-miR-27b  2,699 8,388 9,501 1.86E-12 
mmu-miR-295*  5 62 4 1.37E-03 
mmu-miR-29a  309 776 2,669 0.00E+00 
mmu-miR-30a  445 1,226 2,074 6.16E-13 
mmu-miR-30b  6,269 3,227 3,908 1.05E-04 
mmu-miR-30c  7,827 4,044 3,683 1.61E-07 
mmu-miR-30d  943 1,205 1,717 4.73E-12 
mmu-miR-30e  95 244 514 2.11E-13 
mmu-miR-31  1,136 683 68 0.00E+00 
mmu-miR-320  5,704 4,424 3,131 1.93E-10 
mmu-miR-322  101 115 388 5.57E-10 
mmu-miR-335-5p  59 184 237 1.08E-02 
mmu-miR-361  1,292 711 621 1.44E-10 
mmu-miR-377  98 119 36 5.35E-05 
mmu-miR-378  215 462 511 1.21E-14 
mmu-miR-379  1,042 849 1,439 1.17E-10 
mmu-miR-382  395 235 371 9.26E-05 
mmu-miR-423-5p  688 413 345 1.77E-06 
mmu-miR-429  2,107 1,808 1,089 4.88E-07 
mmu-miR-434-3p  296 465 991 8.07E-13 
mmu-miR-466f-3p  364 2,133 232 8.58E-04 
mmu-miR-466g  79 734 49 1.01E-02 
mmu-miR-467a*  31 187 20 2.28E-03 
mmu-miR-467b*  47 372 22 9.44E-04 
mmu-miR-486  249 294 667 5.49E-12 
mmu-miR-669c  302 191 98 1.48E-04 
mmu-miR-674  359 502 243 0.00E+00 
mmu-miR-676  425 310 250 4.49E-09 
mmu-miR-689  189 313 1,389 0.00E+00 
mmu-miR-690  8,249 2,060 1,247 1.68E-08 
mmu-miR-705  5,692 3,432 4,784 5.89E-05 
mmu-miR-709  41,199 27,175 29,106 2.83E-11 
mmu-miR-720  871 2,393 399 2.27E-11 
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mmu-miR-762  6,228 4,776 5,657 4.81E-02 
mmu-miR-805  503 98 118 4.53E-07 
mmu-miR-92a  5,013 3,545 2,200 9.70E-14 
mmu-miR-92b  1,488 850 681 2.96E-05 
mmu-miR-93  572 848 378 4.18E-04 
mmu-miR-98  2,000 540 715 3.10E-04 
mmu-miR-99a  602 624 989 9.17E-07 
mmu-miR-99b  1,094 1,206 704 9.70E-06 
P a g e  | 231 
 
APPENDIXES B 
RIPA Buffer 
Chemicals Amount Comapny 
Tris-HCL (1M, pH 7.5)  5mls Sigma, UK 
NaCL (5M)  3mls Sigma, UK 
Triton-x100 (10%)  10mls Sigma, UK 
Doc-NA  1g Sigma, UK 
Sodium dodecyle 
sulphate (SDS) (10%)  
1ml Sigma, UK 
Distilled Water  
Add up to 100mls 
- - 
 
 
Transblot Buffer 
Chemicals Amount Company 
Tris Buffer  7.5g  
 
Sigma, UK 
Glycine  
 
36g Sigma, UK 
Distilled Water  
Add up to 250mls  
- - 
 
Tris Buffer (pH 8.9) (Lower stacking gel) 
Chemicals Amount Company 
Tris Base 18.16g Sigma, UK 
SDS 
 
0.4g Sigma, UK 
Distilled Water  
Add up to 100mls  
- - 
 
Tris Buffer (pH 6.9) (upper stacking gel) 
 
Chemicals Amount Company 
Tris Base 6.06g Sigma, UK 
SDS 
 
0.4g Sigma, UK 
Distilled Water  
Add up to 100mls  
- - 
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Composition of electrophoresis separation gel 
Chemicals 8% 
separation 
gel 
3% stacking gel Company 
Bis/Acrylamide 2.0ml 375µl Bio-Rad Corp, 
UK 
Lower Gel 
Tris/*Upper gel Tris 
2.5ml *1.25ml See above 
Temed 15µl 8µl Sigma, UK 
10% Ammonium 
persulphate (APS) 
 
 
56µl 30µl  Bio-Rad Corp, 
UK 
Distilled water 5.5ml 3.375ml  - 
 
 
Sample BufferSample Reagents Amount Source 
Chemicals Amount Company 
Glycerol 7mls Invitrogen, UK 
20% SDS 11.5mls Sigma, UK 
1M Tris/HCL 6.3mls Sigma, UK 
*Dithiothreitol (DTT) 
 
1g Invitrogen, UK 
Bromophenal Blue 
 
0.1 Bio-Rad Corp, UK 
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APPENDIXES C 
 
Changes in gene expression programmers in primary mouse epidermal 
keratinocytes treated with sequence specific antagonist of microRNA-31   
 
Adhesion/Extracellular Matrix  Gene 
Symbol  
Accession 
Number  
Fold 
Change  
catenin (cadherin associated protein), alpha-
like 1  
Ctnnal1  NM_018761  3.28  
ankyrin repeat domain 26  Ankrd26  NM_001081112  2.91  
transmembrane protein 161B  Tmem161b  NM_175187  2.69  
espin-like  Espnl  NM_001033292  2.54  
plexin C1  Plxnc1  NM_018797  2.47  
transmembrane 6 superfamily member 1  Tm6sf1  NM_145375  2.45  
occludin  Ocln  NM_008756  2.43  
neural cell adhesion molecule 1  Ncam1  NM_010875  2.39  
FAT tumor suppressor homolog 3  Fat3  NM_001080814  2.22  
junction-mediating and regulatory protein  Jmy  NM_021310  2.15  
asporin  Aspn  NM_025711  2.09  
cadherin  Cdh17  NM_019753  2.05  
transmembrane protein 44  Tmem44  NM_172614  2.04  
adhesion molecule with Ig like domain 2  Amigo2  NM_178114  2.01  
CEA-related cell adhesion molecule 14  Ceacam14  NM_025957  2.00  
L1 cell adhesion molecule  L1cam  NM_008478  -2.00  
solute carrier family 7  Slc7a4  NM_144852  -2.00  
tetraspanin 32  Tspan32  NM_020286  -2.01  
solute carrier family 6  Slc6a7  NM_201353  -2.01  
tenascin XB  Tnxb  NM_031176  -2.03  
solute carrier family 37 , member 2  Slc37a2  NM_020258  -2.11  
leucine rich repeat containing 23  Lrrc23  NM_013588  -2.13  
ankyrin repeat domain 58  Ankrd58  NM_173779  -2.15  
cadherin 19  Cdh19  NM_001081386  -2.22  
protocadherin beta 6  Pcdhb6  NM_053131  -2.23  
ankyrin repeat domain 12  Ankrd12  NM_001025572  -2.23  
solute carrier family 22 (organic anion 
transporter), member 7  
Slc22a7  NM_144856  -2.27  
transmembrane protein 198  Tmem198  NM_177056  -2.28  
olfactomedin 2  Olfm2  NM_173777  -2.30  
leucine-rich alpha-2-glycoprotein  Lrg1  NM_029796  -2.31  
transmembrane protein 132E  Tmem132e  NM_023438  -2.31  
transmembrane protein 138  Tmem138  NM_028411  -2.34  
solute carrier family 27  Slc27a6  NM_001081072  -2.38  
claudin 18  Cldn18  NM_019815  -2.50  
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protocadherin beta 5  Pcdhb5  NM_053130  -2.51  
fibulin 7  Fbln7  NM_024237  -2.63  
solute carrier family 25, member 42  Slc25a42  NM_001007570  -2.68  
solute carrier family 5 (sodium/glucose 
cotransporter), member 2  
Slc5a2  NM_133254  -2.72  
integrin, alpha E, epithelial-associated  Itgae  NM_008399  -2.77  
solute carrier family 22 (organic cation 
transporter), member 17  
Slc22a17  NM_021551  -2.82  
defensin related cryptdin 20  Defcr20  NM_183268  -2.86  
transmembrane 4 superfamily member 5  Tm4sf5  NM_029360  -2.88  
fermitin family homolog 3  Fermt3  NM_153795  -2.96  
Na+/K+ transporting ATPase interacting 3  Nkain3  NM_172987  -3.11  
solute carrier family 38, member 10  Slc38a10  NM_024249  -3.12  
protocadherin gamma subfamily A  Pcdhga4  NM_033587  -3.29  
transmembrane and coiled-coil domains 7  Tmco7  NM_173037  -3.40  
transmembrane protein 63c  Tmem63c  NM_172583  -3.43  
vascular cell adhesion molecule 1  Vcam1  NM_011693  -3.43  
cadherin 4  Cdh4  NM_009867  -3.55  
transmembrane protein 91  Tmem91  NM_177102  -3.55  
gap junction protein, gamma 2  Gjc2  NM_175452  -3.56  
transmembrane protein 37  Tmem37  NM_019432  -3.62  
Cell cycle/Apoptosis  
nucleolar and coiled-body phosphoprotein 1  Nolc1  NM_001039352  3.97  
tubulin polymerization promoting protein  Tppp  NM_182839  3.21  
Fas apoptotic inhibitory molecule 2  Faim2  NM_028224  2.96  
cyclin-dependent kinase-like 2  Cdkl2  NM_177270  2.64  
cylindromatosis  Cyld  NM_173369  2.45  
IAP promoted placental gene  Ipp  NM_008389  2.34  
Bcl2-interacting killer  Bik  NM_007546  2.23  
heat shock protein 1  Hspb1  NM_013560  2.16  
serine/threonine kinase 4  Stk4  NM_021420  2.05  
microtubule-associated protein 1B  Mtap1b  NM_008634  2.03  
cyclin-dependent kinase 7  Cdk7  NM_009874  2.00  
heat shock protein family, member 7  Hspb7  NM_013868  -2.09  
dedicator of cytokinesis 6  Dock6  NM_177030  -2.09  
heat shock protein family, member 7  Hspb7  NM_013868  -2.20  
cell death-inducing DNA fragmentation factor,  
alpha subunit-like effector B  
Cideb  NM_009894  -2.21  
B-cell leukemia/lymphoma 2 related protein 
A1b  
Bcl2a1b  NM_007534  -2.35  
cell cycle exit and neuronal differentiation 1  Cend1  NM_021316  -2.66  
tumor necrosis factor receptor superfamily,  
member 25  
Tnfrsf25  NM_033042  -2.76  
Fas ligand  Fasl  NM_010177  -2.87  
microtubule-associated protein 1 A  Mtap1a  NM_032393  -3.29  
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Cytoskeleton  
myomesin 1  Myom1  NM_010867  3.68  
keratin 17  Krt17  NM_010663  3.36  
keratin 14  Krt14  NM_016958  2.96  
myosin, heavy polypeptide 8, skeletal muscle, 
perinatal  
Myh8  NM_177369  2.82  
myosin, light polypeptide 6, alkali, smooth 
muscle and non-muscle  
Myl6  NM_010860  2.79  
FERM domain containing 5  Frmd5  NM_172673  2.63  
keratin 6A  Krt6a  NM_008476  2.58  
keratin 5  Krt5  NM_027011  2.49  
keratin 16  Krt16  NM_008470  2.41  
cornifelin  Cnfn  NM_001081375  2.21  
myosin VC  Myo5c  NM_001081322  2.01  
profilin 3  Pfn3  NM_029303  -2.04  
synaptopodin  Synpo  NM_177340  -2.07  
spectrin beta 4  Spnb4  NM_032610  -2.09  
fibrillin 2  Fbn2  NM_010181  -2.24  
spectrin beta 1  Spnb1  NM_013675  -3.13  
epiplakin 1  Eppk1  NM_144848  -3.15  
keratin 84  Krt84  NM_008474  -4.17  
fibronectin type 3 and SPRY domain-
containing protein  
Fsd1  NM_183178  -4.91  
Metabolism  
monooxygenase, DBH-like 2  Moxd2  NM_139296  3.21  
pancreatic lipase  Pnlip  NM_026925  3.07  
membrane metallo endopeptidase  Mme  NM_008604  3.03  
N-acylsphingosine amidohydrolase 2  Asah2  NM_018830  2.96  
cubilin  Cubn  NM_001081084  2.93  
establishment of cohesion 1 homolog 1  Esco1m  NM_001081222  2.89  
carbonic anhydrase 8  Car8  NM_007592  2.83  
iduronidase, alpha-L-  Idua  NM_008325  2.67  
UDP glucuronosyltransferase 2 family,  
polypeptide B35  
Ugt2b35  NM_172881  2.60  
acylphosphatase 2  Acyp2  NM_029344  2.57  
monoacylglycerol O-acyltransferase 1  Mogat1  NM_026713  2.55  
X-prolyl aminopeptidase  Xpnpep3  NM_177310  2.53  
oxidase assembly 1-like  Oxa1l  NM_026936  2.52  
glutathione S-transferase omega 1  Gsto1  NM_010362  2.46  
ubiquitin specific peptidase 33  Usp33  NM_001076676  2.44  
mannoside acetylglucosaminyltransferase 3  Mgat3  NM_010795  2.38  
serine racemase  Srr  NM_013761  2.23  
ST8 alpha-N-acetyl-neuraminide alpha-2,8-
sialyltransferase 2  
St8sia2  NM_009181  2.17  
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protein phosphatase 2, regulatory subunit B  
(PR 52), beta isoform  
Ppp2r2b  NM_028392  2.11  
cytochrome c oxidase, subunit VI a, 
polypeptide 1  
Cox6a1  NM_007748  2.09  
hydroxy-delta-5-steroid dehydrogenase, 3 
beta-  
and steroid delta-isomerase 3  
Hsd3b3  NM_001012306  2.08  
protein phosphatase 2, regulatory subunit A  Ppp2r1b  NM_001034085  2.08  
inositol polyphosphate-5-phosphatase D  Inpp5d  NM_010566  2.07  
beta galactoside alpha 2,6 sialyltransferase 1  St6gal1  NM_145933  2.03  
lactamase, beta  Lactb  NM_030717  2.03  
coiled-coil domain containing 47  Ccdc47  NM_026009  2.02  
acyl-Coenzyme A oxidase 1, palmitoyl  Acox1  NM_015729  2.02  
chondroitin sulfate synthase 3  Chsy3  NM_001081328  2.02  
enolase 2, gamma neuronal  Eno2  NM_013509  -2.01  
granzyme E  Gzme  NM_010373  -2.01  
lysyl oxidase-like 4  Loxl4  NM_053083  -2.02  
calcium/calmodulin-dependent protein  
kinase I gamma  
Camk1g  NM_144817  -2.02  
glycerol-3-phosphate dehydrogenase 1-like  Gpd1l  NM_175380  -2.03  
inositol polyphosphate-4-phosphatase, type I  Inpp4a  NM_030266  -2.07  
hepsin  Hpn  NM_008281  -2.08  
a disintegrin and metallopeptidase domain 
26A  
Adam26a  NM_010085  -2.08  
carboxypeptidase X 1  Cpxm1  NM_019696  -2.09  
methyltransferase like 8  Mettl8  NM_145524  -2.13  
peptidyl arginine deiminase, type VI  Padi6  NM_153106  -2.13  
cytochrome b-245, beta polypeptide  Cybb  NM_007807  -2.16  
myeloperoxidase  Mpo  NM_010824  -2.17  
ATPase family, AAA domain containing 4  Atad4  NM_146026  -2.23  
sphingomyelin phosphodiesterase 3  Smpd3  NM_021491  -2.24  
DEAQ RNA-dependent ATPase  Dqx1  NM_033606  -2.33  
esterase 22  Es22  NM_133660  -2.37  
ethanolamine kinase 2  Etnk2  NM_175443  -2.50  
aspartate-beta-hydroxylase  Asph  NM_133723  -2.60  
carbonic anhydrase 15  Car15  NM_030558  -2.63  
formiminotransferase cyclodeaminase  Ftcd  NM_080845  -2.65  
cytochrome c oxidase subunit VIb polypeptide 
2  
Cox6b2  NM_183405  -2.70  
oviductal glycoprotein 1  Ovgp1  NM_007696  -2.70  
cytochrome P450, family 2, subfamily d,  
polypeptide 12  
Cyp2d12  NM_201360  -2.72  
glycosyltransferase-like domain containing 1  Gtdc1  NM_172662  -2.73  
nicotinamide N-methyltransferase  Nnmt  NM_010924  -2.75  
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cytochrome P450, family 2, subfamily d,  
polypeptide 26  
Cyp2d26  NM_029562  -2.91  
sulfotransferase family 5A, member 1  Sult5a1  NM_020564  -3.08  
hydroxysteroid (17-beta) dehydrogenase 13  Hsd17b13  NM_198030  -3.10  
acetyl-Coenzyme A carboxylase beta  Acacb  NM_133904  -3.10  
DIP2 disco-interacting protein 2 homolog A  Dip2a  NM_001081419  -3.13  
alkaline phosphatase 3  Akp3  NM_007432  -3.17  
cytochrome P450, family 2, subfamily d,  
polypeptide 22  
Cyp2d22  NM_019823  -3.26  
dual specificity phosphatase 13  Dusp13  NM_001007268  -3.40  
sterol O-acyltransferase 2  Soat2  NM_146064  -3.64  
fucosyltransferase 2  Fut2  NM_018876  -3.89  
Molecular Channels/Transport  
solute carrier family 14 (urea transporter), 
member 2  
Slc14a2  NM_030683  5.83  
pallidin  Pldn  NM_019788  2.94  
apolipoprotein L 7c  Apol7c  NM_175391  2.60  
pleckstrin  Plek  NM_019549  2.57  
pannexin 1  Panx1  NM_019482  2.51  
sodium leak channel, non-selective  Nalcn  NM_177393  2.48  
solute carrier family 2 (facilitated glucose 
transporter), member 13  
Slc2a13  NM_001033633  2.46  
SEC22 vesicle trafficking protein-like A  Sec22a  NM_133704  2.46  
bicaudal D homolog 1  Bicd1  NM_009753  2.45  
potassium voltage-gated channel,  
shaker-related subfamily, member 5  
Kcna5  NM_145983  2.32  
muted  Muted  NM_139063  2.25  
LPS-responsive beige-like anchor  Lrba  NM_001077687  2.22  
importin 11  Ipo11  NM_029665  2.18  
solute carrier family 6  Slc6a12  NM_133661  2.18  
transient receptor potential cation channel,  
subfamily M, member 3  
Trpm3  NM_001035239  2.06  
solute carrier family 15  Slc15a1  NM_053079  2.05  
aquaporin 12  Aqp12  NM_177587  2.00  
kinesin family member 9  Kif9  NM_010628  -2.00  
Sec61 alpha 1 subunit  Sec61a1  NM_016906  -2.04  
intersectin 1  Itsn1  NM_010587  -2.51  
apolipoprotein B editing complex 1  Apobec1  NM_031159  -2.53  
kinesin family member 21B  Kif21b  NM_001039472  -2.56  
synaptotagmin I  Syt1  NM_009306  -3.02  
cytoglobin  Cygb  NM_030206  -3.57  
Proteolysis  
parkin  Park2  NM_016694  3.39  
ubiquilin 3  Ubqln3  NM_198623  2.65  
dipeptidylpeptidase 4  Dpp4  NM_010074  2.24  
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ubiquitin B  Ubb  NM_011664  2.06  
lysozyme-like 1  Lyzl1  NM_026092  -2.21  
meprin 1 alpha  Mep1a  NM_008585  -2.25  
inter alpha-trypsin inhibitor, heavy chain 4  Itih4  NM_018746  -2.29  
WAP four-disulfide core domain 15A  Wfdc15a  NM_183271  -2.61  
rhomboid, veinlet-like 3  Rhbdl3  NM_139228  -2.89  
protease, serine, 3  Prss3  NM_011645  -2.93  
chymotrypsin C  Ctrc  NM_001033875  -2.99  
serine (or cysteine) peptidase inhibitor,  
clade F, member 2  
Serpinf2  NM_008878  -3.29  
Signalling  
CD19 antigen  Cd19  NM_009844  4.36  
G protein-coupled receptor 158  Gpr158  NM_001004761  3.44  
sclerostin  Sost  NM_024449  3.30  
CD109 antigen  Cd109  NM_153098  3.29  
olfactory receptor 646  Olfr646  NM_147056  3.26  
calcium/calmodulin-dependent protein kinase 
II inhibitor 1  
Camk2n1  NM_025451  3.24  
vomeronasal 1 receptor, G5  V1rg5  NM_134206  3.20  
olfactory receptor 691  Olfr691  NM_147061  3.12  
synaptojanin 2 binding protein  Synj2bp  NM_025292  3.01  
olfactory receptor 665  Olfr665  NM_146814  2.95  
olfactory receptor 1284  Olfr1284  NM_146381  2.93  
CASK interacting protein 1  Caskin1  NM_027937  2.78  
fibroblast growth factor 10  Fgf10  NM_008002  2.78  
olfactory receptor 157  Olfr157  NM_019475  2.74  
olfactory receptor 821  Olfr821  NM_146776  2.67  
olfactory receptor 174  Olfr174  NM_147002  2.57  
fibroblast growth factor 14  Fgf14  NM_207667  2.53  
olfactory receptor 1056  Olfr1056  NM_147018  2.50  
follistatin-like 5  Fstl5  NM_178673  2.47  
mitogen-activated protein kinase 15  Mapk15  NM_177922  2.46  
olfactory receptor 183  Olfr183  NM_146485  2.44  
gephyrin  Gphn  NM_172952  2.44  
angiotensin II receptor, type 1a  Agtr1a  NM_177322  2.41  
BMP and activin membrane-bound inhibitor, 
homolog  
Bambi  NM_026505  2.41  
mitogen-activated protein kinase kinase 
kinase 2  
Map3k2  NM_011946  2.39  
olfactory receptor 1155  Olfr1155  NM_146643  2.38  
visinin-like 1  Vsnl1  NM_012038  2.38  
protein kinase C, theta  Prkcq  NM_008859  2.33  
betacellulin, epidermal growth factor family 
member  
Btc  NM_007568  2.32  
glutamate receptor, metabotropic 8  Grm8  NM_008174  2.31  
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guanine nucleotide binding protein, alpha  
transducing 1  
Gnat1  NM_008140  2.30  
phosphatidylinositol 3-kinase, catalytic, beta 
polypeptide  
Pik3cb  NM_029094  2.28  
interleukin 1 beta  Il1b  NM_008361  2.27  
olfactory receptor 552  Olfr552  NM_147102  2.24  
olfactory receptor 380  Olfr380  NM_147025  2.24  
olfactory receptor 273  Olfr273  NM_146824  2.19  
receptor (calcitonin) activity modifying protein 
2  
Ramp2  NM_019444  2.18  
striatin, calmodulin binding protein  Strn  NM_011500  2.17  
olfactory receptor 1278  Olfr1278  NM_146394  2.16  
olfactory receptor 554  Olfr554  NM_146325  2.15  
olfactory receptor 615  Olfr615  NM_147080  2.14  
vomeronasal 1 receptor, C33  V1rc33  NM_134436  2.11  
receptor (TNFRSF)-interacting serine-
threonine kinase 2  
Ripk2  NM_138952  2.11  
olfactory receptor 668  Olfr668  NM_147059  2.09  
androgen binding protein epsilon  Abpe  NM_207262  2.09  
olfactory receptor 435  Olfr435  NM_146653  2.09  
signal recognition particle receptor, B subunit  Srprb  NM_009275  2.07  
protein kinase C, beta 1  Prkcb1  NM_008855  2.07  
hepatoma-derived growth factor, related 
protein 3  
Hdgfrp3  NM_013886  2.07  
G protein-coupled receptor kinase 4  Grk4  NM_019497  2.07  
doublecortin  Dcx  NM_010025  2.06  
olfactory receptor 1231  Olfr1231  NM_146454  2.05  
G protein-coupled receptor 98  Gpr98  NM_054053  2.04  
chemokine (C-C motif) receptor 2  Ccr2  NM_009915  2.02  
progesterone receptor  Pgr  NM_008829  2.01  
olfactory receptor 160  Olfr160  NM_030553  2.01  
olfactory receptor 49  Olfr49  NM_010991  2.00  
olfactory receptor 1100  Olfr1100  NM_146594  2.00  
dapper homolog 2, antagonist of beta-catenin  Dact2  NM_172826  -2.00  
ghrelin  Ghrl  NM_021488  -2.00  
pleckstrin homology, Sec7 and coiled-coil 
domains, binding protein  
Pscdbp  NM_139200  -2.03  
interleukin 9 receptor  Il9r  NM_008374  -2.04  
endothelin converting enzyme 2  Ece2  NM_139293  -2.04  
G protein-coupled receptor 20  Gpr20  NM_173365  -2.04  
adrenergic receptor, beta 1  Adrb1  NM_007419  -2.05  
leukocyte-associated Ig-like receptor 1  Lair1  NM_178611  -2.05  
sonic hedgehog  Shh  NM_009170  -2.06  
bradykinin receptor, beta 2  Bdkrb2  NM_009747  -2.06  
wingless-related MMTV integration site 11  Wnt11  NM_009519  -2.06  
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cholinergic receptor, nicotinic, alpha 
polypeptide 5  
Chrna5  NM_176844  -2.06  
insulin II  Ins2  NM_008387  -2.08  
olfactory receptor 703  Olfr703  NM_146596  -2.08  
fos-like antigen 2  Fosl2  NM_008037  -2.09  
disabled homolog 2  Dab2  NM_001037905  -2.12  
G protein-coupled receptor 161  Gpr161  NM_001081126  -2.12  
protein kinase, cAMP dependent regulatory, 
type II alpha  
Prkar2a  NM_008924  -2.12  
platelet derived growth factor receptor, alpha 
polypeptide  
Pdgfra  NM_011058  -2.13  
interleukin 13 receptor, alpha 1  Il13ra1  NM_133990  -2.15  
olfactory receptor 1036  Olfr1036  NM_207142  -2.16  
ankyrin 1, erythroid (Ank1), transcript variant 
2  
Ank1  NM_031158  -2.16  
prolactin releasing hormone receptor  Prlhr  NM_201615  -2.17  
brain-specific angiogenesis inhibitor 1  Bai1  NM_174991  -2.17  
prolactin family 7, subfamily b, member 1  Prl7b1  NM_029355  -2.19  
bone morphogenetic protein 2  Bmp2  NM_007553  -2.19  
G protein-coupled receptor 141  Gpr141  NM_181754  -2.21  
olfactory receptor 476  Olfr476  NM_146924  -2.23  
cholinergic receptor, nicotinic, alpha 
polypeptide 9  
Chrna9  NM_001081104  -2.23  
neurotensin receptor 1  Ntsr1  NM_018766  -2.23  
calcitonin/calcitonin-related polypeptide  Calca  NM_007587  -2.23  
thromboxane A2 receptor  Tbxa2r  NM_009325  -2.24  
olfactory receptor 508  Olfr508  NM_146773  -2.24  
interferon regulatory factor 1  Irf1  NM_008390  -2.25  
prostaglandin E receptor 4  Ptger4  NM_008965  -2.26  
interleukin 12 receptor, beta 1  Il12rb1  NM_008353  -2.27  
inhibitor of growth family, member 3  Ing3  NM_023626  -2.27  
retinoid X receptor gamma  Rxrg  NM_009107  -2.28  
olfactory receptor 1245  Olfr1245  NM_146788  -2.30  
glutathione peroxidase 2  Gpx2  NM_030677  -2.30  
G protein-coupled bile acid receptor 1  Gpbar1  NM_174985  -2.30  
olfactory receptor 720  Olfr720  NM_146392  -2.30  
advanced glycosylation end product-specific 
receptor  
Ager  NM_007425  -2.36  
chemokine (C-X3-C motif) ligand 1  Cx3cl1  NM_009142  -2.36  
chemokine (C-C motif) receptor-like 2  Ccrl2  NM_017466  -2.36  
glutamate receptor, ionotropic, NMDA1 (zeta 
1)  
Grin1  NM_008169  -2.39  
fibroblast growth factor receptor substrate 2  Frs2  NM_177798  -2.39  
glutamate receptor, ionotropic, AMPA1 (alpha 
1)  
Gria1  NM_008165  -2.39  
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calcitonin receptor (Calcr), transcript variant a  Calcr  NM_007588  -2.42  
selectin, platelet (p-selectin) ligand  Selplg  NM_009151  -2.43  
olfactory receptor 360  Olfr360  NM_146622  -2.44  
galanin  Gal  NM_010253  -2.44  
chemokine (C-X3-C) receptor 1  Cx3cr1  NM_009987  -2.48  
insulin-like growth factor 1  Igf1  NM_184052  -2.49  
somatostatin receptor 1  Sstr1  NM_009216  -2.51  
olfactory receptor 1352  Olfr1352  NM_147071  -2.52  
G protein-coupled receptor 35  Gpr35  NM_022320  -2.53  
galanin receptor 3  Galr3  NM_015738  -2.54  
nephrosis 1 homolog, nephrin  Nphs1  NM_019459  -2.55  
G protein-coupled receptor 84  Gpr84  NM_030720  -2.56  
insulin receptor  Insr  NM_010568  -2.58  
olfactory receptor 524  Olfr524  NM_001011814  -2.58  
interleukin 27 receptor, alpha  Il27ra  NM_016671  -2.59  
kelch-like 12  Klhl12  NM_153128  -2.61  
leptin receptor  Lepr  NM_010704  -2.65  
trace amine-associated receptor 9  Taar9  NM_001010831  -2.66  
DAZ interacting protein 1  Dzip1  NM_025943  -2.66  
cortistatin  Cort  NM_007745  -2.67  
G protein-coupled receptor 77  Gpr77  NM_176912  -2.68  
natriuretic peptide precursor type A  Nppa  NM_008725  -2.69  
semaphorin 6C  Sema6c  NM_011351  -2.70  
olfactory receptor 734  Olfr734  NM_146664  -2.73  
endothelial differentiation, G-protein-coupled 
receptor 6  
Edg6  NM_010102  -2.76  
estrogen receptor 2 (beta)  Esr2  NM_207707  -2.78  
olfactory receptor 1331  Olfr1331  NM_001011856  -2.78  
luteinizing hormone beta  Lhb  NM_008497  -2.80  
free fatty acid receptor 1  Ffar1  NM_194057  -2.81  
actin-binding LIM protein 2  Ablim2  NM_177678  -2.82  
gonadotropin releasing hormone 1  Gnrh1  NM_008145  -2.85  
CD40 antigen  Cd40  NM_170701  -2.87  
prepronociceptin  Pnoc  NM_010932  -2.88  
patched homolog 2  Ptch2  NM_008958  -2.93  
ficolin A  Fcna  NM_007995  -2.94  
transforming growth factor, beta 1  Tgfb1  NM_011577  -3.00  
interferon regulatory factor 7  Irf7  NM_016850  -3.01  
olfactory receptor 1344  Olfr1344  NM_177061  -3.04  
olfactory receptor 1393  Olfr1393  NM_146471  -3.05  
MAGI family member, X-linked  Magix  NM_018832  -3.06  
neurotrophic tyrosine kinase, receptor, type 2  Ntrk2  NM_001025074  -3.07  
chordin-like 1  Chrdl1  NM_001114385  -3.15  
olfactory receptor 128  Olfr128  NM_206816  -3.16  
cholecystokinin B receptor  Cckbr  NM_007627  -3.17  
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GABA-B1a receptor  Gabbr1  AF114168  -3.24  
olfactomedin 3  Olfm3  NM_153157  -3.29  
interferon gamma inducible protein 47  Ifi47  NM_008330  -3.49  
fibroblast growth factor 3  Fgf3  NM_008007  -3.61  
glutamate receptor, ionotropic, NMDA2B  Grin2b  NM_008171  -3.74  
CD22 antigen  Cd22  NM_009845  -3.75  
G protein-coupled receptor 137  Gpr137  NM_207220  -3.89  
olfactory receptor 609  Olfr609  NM_147082  -5.18  
anti-Mullerian hormone  Amh  NM_007445  -7.41  
glutamate receptor  Grin2d  NM_008172  -8.66  
Transcription  
RAR-related orphan receptor gamma  Rorc  NM_011281  3.53  
peroxisome proliferator activated receptor 
alpha  
Ppara  NM_011144  3.15  
pleiomorphic adenoma gene 1  Plag1  NM_019969  3.02  
vestigial like 4  Vgll4  NM_177683  2.88  
testis specific X-linked gene  Tsx  NM_009440  2.76  
SRY-box containing gene 2  Sox2  NM_011443  2.54  
peroxisome proliferator activated receptor 
gamma  
Pparg  NM_011146  2.52  
regulatory factor X, 4  Rfx4  NM_001024918  2.50  
empty spiracles homolog 2  Emx2  NM_010132  2.50  
activator of basal transcription 1  Abt1  NM_013924  2.48  
v-myc myelocytomatosis viral oncogene 
homolog 1, lung carcinoma derived  
Mycl1  NM_008506  2.46  
jerky  Jrk  NM_008415  2.44  
zinc finger protein 467  Zfp467  NM_020589  2.44  
distal-less homeobox 3  Dlx3  NM_010055  2.44  
T-cell leukemia, homeobox 3  Tlx3  NM_019916  2.40  
zinc finger protein 9  Zfp9  NM_011763  2.30  
LAG1 homolog, ceramide synthase 6  Lass6  NM_172856  2.26  
NK6 transcription factor related, locus 2  Nkx6-2  NM_183248  2.22  
zinc finger E-box binding homeobox 2  Zeb2  NM_015753  2.19  
distal-less homeobox 1  Dlx1  NM_010053  2.14  
ELK4, member of ETS oncogene family  Elk4  NM_007923  2.10  
IWS1 homolog  Iws1  NM_173441  2.06  
T-box 15  Tbx15  NM_009323  2.02  
AF4/FMR2 family, member 4  Aff4  NM_033565  2.02  
F-box and leucine-rich repeat protein 14  Fbxl14  NM_133940  -2.00  
Kruppel-like factor 2  Klf2  NM_008452  -2.00  
elongation factor RNA polymerase II  Ell  NM_007924  -2.02  
NK2 transcription factor related, locus 6  Nkx2-6  NM_010920  -2.03  
zinc finger homeobox 2 m  Zfhx2  NM_001039198  -2.09  
achaete-scute complex homolog 1  Ascl1  NM_008553  -2.11  
mesenchyme homeobox 1  Meox1  NM_010791  -2.12  
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GATA binding protein 2  Gata2  NM_008090  -2.12  
SRY-box containing gene 17  Sox17  NM_011441  -2.17  
forkhead box E1  Foxe1  NM_183298  -2.21  
zinc finger protein 316  Zfp316  NM_017467  -2.22  
sine oculis-related homeobox 1 homolog  Six1  NM_009189  -2.23  
SAM pointed domain containing ets  
transcription factor  
Spdef  NM_013891  -2.30  
runt related transcription factor 3  Runx3  NM_019732  -2.36  
SRY-box containing gene 1  Sox1  NM_009233  -2.39  
microphthalmia-associated transcription factor  Mitf  NM_008601  -2.41  
four jointed box 1  Fjx1  NM_010218  -2.48  
TEA domain family member 3  Tead3  NM_011566  -2.49  
snail homolog 3  Snai3  NM_013914  -2.54  
SRY-box containing gene 11  Sox11  NM_009234  -2.59  
aristaless related homeobox gene  Arx  NM_007492  -2.62  
F-box protein 27  Fbxo27  NM_207238  -2.62  
Spi-C transcription factor  Spic  NM_011461  -2.63  
SRY-box containing gene 21  Sox21  NM_145464  -2.67  
ring finger protein 183  Rnf183  NM_153504  -2.74  
eukaryotic translation elongation factor 1 delta  Eef1d  NM_029663  -2.82  
ring finger protein 186  Rnf186  NM_025786  -2.87  
zinc finger protein 345  Zfp345  NM_001034900  -2.92  
zinc finger protein 748  Zfp748  NM_001035231  -3.08  
LIM homeobox protein 3  Lhx3  NM_001039653  -3.19  
paired box gene 1  Pax1  NM_008780  -3.20  
hairy and enhancer of split 5  Hes5  NM_010419  -3.31  
undifferentiated embryonic cell transcription 
factor 1  
Utf1  NM_009482  -3.96  
 
 
 
 
